СПИСОК ЛИТЕРАТУРЫ

1. Абрамова Ж. И., Оксенгендлер Г. И. Человек и противоокислительные вещества. — Л.: Наука, 1985. — 232 с.

2. Азизова О. А., Вахрушева Т. Н., Дремина Е. С. и др. Динамика образования первичных и вторичных продуктов перекисного окисления липидов при медьзависимом окислении липопротеинов низкой плотности сыворотки крови больных ишемической болезнью сердца // Бюл.

3. Александровский Ю. А., Поюровский М. В., Незнамов Г. Г. Неврозы и перекисное окисление липидов. — М.: Наука, 1991. — 144 с.

4. Александровский Я. А. Молекулярные механизмы взаимовлияния патологических процессов при совместном протекании сахарного диабета и рака. Научные и клинические аспекты // Биохимия. — 2002. — Т. 67, вып. 12. — С. 1611—1631.

5. Аметов А. С., Демидова Т. Ю., Косых С. А. Синтез оксида азота в эндотелии сосудов у больных сахарным диабетом 2-го типа // Клин. медицина. — 2005. — № 8. — С. 62—68.

6. Аметов А. С., Строков И. А., Баринов А. Н. и др. Альфа-липоевая кислота в лечении симп- томной диабетической полиневропатии: symptomatic diabetic neuropathy (SYDNEY) trial // Фарматека. — 2004. — № 11. — С. 69—73.

7. Анисимов В. Н. Молекулярные и физиологические механизмы старения. — СПб.: Наука, 2003. — 468 c.

8. Анисимов В. Н. Средства профилактики преждевременного старения (геропротекторы) // Успехи геронтол. — 2000. — № 4. — C. 275—277.

9. Арутюнов Г. П. Витамины С, Е и β-каротин в терапии больных ИБС. Крах иллюзий и формирование нового стандарта // Сердце. — Т. 1, № 3. — С. 3—6.

10. Архипова М. М. Изучение роли оксида азота в патогенезе сосудистых заболеваний глаз: Ав- тореф. дисс. ... канд. мед. наук. — М., 2000.

11. Архипова М. М., Нероев В. В., Баратова Л. А., Лысенко В. С. L-аргинин в слезной жидкости больных с диабетической ретинопатией и возможная роль оксида азота в патогенезе ишемии сетчатки // Вестн.

12. Афонина Г. Б., Бордонос В. Г. Роль свободнорадикального окисления мембранных липидов лимфоцитов в развитии иммунологической недостаточности и ее коррекция α-токоферо- лом // Иммунология. — 1990. — № 5. — С. 33—35.

13. Бакшинский П. П. Эндотелины и оксид азота: их значение в регуляции глазного кровотока и внутриглазного давления и роль в патогенезе первичной глаукомы // Вестн. офтальмол. — 1999. — № 3. — C. 33-37.

14. Балаболкин М. И. Диабетология. — М.: Медицина, 2000. — 672 с.

15. Балаболкин М. И. Роль окислительного стресса в патогенезе сосудистых осложнений сахарного диабета и применение витаминов и микроэлементов для их лечения и профилактики // Клин. эндокринол. Новости науки и техники, серия «Медицина». — М.: ВИНИТИ, 2006. — № 6. — P. 1-7.

16. Балашова Т. С., Кубатиев А. А. Влияние танакана на перекисное окисление липидов крови и агрегационные свойства тромбоцитов у больных инсулинзависимым сахарным диабетом // Терапевт. арх. — 1998. — № 12. — С. 49-54.

17. Балтийская Н. В., Коркина Л. Г., Селиванов И. И. и др. Исследование хемилюминесценции изолированных полиморфноядерных лейкоцитов и цельной крови у больных острыми пневмониями // Терапевт. арх. — 1991. — № 12. — С. 23-27.

18. Барабой В. А., Орел В. Э. Спонтанная хемилюминесценция сыворотки крови в норме и при воздействии ионизирующей радиации // Биохемилюминесценция. — М.: Наука, 1983. — С. 222-240.

19. Барабой В. А., Шестакова Е. Н. Селен: биологическая роль и антиоксидантная активность // Укр. биохим. журн. — 2004. — Т. 76, № 1. — С. 23-31.

20. Барабой В. А., Брехман И. И., Голоткин В. Г., Кудряшов Ю. Б. Перекисное окисление и стресс. — СПб.: Наука, 1992. — 148 с.

21. Барсель В. А., Корочкин И. М., Архипова Г. В. и др. Коррекция некоторых биохимических нарушений липидного обмена у больных атеросклерозом с помощью антиоксиданта дибу- нола // Изв. АН СССР. Сер. биол. — 1988. — № 1. — С. 75-85.

22. Барсель В. А., Шедрина И.

23. Бачурин С. О. Медико-химические подходы к направленному поиску препаратов для лечения и предупреждения болезни Альцгеймера // Вопр. мед. химии. — 2001. — № 2. — С. 155— 197.

24. Беленков Ю. Н., Батыралиев Т. А., Першуков И. В., Самко А. Н. Инвазивная кардиология: фокус на рестеноз // Кардиология. — 2002. — Т. 42, № 11. — С. 68—72.

25. Биленко М. В. Ишемические и реперфузионные повреждения органов. — М.: Медицина, 1989. — 368 с.

26. Бобырев В. Н. Свободнорадикальное окисление в патогенезе заболеваний, сопряженных со старением // Патол. физиология и эксперим. медицина. — 1989. — № 5. — С. 90—94.

27. Бобырева Л. Е. Антиоксиданты в комплексной терапии диабетических ангиопатий // Экс- пер. клин. фармакол. — 1998. — Т. 61, № 1. — С. 74—80.

28. Бойко А. Г. Дифференцировка клеток радиальной глии в астроциты — вероятный механизм старения млекопитающих // Журн. общей биол. — 2007. — Т. 68, № 1. — С. 35—51.

29. Бондарь И. А., Климонтов В. В., Поршенников И. А. Окислительная модификация белков при диабетических микроангиопатиях // Сахарный диабет. — 2000. — № 3. — С. 9—11.

30. Бондарь И. А., Пупышев А. Б., Климонтов В. В. Перекисное окисление липидов и активность лизосомальных ферментов в сыворотке крови при сахарном диабете 1 типа и их коррекция // Консилиум. — 1999. — № 6. — С. 23—26.

31. Бондарь Т. М., Ланкин В. З., Антоновский В. Л. Восстановление органических гидропероксидов глутатионпероксидазой и глутатион-8-трансферазой: влияние структуры субстрата // Докл. АН СССР. — 1989. — Т. 304. — С. 217-220.

32. Борец В. М. Метаболизм витаминов и их применение при ишемической болезни // Вопр. мед. химии. — 1992. — № 4. — С. 37-42.

33. Бурлакова Е. Б., Алексеенко Е. Б., Молочкина Е. М. и др. Биоантиоксиданты в лучевом поражении и злокачественном росте. — М.: Наука, 1975. — 211 с.

34. Бурлакова Е.

35. Бурмистров С. О. Роль свободнорадикальных реакций в действии этанола на центральную нервную систему // Вопр. мед. химии. — 1993. — № 6. — С. 2-5.

36. Ванин А. Ф. Оксид азота — регулятор клеточного метаболизма // Сорос. образоват. журн. — 2001. — Т. 7, № 11. — С. 7-12.

37. Васильева Г. И., Киселева А. К., Рублев Б. Д. и др. Тканевая гетерогенность системы моно- нуклеарных фагоцитов при взаимодействии с Yersinia pestis // Журн. микробиологии, эпидемиологии и иммунобиологии. — 1990. — № 11. — С. 75-78.

38. Васканьянц А. М., Нагорнев В. А. Пролиферация клеток стенки артерий человека при ате- рогенезе как фактор проявления иммунного воспаления // Цитокины и восп. — 2004. — Т. 3, № 4. — С. 10-13.

39. Владимиров Ю. А. Развитие хемилюминесцентных методов исследования для диагностики сердечно-сосудистых заболеваний // Биохемилюминесценция в сельском хозяйстве. — М.: Наука, 1986. — С. 57-50.

40. Владимиров Ю. А. Свободные радикалы и антиоксиданты // Вестн. РАМН. — 1998. — № 7. — С. 43-50.

41. Владимиров Ю. А., Азизова О. А., Деев А. И. и др. Свободные радикалы в живых системах // Итоги науки и техники. Сер. Биофизика. — Т. 29. — М., 1991. — С. 1-249.

42. Волчегорский И. А., Малиновская Н. В., Шумелева О. В., Шемяков С. Е. Динамика содержания продуктов ПОЛ и окислительной модификации белков в головном мозге на этапах постнатального развития человека // Бюл. эксперим. биологии и медицины. — 2007. — Т. 144, № 8. — С. 159-166.

43. Волчегорский И. А., Шемяков С. Е., Турыгин В. В., Малиновская Н. В. Сравнительный анализ возрастной динамики активности моноаминоксидазы-Б и ферментов антиоксидантной зашиты в различных отделах головного мозга человека // Бюл. эксперим. биологии и медицины. — 2001. — Т. 132, № 8. — С. 174-177.

44. Волчегорский И. А., Телешева И. Б., Турыгин В.

45. Волчегорский И. А., Харченкова Н. В. Содержание продуктов перекисного оксиления липидов, α-токоферола и церулоплазмина в крови больных с сосудистыми осложнениями инсулинзависимого сахарного диабета // Клин. лаб. диагност. — 2003. — № 4. — С. 13—15.

46. Воскресенский О. Н., Бобырев В. Н. Биоантиоксиданты — облигатные факторы питания // Вопр. мед. химии. — 1992. — № 4. — С. 21—26.

47. Гесслер Н. Н., Гомбоева С. Б., Шумаев К. Б. и др. Свободнорадикальное окисление липидов подавляет ферментативную конверсию β-каротина в витамин А // Бюл. эксперим. биологии и медицины. — 2001. — Т. 131, № 5. — С. 532-535.

48. Гилинский М. А. Асимметричный диметиларгинин: метаболизм, аргининовый парадокс, патофизиология // Успехи физиол. наук. — 2007. — Т. 38, № 3. — С. 21-39.

49. Голиков А. П., Берестов А. А., Полумисков В. Б. Опыт применения антиоксиданта дибунола у больных острым инфарктом миокарда // Биоантиоксидант. — 1983. — Т. 1. — С. 97-99.

50. Голубев А. Г. Биохимия продления жизни // Успехи геронтол. — 2003. — С. 57-76.

51. Горбатенкова Е. А., Владимиров Ю. А., Парамонов Н. В., Азизова О. А. Красный свет гелий-неонового лазера реактивирует супероксид-дисмутазу // Бюл. эксперим. биологии и медицины. — 1989. — С. 302-305.

52. Грацианский Н. А. Очередное (окончательное?) подтверждение неэффективности антиоксидантных витаминов в профилактике коронарной болезни сердца и ее осложнений // Кардиология. — 2002. — Т. 42, № 2. — С. 85-86.

53. Грацианский Н. А. Предупреждение обострении коронарной болезни сердца. Вмешательства с недоказанным клиническим эффектом: ингибиторы ангиотензин-превращающего фермента и антиоксиданты // Кардиология. — 1998. — Т. 38, № 6. — С. 4-19.

54. Грибаускас П.

55. Григорьева И. В., Ракита Д. Р., Гормаш В. Я. Особенности регуляции перекисного окисления липидов при острой пневмонии и при острой пневмонии в сочетании с сахарным диабетом // Терапевт. арх. — 1993. — № 3. — С. 27-31.

56. Громова А. Ю., Симбирцев А. С. Полиморфизм генов семейства IL-1 человека // Цитокины и восп. — 2005. — Т. 4, № 2. — С. 3-12.

57. Гуревич В. С., Шаталина Л. В., Ковалева И. Г., Бершадский И. Г. Роль холестерина в активации перекисного окисления липидов в тромбоцитах // Биохимия. — 1992. — Т. 57, вып. 2. — С. 267-275.

58. Гусев В. А., Даниловская Е. В. Роль активных форм кислорода в патогенезе пневмоконио- зов // Вопр. мед. химии. — 1987. — № 5. — С. 9-15.

59. Гусев В. А., Даниловская Е. В., Ватолкина О. Е. Влияние минеральных пылей на генерацию супероксидных радикалов и перекиси водорода альвеолярными макрофагами, гранулоцитами и моноцитами // Бюл. эксперим. биологии и медицины. — 1990. — № 10. — С. 372-375.

60. Гуткин В. С., Горбытов В. А., Востряков А. П., Кадошников В. И. Бактерицидная активность и хемилюминесценция мононуклеарных фагоцитов животных // С.-х. биология. — 1986. — № 6. — С. 78-86.

61. Давиденкова Е. Ф., Шаффан М. Г., Векслер Б. М. и др. Липиды и липопероксиды крови в семьях больных ишемической болезнью сердца // Кардиология. — 1989. — № 6. — С. 10-14.

62. Данилов Л. Н., Лебедева Е. С., Двораковская И. В. и др. Влияние рецепторного антагониста IL-1 на развитие оксидативного стресса в легких // Цитокины и восп. — 2003. — Т. 2, № 4. — С. 14-20.

63. Дедов И. И., Балаболкин М. И., Мамаева Г. Г. и др. Сахарный диабет: ангиопатии и окислительный стресс. — М., 2003. — 88 с.

64. Дедов И. И., Мельниченко Г. А.,Фадеев В. В. Эндокринология: Учебник. —М.: Медицина, 2000. — 622 с.

65. Дубинина Е. Е. Характеристика внеклеточной супероксиддисмутазы // Вопр. мед. химии. — 1995. — Т. 41, вып. 6. — С. 8-12.

66. Душкин М. И., Зенков Н. К., Меньшикова Е. Б. и др. Влияние ингибиторов цитохрома Р-450 на окислительный метаболизм липопротеинов низкой плотности макрофагами // Вопр. мед. химии. — 1996. — Т. 42, вып. 1. — С. 23-30.

67. Евгина С. А., Панасенко О. М., Сергиенко В. И. Владимиров Ю. А. Перекисное окисление липопротеинов крови человека, индуцированное гипохлоританионом // Биол. мембраны. — 1992. — Т. 9. — С. 946-953.

68. Журавлев А. И. Спонтанная свехслабая биохемилюминесценция — основа квантовой биологии // Успехи соврем. биологии. — 1991. — Т. 111, вып. 1. — C. 144—153.

69. Журавлев А. И., Журавлева А. И. Сверхслабое свечение сыворотки крови и его значение в комплексной диагностике. — М.: Медицина, 1975.

70. Журавлев А. И., Пантюшенко В. Т. Свободнорадикальная биология. — М: Изд-во Моск. вет. акад., 1989. — 60 с.

71. Зайковский Ю. Я., Ивченко В. Н. Респираторный дистресс-синдром у взрослых. — Киев: Здоров’я, 1987. — 184 с.

72. Закирова А. Н. Клинико-диагностическое значение показателей перекисного окисления липидов при ишемической болезни сердца: Автореф. дисс. ... канд. мед. наук. — М.: ВКНЦ АМН СССР, 1981.

73. Зенков Н. К., Душкин М. И., Любимов Г. Ю., Меньшикова Е. Б. Изменение окислительного метаболизма макрофагов при трансформации в пенистые клетки // Вопр. мед. химии. — 1994. — № 1. — С. 2-4.

74. Зенков Н. К., Кандалинцева Н. В., Ланкин В. З. и др. Фенольные биоантиоксиданты. — Новосибирск, 2003. — 328 с.

75. Зенков Н. К., Ланкин В. З., Меньшикова Е. Б. Окислительный стресс. Биохимический и патофизиологический аспекты. — М.: Наука/Интерпериодика, 2001. — 340 с.

76. Зенков Н. К., Меньшикова Е. Б. Активированные кислородные метаболиты в биологических системах // Успехи соврем. биологии. — 1993. — Т. 113, вып. 3. — С. 286-296.

77. Зенков Н. К., Меньшикова Е. Б. Окислительная модификация липопротеинов низкой плотности // Успехи соврем. биологии. — 1996. — Т. 116, вып. 6. — С. 729-748.

78. Зенков Н. К., Меньшикова Е. Б., Вольский Н. Н., Козлов В. А. Внутриклеточный окислительный стресс и апоптоз // Успехи соврем. биологии. — 1999. — Т. 117, вып. 5. — С. 439449.

79. Зенков Н. К., Меньшикова Е. Б., Кандалинцева Н. В. и др. Антиоксидантные и противовоспалительные свойства новых водорастворимых серосодержаших фенольных соединений // Биохимия. — 2007. — Т. 72, вып. 6. — С. 790-798.

80. Зенков Н. К., Меньшикова Е. Б., Шкурупий В. А. Механизмы активации макрофагов // Успехи соврем. биологии. — 2007. — Т. 127, вып. 3. — С. 243-256.

81. Зимин Ю. В. Липидснижаюшая терапия при ишемической болезни сердца // Кардиология. — 2003. — № 4. — С. 74-83.

82. Зотова Е. В., Савостьянов К. В., Чистяков Д. А. и др. Поиск ассоциации полимерных маркеров генов, кодируюших ферменты антиокислительной зашиты, с развитием диабетической полинейропатии у больных сахарным диабетом типа 1 // Мол. биол. — 2004. — Т. 38, № 2. — С. 244-249.

83. Иммунореактивность и атеросклероз / Под ред. А. Н. Климова. — Л.: Медицина, 1986. — 192 с.

84. Калмыков С. В., Романовская В. Г., Фиалковский В. И. Люминолзависимая хемилюминесценция лейкоцитов цельной крови больных инфарктом миокарда // Лаб. дело. — 1989. — № 11. — С. 72-74.

85. Калмыкова В. И. Витамины-антиоксиданты в патогенезе и терапии атеросклероза и ишемической болезни сердца // Биоантиокислители в регуляции метаболизма в норме и патологии. — М., 1982. — С. 181-194.

86. Каминный А. И., Ланкин В. З., Самко А. Н. и др. Антиоксидант пробукол в низкой суточной дозе снижает частоту и степень рестенозирования коронарных артерий после транслюминальной баллонной ангиопластики // Бюл. эксперим. биологии и медицины. — 2005. — Т. 139, № 2. — С. 150-152.

87. Караш Ю. М., Стрелков Р. Б., Чижов А. Я. Нормобарическая гипоксия в лечении, профилактике и реабилитации. — М.: Медицина, 1988. — 352 с.

88. Кетлинский С. А., Симбирцев А. С., Воробьев А. А. Эндогенные иммуномодуляторы. — СПб.: Гиппократ, 1992.

89. Киреев Р. А., Курмачева Н. А., Иванова С. Б. Влияние препарата танакан на свободнорадикальные процессы в мембранах эритроцитов у детей с инсулинзависимым сахарным диабетом // Сах. диабет. — 2000. — № 1. — С. 41-43.

90. Клебанов Г. И., Крейнина М. В., Позин В. М. и др. Динамика изменения функциональной активности полиморфноядерных лейкоцитов крови при обратимой ишемии миокарда у собак // Бюл. эксперим. биологии и медицины. — 1988. — № 9. — С. 297-299.

91. Клебанов Г. И., Наумов О. Г., Владимиров Ю. А. и др. Функциональная активность полиморфноядерных лейкоцитов крови при изопреналиновой кардиомиопатии крыс // Бюл. эксперим. биологии и медицины. — 1990. — № 12. — С. 592—594.

92. Климов А. Н., Гуревич В. С., Никифорова А. А. и др. Антиоксидантная активность липопротеидов высокой плотности in vivo // Бюл. эксперим. биологии и медицины. — 1992. — № 7. — С. 40-42.

93. Климов А. Н., Никульчева Н. Г. Обмен липидов и липопротеидов и его нарушения. — СПб.: Питер, 1999. — 512 с.

94. Ковальзон В. М. Мелатонин, эпифиз и сон млекопитающих // Нейрохимия. — 2003. — Т. 20, № 2. — С. 93-100.

95. Коган А. Х., Кудрин А. Н., Кактурский Л. В., Лосев Н. И. Свободнорадикальные перекисные механизмы патогенеза ишемии и инфаркта миокарда и их фармакологическая регуляция // Патол. физиология и эксперим. терапия. — 1992. — № 2. — С. 5-15.

96. Колхир В. К., Тюкавкина Н. А., Быков В. А. и др. Диквертин — новое антиоксидантное и капилляропротекторное средство // Хим.-фарм. журн. — 1995. — № 9. — С. 61-64.

97. Кольтовер В. К. Свободнорадикальная теория старения: исторический очерк // Успехи ге- ронтол. — 2000. — № 4. — С. 33-40.

98. Коновалова Г. Г., Ланкин В. З., Тихазе А. К. и др. Комплекс витаминов-антиоксидантов защищает липопротеиды низкой плотности плазмы крови от свободнорадикального окисления и повышает активность антиоксидантных ферментов в эритроцитах больных ИБС // Бюл. эксперим. биологии и медицины. — 2003. — Т. 136, № 8. — С. 163-166.

99. Копьева Т. Н., Амосова О. М. Полиморфноядерный лейкоцит: роль в развитии острого и хронического неспецифического воспаления в легких // Терапевт. арх. — 1987. — № 3. — С. 142-145.

100. Коркина Л. Г., Суслова Т. Б., Николаева С. И. и др. Механизм цитотоксического действия природного цеолита клиноптиолита // Фармакология и токсикология. — 1984. — № 5. — С. 63-67.

101. Коркина Л. Г., Трахтман П. Е., Пагано Дж. Сравнительная характеристика оксидативного стресса при некоторых наследственных заболеваниях, отличающихся предрасположенностью к злокачественным новообразованиям и раннему старению // Вестн. РАМН. — 1998. — № 7. — С. 51-55.

102. Коротаева А. А. Липиды и статины в процессах воспаления, тромбообразования и тромболизиса // Фундаментальные исследования и прогресс кардиологии. — М.: Машмир, 2002. — С. 141-146.

103. Корочкин И. М., Клебанов Г. И., Чукаева И. И. и др. Хемилюминесценция лейкоцитарной массы в диагностике острого инфаркта миокарда // Терапевт. арх. — 1984. — Т. 56, № 8. — С. 29-31.

104. Краснов В. А., Зенков Н. К., Колпаков А. Р., Меньщикова Е. Б. Активированные кислородные метаболиты при туберкулезе // Пробл. туберкулеза и болезней легких. — 2005. — № 9. — С. 9-17.

105. Кубатиев А. А., Тюкавкина Н. А., Ядигарова З. Т. и др. Влияние диквертина на содержание циклических нуклеотидов в тромбоцитах // Бюл. эксперим. биологии и медицины. — 1999. — Т. 128, № 9. — С. 267-269.

106. Кулинский В. И. Биохимические аспекты воспаления // Биохимия. — 2007. — Т. 72. — С. 733746.

107. Кумерова А. О., Шкестерс А. П., Шкестере И. Я. Изучение кардиозащитного эффекта α-то- коферола и пантенола на модели экспериментальной ишемии-реперфузии изолированного сердца // Бюл. эксперим. биологии и медицины. — 1994. — № 6. — С. 574-576.

108. Купчинский Р. А. Доказательства причинно-следственных отношений между вирусом Эпштейна - Барр и атеросклерозом // Кардиология. — 1993. — № 4. — С. 66-70.

109. Курцмен Дж., Гордон Ф. Да сгинет смерть. — М.: Мир, 1987. — 223 с.

110. Лаврова И. Н., Моргоева Ф. Э., Строков И. А. Антиоксидантная терапия полиневропатии и ретинопатии у больных сахарным диабетом 2 типа // Рус. мед. журн. — 2004. — Т. 12, № 10. — P. 585-591.

111. Лакомкин В. Л., Коркина О. В., Цыпленкова В. Г. и др. Влияние гидрофильной формы уби- хинона на сердечную мышцу при окислительном стрессе // Кардиология. — 2004. — Т. 44, № 1. — С. 43-47.

112. Ланкин В. З. Перекиси липидов и атеросклероз. Гипотеза: роль холестерина и свободнорадикального перекисного окисления липидов в изменении свойств клеточных мембран при гиперхолестеринемии и атеросклерозе // Кардиология. — 1980. — Т. 20, № 8. — С. 42—48.

113. Ланкин В. З., Вихерт А. М. Перекисное окисление липидов в этиологии и патогенезе атеросклероза // Арх. патологии. — 1989. — Т. 51, вып. 1. — С. 80—84.

114. Ланкин В. З., Вихерт А. М., Косых В. А. и др. Ферментативная детоксикация супероксидного анион-радикала и липопероксидов в интиме и медии аорты при атеросклерозе // Бюл. эксперим. биологии и медицины. — 1982. — № 9. — С. 48—50.

115. Ланкин В. З., Вихерт А. М., Тихазе А. К. и др. Роль перекисного окисления липидов в этиологии и патогенезе атеросклероза // Вопр. мед. химии. — 1989. — № 3. — С. 18—24.

116. Ланкин В. З., Герасимова Е. Н., Касаткина Л. В. и др. Перекиси липидов и атеросклероз. Ферментативная детоксикация перекисей липидов в крови больных ишемической болезнью сердца, обусловленной атеросклерозом коронарных артерий // Кардиология. — 1979. — Т. 19, № 6. — С. 71-76.

117. Ланкин В. З., Гордеева Н. Т., Тихазе А. К., Вихерт А. М. Липоксигеназы животных. Природа субстрата и изменение конформации липоксигеназы ретикулоцитов при взаимодействии с мембранами // Биохимия. — 1985. — Т. 50, вып. 11. — С. 1894-1900.

118. Ланкин В. З., Каценович Э. Р., Костко С. З. и др. Изменение активности антиоксидантных ферментов в крови больных ишемической болезнью сердца при лечении нитросорбидом // Кардиология. — 1987. — № 10. — С. 117-119.

119. Ланкин В. З., Лисина М. О., Арзамасцева Н. Е. и др. Окислительный стресс при атеросклерозе и диабете // Бюл. эксперим. биологии и медицины. — 2005. — Т. 140, № 7. — С. 48-51.

120. Ланкин В. З., Рогинский В. А., Тихазе А. К. и др. Антирадикальные и антиокислительные свойства пробукола и его структурных аналогов при окислении ненасыщенных фосфолипидов природных и искуственных мембран // Докл. РАН. — 1996. — Т. 351, № 4. — С. 554-557.

121. Ланкин В. З., Тихазе А. К., Беленков Ю. Н. Свободнорадикальные процессы при заболеваниях сердечно-сосудистой системы // Кардиология. — 2000. — Т. 40, № 7. — С. 48-61.

122. Ланкин В. З., Тихазе А. К., Каминная В. И. и др. Интенсификация in vivo свободнорадикального окисления липопротеинов низкой плотности в плазме крови больных ИБС при терапии ингибитором HMG-CoA-редуктазы правастатином и подавление липопероксида- ции убихиноном Q10 // Бюл. эксперим. биологии и медицины. — 2000. — Т. 129, № 2. — С. 176-179.

123. Ланкин В. З., Тихазе А. К., Коновалова Г. Г. и др. Интенсификация свободнорадикального окисления ЛПНП в плазме крови больных ИБС при терапии ингибитором ГМГ-КоА-ре- дуктазы церивастатином и подавление липопероксидации ЛПНП антиоксидантом пробуколом // Бюл. эксперим. биологии и медицины. — 2002. — Т. 134, № 7. — С. 48-51.

124. Ланкин В. З., Тихазе А. К., Коновалова Г. Г., Козаченко А. И. Концентрационная инверсия антиоксидантного и прооксидантного действия β-каротина в тканях in vivo // Бюл. эксперим. биологии и медицины. — 1999. — Т. 128, № 9. — С. 314-316.

125. Ланкин В. З., Тихазе А. К., Ракита Д. Р. и др. Утилизация активных форм кислорода и липопероксидов в крови больных инфарктом миокарда // Терапевт. арх. — 1985. — № 5. — С. 58-62.

126. Леденев А. Н., Рууге Э. К. Генерация супероксидных радикалов митохондриями сердца в условиях ишемии // Бюл. эксперим. биологии и медицины. — 1985. — Т. 100, № 9. — С. 303-305.

127. Луста И. В., Ситожевский А. В., Груздева О. В. и др. Интегральный показатель антиоксидантной защиты и его компоненты в сыворотке крови больных инсулиннезависимым сахарным диабетом // Бюл. эксперим. биологии и медицины. — 1999. — Т. 127, Прил. 1. — С. 27-28.

128. Лущак В. И. Свободнорадикальное окисление белков и его связь с функциональным состоянием организма // Биохимия. — 2007. — Т. 72, вып. 8. — С. 995-1017.

129. Любимов Г. Ю., Зенков Н. К., Вольский Н. Н., Козлов В. А. Хемилюминесценция перитонеальный макрофагов при действии макрофаг-активирующего фактора //Иммунология. — 1992. — № 1. — С. 40-43.

130. Лякишев А. А., Лупанов В. П., Смирнов Л. Д. Гиполипидемический препарат — пробу- кол (механизмы действия, гиполипидемические эффекты и клинические исследования) // Хим.-фарм. журн. — 1995. — № 10. — С. 3-8.

131. Ляхович В. В., Вавилин В. А., Зенков Н. К., Меньщикова Е. Б. Активная защита при окислительном стрессе. Антиоксидант-респонсивный элемент // Биохимия. — 2006. — Т. 71, вып. 9. — С. 1183-1197.

132. Маеда Х., Акаике Т. Оксид азота и кислородные радикалы при инфекции, воспалении и раке // Биохимия. — 1998. — Т. 63, вып. 7. — С. 1007—1019.

133. Макарова О. П., Шишкина Л. Н., Огиренко А. П. и др. Функциональная активность альвеолярных макрофагов при обострении туберкулеза легких // Пробл. туберкулеза и болезней легких. — 2003. — № 11. — С. 29-32.

134. Малышев И. Ю., Манухина Е. Б. Стресс, адаптация и оксид азота // Биохимия. — 1998. — Т. 63, № 7. — С. 992-1006.

135. Манухина Е. Б., Малышев И. Ю., Архипенко Ю. В. Оксид азота в сердечно-сосудистой системе: роль в адаптационной защите // Вестн. РАМН. — 2000. — № 4. — С. 16-21.

136. Мареев В. Ю., Беленков Ю. Н. Хроническая сердечная недостаточность и инсулиннезави- симый сахарный диабет: случайная связь или закономерность // Терапевт. арх. — 2003. — № 10. — С. 5-11.

137. Мартинович Г. Г., Черенкевич С. Н. Окислительно-восстановительные процессы в клетках. — Минск: БГУ, 2006. — 154 с.

138. Матвейков Г. П., Калия Е. С., Левин В. И., Санько Н. М. Активность супероксиддисмутазы и ее изоферментов в иммунокомпетентных клетках периферической крови при системной красной волчанке и ревматоидном артрите // Терапевт. арх. — 1994. — № 4. — С. 57-61.

139. Маянский А. Н., Маянский Д. Н. Очерки о нейтрофиле и макрофаге. — Новосибирск: Наука, 1989. — 344 с.

140. Маянский А. Н., Маянский Н. А., Абаджиди М. А., Заславская М. И. Апоптоз: начало будущего // Журн. микробиол. — 1997. — № 2. — С. 88-94.

141. Маянский Д. Н. Хроническое воспаление. — М.: Медицина, 1991. — 272 с.

142. Маянский Д. Н., Урсов И. Г. Лекции по клинической патологии. — Новосибирск, 1997. — 249 с.

143. Меньщикова Е. Б., Зенков Н. К. Метаболическая активность гранулоцитов при хронических неспецифических заболеваниях легких // Терапевт. арх. — 1991. — № 11. — С. 85-87.

144. Меньщикова Е. Б., Зенков Н. К. Окислительный стресс при воспалении // Успехи соврем. биологии. — 1997. — Т. 117, вып. 2. — С. 155-171.

145. Меньщикова Е. Б., Зенков Н. К. Примирование гранулоцитов крови при воспалении // Па- тол. физиология и эксперим. терапия. — 1992. — № 3. — С. 14-16.

146. Меньщикова Е. Б., Зенков Н. К., Сафина А. Ф. Окислительный стресс при ишемическом и реперфузионном повреждении миокарда // Успехи соврем. биологии. — 1997. — Т. 117, вып. 3. — С. 362-373.

147. Меньщикова Е. Б., Ланкин В. З., Зенков Н. К. и др. Окислительный стресс. Прооксиданты и антиоксиданты. — М.: Слово, 2006. — 556 с.

148. Микунис Р. И., Станиславчук Н. А. Состояние оксидантной и антиоксидантной системы у больных ревматоидным артритом // Терапевт. арх. — 1989. — № 6. — С. 121-123.

149. Мульдияров П. А., Пирязева Н. А., Пирязев А. П. Хемилюминесценция цельной крови и цельной синовиальной жидкости при ревматоидном артрите // Ревматология. — 1992. — № 1. — С. 16-18.

150. Муминов Т. А. Показатели окислительного метаболизма фагоцитирующих и иммунокомпетентных клеток у больных туберкулезом легких // Терапевт. арх. — 1990. — № 11. — С. 57-59.

151. Нагорнев В. А., Восканьянц А. Н., Виноградов А. Г. и др. Цитотоксический эффект липопротеинов низкой плотности // Бюл. эксперим. биологии и медицины. — 2003. — Т. 135, № 1. — С. 107-109.

152. Невзорова В. А., Зуга М. В., Гельцер Б. И. Роль окиси азота в регуляции легочных функций // Терапевт. арх. — 1997. — № 3. — С. 68-73.

153. Недоспасов А. А. Биогенный NO в конкурентных отношениях // Биохимия. — 1998. — Т. 63, вып. 7. — С. 881-904.

154. Недосугова Л. В., Ланкин В. З., Балаболкин М. И. Взаимосвязь между компенсацией углеводного обмена и выраженностью проявлений окислительного стресса при сахарном диабете II типа // Бюл. эксперим. биологии и медицины. — 2003. — Т. 136, № 8. — С. 152-155.

155. Нечаева О. Б., Скачкова Е. И. Причины и факторы формирования лекарственной устойчивости при туберкулезе легких // Пробл. туберкулеза и болезней легких. — 2003. — № 9. — С. 6-9.

156. Никитин Ю. П., Душкин М. И., Рагино Ю. И. Резистентность к окислению субфракций липопротеинов низкой плотности у больных ишемической болезнью сердца // Кардиология. — 1998. — Т. 38. — № 10. — С. 48-52.

157. Новицкий В. В., Стрелис А. К., Ткаченко С. Б. и др. Активность ПОЛ и апоптоза при туберкулезе легких // Бюл. эксперим. биологии и медицины. — 2005. — Т. 140, № 11. — С. 497—499.

158. Носков С. М., Козлов Г. С., Широкова Л. Ю. Свободнорадикальные реакции при ревматоидном артрите // Ревматология. — 1988. — № 4. — С. 72—76.

159. Обухова Л. К., Измайлов Д. М., Соловьева А. С. Академик Н. М. Эмануэль о природе старения и возможности продления жизни // Клин. геронтология. — 2006. — Т. 12, № 3. — С. 3—14.

160. Октябрьский О. Н., Смирнова Г. В. Редокс-регуляция клеточных функций // Биохимия. — 2007. — Т. 72, вып. 2. — С. 158-174.

161. Олесин А. И., Максимов В. А., Мажара Ю. П. и др. Применение лазерного облучения венозной крови для предупреждения реперфузионного синдрома при инфаркте миокарда // Патол. физиология и эксперим. терапия. — 1992. — № 5-6. — С. 20-23.

162. Олферьев А. М., Ильина М. В., Александрович О. В. и др. Коррекция факторов риска развития атеротромбоза липофильным антиоксидантом ликопином // Серия. Критические технологии. Мембраны. — 2003. — № 2 (18). — С. 31-39.

163. Осиева Э. А. Влияние алиментарных факторов на структурно-функциональную организацию клеточных мембран эритроцитов при инсулинзависимом сахарном диабете: Автореф. дисс. ... канд. мед. наук. — Тюмень, 1995.

164. Пальцев М. А. Значение биомедицинских фундаментальных исследований для фтизиатрии // Пробл. туберкулеза и болезней легких. — 2004. — № 2. — С. 3-7.

165. Панасенко О. М., Арнхольд Ю., Владимиров Ю. А, Сергиенко В. И. Взаимодействие гипохлорита с гидропероксидами и другими продуктами окисления фосфатидилхолиновых липосом // Биохимия. — 1995. — Т. 60, вып. 9. — С. 1419-1427.

166. Панасенко О. М., Арнхольд Ю., Шиллер Ю. Гипохлорит взаимодействует с органическим гидропероксидом с образованием свободных радикалов, но не синглетного кислорода, инициируя перекисное окисление липидов // Биохимия. — 1997. — Т. 62, вып. 9. — С. 1111-1121.

167. Панасенко О. М., Евгина С. А., Сергиенко В. И. Изучение способности гипохлорита проникать в липидную фазу липопротеинов крови человека // Бюл. эксперим. биологии и медицины. — 1993. — № 4. — С. 358-360.

168. Панасенко О. М., Осипов А. Н., Шиллер Ю., Арнхольд Ю. Взаимодействие экзогенного гипохлорита и гипохлорита, продуцируемого в системе миелопероксидаза + Н₂О₂ + Cl^-, с ненасыщенными фосфатидилхолинами // Биохимия. — 2002. — Т. 67, вып. 8. — P. 1071-1084.

169. Панасенко О. М., Сдвигова А. Г., Сергиенко В. И., Лопухин Ю. М. Печень кролика при экспериментальном атеросклерозе секретирует окисленные липопротеины // Бюл. эксперим. биологии и медицины. — 1992. — № 2. — С. 143-144.

170. Панасенко О. М., Сергиенко В. И. Гипохлорит, окислительная модификация липопротеинов крови и атеросклероз // Бюл. эксперим. биологии и медицины. — 2001. — № 5. — С. 484-494.

171. Панасенко О. М., Сергиенко В. И. Свободнорадикальная модификация липопротеинов крови и атеросклероз // Биол. мембраны. — 1993. — Т. 10, № 4. — С. 341-382.

172. Панасюк А. Ф., Ярошук Г. В., Митрович Д. Влияние свободных радикалов на пролиферацию и обмен хондроцитов и на чувствительность клеточного монослоя к действию протеаз // Вопр. мед. химии. — 1995. — Т. 41, вып. 6. — С. 19-22.

173. Панин Л. Е., Останина Л. С., Колпаков А. Р. К механизму контринсулярного эффекта апо- протеина В // Вопр. мед. химии. — 1995. — Т. 41, вып. 6. — С. 12-16.

174. Перминова О. М., Сенюков В. В., Вольский Н. Н., Козлов В. А. Роль НАД(Ф)Н-оксидазы в регуляции уровня пролиферативного ответа лимфоцитов на митоген // Иммунология. — 2005. — № 6. — С. 329-332.

175. Перова Н. В. Перспективные направления исследований роли липопротеидов в атерогенезе у человека: влияние на прогрессирование заболевания, значение в диагностике, возможности корригирующих вмешательств // Кардиология. — 1989. — № 6. — С. 5-9.

176. Пескин А. В. Взаимодействие активного кислорода с ДНК // Биохимия. — 1997. — Т. 62, вып. 12. — С. 1571-1578.

177. Плехова Н. Г. Бактерицидная активность фагоцитов // Журн. микробиол., эпидемиол. и иммунол. — 2006. — № 6. — С. 89-96.

178. Плотников М. Б., Маслов М. Ю., Алиев О. И. и др. Коррекция гемореологических расстройств при остром инфаркте миокарда у крыс комплексом диквертина и аскорбиновой кислоты // Вопр. биол., мед. и фарм. химии. — 2000. — № 2. — С. 31-33.

179. Плотников М. Б., Тюкавкина Н. А., Плотникова Т. М. Лекарственные препараты на основе диквертина. — Томск: Изд-во Том. ун-та, 2005. — 228 с.

180. Подильчак М. Д., Терлецкая Л. М., Красивский Э. З. Активность катионных белков, перок- сидазы и щелочной фосфатазы в нейтрофилах крови больных сахарным диабетом // Врачебное дело. — 1989. — № 11. — С. 81—83.

181. Полыткин И. А., Колесова О. Е. Влияние инсулина на скорость генерации перекиси водорода митохондриями // Бюл. эксперим. биологии и медицины. — 2003. — № 6. — С. 634—637.

182. Рагино Ю. И., Душкин М. И., Никитин Ю. П. Снижение резистентности к окислению липопротеинов очень низкой плотности и отдельных субфракций липопротеинов низкой плотности у больных с инсулиннезависимым сахарным диабетом // Терапевт. арх. — 1999. — № 4. — С. 52-55.

183. Рахматуллина А. И. Кислородзависимые механизмы адаптации нейтрофилов при ревматоидном артрите // Казанский мед. журн. — 1990. — Т. 71, № 5. — С. 381-384.

184. Рашба Ю. Э., Наглер Л. Г., Вартанян Л. С. и др. Является ли ксантиноксидаза универсальным источником супероксидных радикалов при ишемических и реперфузионных повреждениях? // Бюл. эксперим. биологии и медицины. — 1990. — № 6. — С. 548-550.

185. Редчиц Е. Г. Участие полиморфноядерных лейкоцитов в патогенезе ишемической болезни сердца // Кардиология. — 1989. — № 12. — С. 115-117.

186. Репин В. С. Клеточные механизмы атеросклероза // Сорос. образоват. журн. — 1998. — № 9. — С. 34-38.

187. Реутов B. П. Цикл окиси азота в организме млекопитающих // Успехи биол. химии. — 1995. — Т. 35. — С. 189-228.

188. Ром-Бугославская Е. С., Бондаренко Л. А. Эпифиз и эндокринная функция поджелудочной железы // Успехи соврем. биологии. — 1995. — Т. 115, вып. 3. — С. 368-382.

189. Сальников М. И., Барсель В. А., Архипова Г. В. Влияние антиоксиданта дибунола на состав и интенсивность перекисного окисления липидов крови больных ишемической болезнью сердца // Докл. АН СССР. — 1984. — Т. 278. — С. 745-751.

190. Семенов В. Л. Перекисное окисление липидов как механизм биоэнергетической регуляции при воспалении органов дыхания // Патол. физиология и эксперим. терапия. — 1989. — № 2. — С. 17-20.

191. Сидорова Л. Д., Бондарь И. А., Климонтов В. В. и др. Окислительный стресс при сахарном диабете и его коррекция тиоктовой кислотой // Бюл. СО РАМН. — 2000. — № 1. — С. 94-98.

192. Сидорова Л. Д., Шанин И. А., Логвиненко А. С., Закирова Н. А. Неспецифические заболевания легких в условиях Западной Сибири. — Новосибирск: Наука, 1984. — 222 с.

193. Скворцова Л. А., Павлова М. В., Виноградова Т. И., Арчакова Л. И. Комплексная терапия туберкулеза с применением рекомбинантных интерлейкинов // Пробл. туберкулеза и болезней легких. — 2003. — № 10. — С. 9-12.

194. Скулачев В. П. В своем межмембранном пространстве митохондрия таит «белок самоубийства», который, выйдя в цитозоль, вызывает апоптоз // Биохимия. — 1997. — Т. 61, № 11. — С. 2060-2063.

195. Скулачев В. П. Явления запрограммированной смерти. Митохондрии, клетки и органы: роль активных форм кислорода // Сорос. образоват. журн. — 2001. — Т. 7, № 6. — С. 4-10.

196. Смирнова О. М., Никонова Т. В. Свободно-радикальное окисление и антиоксидантная защита при сахарном диабете. — М., 2003. — 44 с.

197. Согоян С. М., Ланкин В. З., Родина Л. Г. и др. Влияние продуктов окисления холестерина, полиненасыщенных жирных кислот и синтетического антиоксиданта ионола на экспериментальную гиперхолестеринемию у кроликов // Бюл. эксперим. биологии и медицины. — 1984. — Т. 97, № 6. — С. 663-664.

198. Соколов Е. И. Сахарный диабет и атеросклероз. — М.: Наука, 1996. — 404 с.

199. Соодаева С. К., Коркина Л. Г., Величковский Б. Т., Клегерис А. М. Образование активных форм кислорода перитонеальными макрофагами крыс под влиянием цитотоксических пылей // Бюл. эксперим. биологии и медицины. — 1991. — № 9. — С. 252-254.

200. Спиричев В. Б. Сколько витаминов человеку надо. — М., 2000. — 185 с.

201. Степаншин Ю. Г., Степаншина В. Н., Шемякин И. Г. Молекулярные механизмы устойчивости Mycobacterium tuberculosis // Антибиотики и химиотерапия. — 1999. — № 4. — С. 39-43.

202. Строков И. А., Манухина Е. Б., Бахтина Л. Ю. и др. Состояние эндогенных протекторных систем у больных инсулинзависимым сахарным диабетом с полинейропатией: эффект антиоксидантной терапии // Бюл. эксперим. биологии и медицины. — 2000. — № 10. — С. 437-441.

203. Сыркин А. Л., Азизова О. А., Коган А. Х. и др. Влияние антиоксиданта коэнзима Q₁₀ на окисляемость липопротеинов в плазме и антиперекисную резистентность плазмы у больных ишемической болезнью сердца // Кардиология. — 1998. — № 10. — С. 44-46.

204. Танбаева Г. З. Особенности сахарного диабета в пожилом возрасте // Клин. геронтология. - 2003. - №1. - С. 29-33.

205. Тарусов Б. Н. Основы биологического действия радиоактивных излучений. — М.: Медгиз, 1954. — 130 с.

206. Тимошин А. А., Цкитишвили О. В., Серебрякова Л. И. и др. Образование гидроксильных радикалов при локальной ишемии сердца собаки // Биофизика. — 1994. — Т. 39, вып. 3. — С. 502-506.

207. Тиунов Л. А., Головенко Н. Я., Галкин Б. Н., Баринов В. А. Биохимические механизмы токсичности окислов азота // Успехи соврем. биологии. — 1991. — Т. 111, вып. 5. — С. 738-750.

208. Тихазе А. К., Ланкин В. З., Коновалова Г. Г. и др. Антиоксидант пробукол является эффективной ловушкой липидных радикалов в липопротеинах низкой плотности in vitro и in vivo // Бюл. эксперим. биологии и медицины. — 1999. — Т. 128, № 8. — С. 186-189.

209. Тихазе А. К., Ланкин В. З., Михин В. П. и др. Антиоксидант пробукол как регулятор интенсивности процессов свободнорадикального перекисного окисления липидов в крови больных коронарным атеросклерозом // Терапевт. арх. — 1997. — № 9. — С. 35-41.

210. Усынин И. Ф., Харьковский А. В., Балицкая Н. И., Панин Л. Е. Блокада клеток Купфера хлористым гадолинием повышает поглощение окисленных липопротеинов низкой плотности сердцем и аортой крыс // Биохимия. — 1999. — Т. 64, № 6. — С. 746-750.

211. Фролькис В. В., Мурадян Х. К. Экспериментальные пути продления жизни. — Л.: Наука, 1988. — 248 с.

212. Хегай М. Д., Зайчик С. Е. Перекисное окисление липидов и гликозилирование белков в аорте кроликов с аллоксановым диабетом при инсулинокоррекции // Патол. физиология и эксперим. терапия. — 1995. — № 4. — С. 6-7.

213. Хмелевский Ю. В., Поберезкина Н. Б., Задорина О. В. и др. Витамин Е и его синтетические аналоги при экспериментальной сердечно-сосудистой патологии // Вопр. мед. химии. — 1992. — № 5. — С. 30-33.

214. Чан Дж., Кауфман С. Х. Е. Механизмы иммунной защиты // Туберкулез. Патогенез, защита, контроль. — М.: Медицина, 2002. — С. 415-448.

215. Чаяло П. П., Чоботько Г. М., Колпаков И. Е. Оценка свободнорадикальных процессов в конденсатах выдыхаемого воздуха у детей с рецидивирующим бронхитом // Лаб. дело. — 1990. — № 11. — С. 35-36.

216. Чеботарев Е. Е., Барабой В. А., Дружина Н. А. и др. Окислительные процессы при гамманейтронном облучении организма. — Киев: Наук. думка, 1986. — 216 с.

217. Шаронов Б. П., Чурилова И. В. Окислительная модификация и инактивация супероксид- дисмутазы гипохлоритом // Биохимия. — 1992. — Т. 57, вып. 5. — С. 719-727.

218. Шергин С. М., Зенков Н. К., Меньщикова Е. Б. и др. Применение электромагнитных полей и излучений в терапии хронических воспалительных процессов // Патогенез хронического воспаления. — Новосибирск, 1991. — С. 183-184.

219. Шерстнев М. П., Сергиенко В. И., Халилов Э. М., Ли В. С. Хемилюминесценция эритроцитов, насыщенных холестерином, в присутствии перекиси водорода // Биофизика. — 1982. — № 2. — С. 335-336.

220. Шестакова М. В. Многокомпонентный подход к лечению сахарного диабета и его осложнений // Терапевтич. арх. — 2006. — № 10. — С. 33-36.

221. Эмануэль Н. М. Физико-химия рака // Природа. — 1982. — № 1. — С. 76-83.

222. Ярема Н. И., Коновалова Г. Г., Ланкин В. З. Изменение активности антиоксидантных ферментов у больных гипертонической болезнью // Кардиология. — 1992. — Т. 32, № 3. — С. 46-48.

223. Abahusain M. A., Wright J., Dickerson J. W., de Vol E. B. Retinol, alpha-tocopherol and carotenoids in diabetes // Eur. J. Clin. Nutr. — 1999. — Vol. 53. — P. 630-635.

224. Abarca-Rojano E., Rosas-Medina P., Zam^^i-Cort^z P. et al. Mycobacterium tuberculosis virulence correlates with mitochondrial cytochrome c release in infected macrophages // Scand. J. Immunol. — 2003. — Vol. 58. — P. 419-427.

225. Abd El Mohsen M. M., Iravani M. M., Spencer J. P. et al. Age-associated changes in protein oxidation and proteasome activities in rat brain: modulation by antioxidants // Biochem. Biophys. Res. Commun. — 2005. — Vol. 336. — P. 386-391.

226. Abdalla D. S. P., Campa A., Monteiro H. P. Low density lipoprotein oxidation by stimulated neutrophils and ferritin // Atherosclerosis. — 1992. — Vol. 97. — P. 149-159.

227. Abramson S. L., Gallin J. I. IL-4 inhibits superoxide production by human mononuclear phagocytes // J. Immunol. — 1991. — Vol. 244. — P. 625-630.

228. Accardo-Palumbo A., Triolo G., Giardina E. et al. Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus // Acta Diabetol. — 1996. — Vol. 33. — P. 103—107.

229. Adachi T., Fukushima T., Usami Y., Hirano K. Binding of human xanthine oxidase to sulfated glycosaminoglycans on the endothelial-cell surface // Biochem. J. — 1993. — Vol. 289, Part 2. — P. 523-527.

230. Adaikalakoteswari A., Balasubramanyam M., Rema M., Mohan V. Differential gene expression of NADPH oxidase (p22^phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy // Diabet. Med. — 2006. — Vol. 23. — P. 666-674.

231. Adams J. D., Odunze I. N. Could oxidative stress be involved in brain? // Biochem. Parmacol. — 1991. — Vol. 41. — P. 1099-1105.

232. Adams J. D., Odunze I. N. Oxygen free radicals and Parkinson’s disease // Free Radic. Biol. Med. — 1991. — Vol. 10. — P. 161-169.

233. Adams L. B., Dinauer M. C., Morgenstern D. E., Krahenbuhl J. L. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice // Tuberc. Lung Dis. — 1997. — Vol. 78. — P. 237-246.

234. Adler V., Yin Z., Tew K. D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling // Oncogene. — 1999. — Vol. 18. — P. 6104-6111.

235. Agel N. M., Ball R. Y., Waldmann H., Mitchinson M. J. Monocytic origins of foam cells in human atherosclerotic plaques // Atherosclerosis. — 1984. — Vol. 53. — P. 265-271.

236. Aguirre V., Uchida T., Yenush L. et al. The c-jun NH₂-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser³⁰⁷ // J. Biol. Chem. — 2000. — Vol. 275. — P. 9047-9054.

237. Aiello L. P., Bursell S. E., Clermont A. et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor // Diabetes. — 1997. — Vol. 46. — P. 1473-1480.

238. Aikens J., Dix T. A. Hydrodioxyl (perhydroxyl), peroxyl and hydroxyl radical-initiated lipid peroxidation of large unilamellar vesicles (liposomes): comparative and mechanistic studies // Arch. Biochem. Biophys. — 1993. — Vol. 305. — P. 516-525.

239. Aisen P., Leibman A., Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin // J. Biol. Chem. — 1978. — Vol. 253. — P. 1930-1937.

240. Alanko J., Riutta A., Vapaatalo H. Effects of catecholamines on eicosanoid synthesis with special reference to prostanoid/leukotriene ratio // Free Radic. Biol. Med. — 1992. — Vol. 13. — P. 677-688.

241. Albina J. E. On the expression of nitric oxide synthase by human macrophages. Why no NO? // J. Leukoc. Biol. — 1995. — Vol. 58. — P. 643-649.

242. Albina J. E., Caldwell M. D., Henry Jr. W. L., Mills C. D. Regulation of macrophage functions by L-arginine // J. Exp. Med. — 1989. — Vol. 169. — P. 1021-1029.

243. Albina J. E., Cui S., Mateo R. B., Reichner J. S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages // J. Immunol. — 1993. — Vol. 150. — P. 5080-5085.

244. Alessi D. R., Deak M., Casamayor A. et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with Drosophila DSTPK61 kinase // Curr. Biol. — 1997. — Vol. 7. — P. 776-789.

245. Ali S. F., LeBel C. P., Bondy S. C. Reactive oxygen species formation as a biomarker of methylmer- cury and trimethylin neurotoxicity // Neurotoxicology. — 1992. — Vol. 13. — P. 637-648.

246. Allen R. C., Loose L. D. Phagocytic activation of luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages // Biochem. Biophys. Res. Commun. — 1976. — Vol. 69. — P. 245-252.

247. Almind K., Doria A., Kahn C. R. Putting the genes for type II diabetes on the map // Nat. Med. —

2001. — Vol. 7. — P. 277-279.

248. Alpert S. E., Kramer C. M., Hayes M. M., Dennery P. A. Morphologic injury and lipid peroxidation in monolayer cultures of rabbit tracheal epithelium exposed in vitro to ozone // J. Toxicol. Environ. Health. — 1990. — Vol. 30. — P. 287-304.

249. Al-Ramadi B. K., Meissler J. J., Huang D., Eisenstein T. K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4 // Eur. J. Immunol. — 1992. — Vol. 22. — P. 2249-2254.

250. Alvarado C., Alvarez P., Puerto M. et al. Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice // Nutrition. — 2006. — Vol. 22. — P. 767-777.

251. Amber I. J., Hibbs J. B. Jr., Taintor R. R., Vavrin Z. Cytokines induce an L-arginine-dependent effector system in non-macrophage cells // J. Leukoc. Biol. — 1988. — Vol. 44. — P. 58-65.

252. Ambrosio G., Flaherty J. T. Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts // Cardio- vasc. Drugs Ther. — 1992. — Vol. 6. — P. 623—632.

253. Ambrosio G., Zweier J. L., Duilio C. et al. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow // J. Biol. Chem. — 1993. — Vol. 268. — P. 18532-18541.

254. Amer M., El-Habibi E. S., El-Gendy A. Effects of Trifolium alexandrinum extracts on streptozoto- cin-induced diabetes in male rats // Ann. Nutr. Metab. — 2004. — Vol. 48. — P. 343-347.

255. Ananthan R., Baskar C., NarmathaBai V. et al. Antidiabetic effect of Gymnema montanum leaves: effect on lipid peroxidation induced oxidative stress in experimental diabetes // Pharmacol. Res. — 2003. — Vol. 48. — P. 551-556.

256. Ananthan R., Latha M., Ramkumar K. M. et al. Modulatory effects ofGymnema montanumleafextract on alloxan-induced oxidative stress in Wistar rats // Nutrition. — 2004. — Vol. 20. — P. 280-285.

257. Andallu B., Varadacharyulu N. Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats // Clin. Chim. Acta. — 2003. — Vol. 338. — P. 3-10.

258. Andersen P., Askgaard D., Ljungqvist L. et al. Proteins released from Mycobacterium tuberculosis during growth // Infect. Immun. — 1991. — Vol. 59. — P. 1905-1910.

259. Anderson R., Theron A. J., Ras G. J. Regulation by the antioxidants ascorbate, cysteine and dapsone of the increased extracellular generation of reactive oxidants by activated phagocytes from cigarette smokers // Am. Rev. Respir. Dis. — 1987. — Vol. 135. — P. 1027-1032.

260. Andziak B., O’Connor T. P., Buffenstein R. Antioxidants do not explain the disparate longevity between mice and the longest-living rodent, the naked mole-rat // Mech. Ageing Dev. — 2005. — Vol. 126. — P. 1206-1212.

261. Anisimov V. N., Popovich I. G., Zabezhinski M. A. et al. Melatonin as antioxidant, geroprotector and anticarcinogen // Biochim. Biophys. Acta. — 2006. — Vol. 1757. — P. 573-589.

262. Annida B., Stanely Mainzen Prince P. Supplementation of fenugreek leaves reduces oxidative stress in streptozotocin-induced diabetic rats // J. Med. Food. — 2005. — Vol. 8. — P. 382-385.

263. Anonym. Safety of oral vitamin E // VERIS Res. Summary. — 1998. — July. — P. 1-12.

264. Anwar M. M., Meki A. R. Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin // Comp. Biochem. Physiol. A Physiol. — 2003. — Vol. 135. — P. 347-539.

265. Anwer T., Sharma M., Pillai K. K. et al. Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats // Toxicology. — 2007. — Vol. 229. — P. 165-172.

266. Appelberg R. Macrophage nutriprive antimicrobial mechanisms // J. Leukoc. Biol. — 2006. — Vol. 79. — P. 1117-1128.

267. Aragno M., Tamagno E., Gatto V. et al. Dehydroepiandrosterone protects tissues of streptozotocin- treated rats against oxidative stress // Free Radic. Biol. Med. — 1999. — Vol. 26. — P. 1467-1474.

268. Arai K., Maguchi S., Fujii S. et al. Glycation and inactivation ofhuman Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites // J. Biol. Chem. — 1987. — Vol. 262. — P. 16969-16972.

269. Araki N., Higashi T., Mori T. et al. Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of Maillard reaction // Eur. J. Biochem. — 1995. — Vol. 230. — P. 408-415.

270. Araujo J. A., Romano E. L., Brito B. E. et al. Iron overload augments the development of atherosclerotic lesions in rabbits // Arterioscler. Thromb. Vasc. Biol. — 1995. — Vol. 15. — P. 1172-1180.

271. Arend W. P. The balance between IL-1 and IL-1Ra in disease // Cytokine Growth Factor Rev. —

2002. — Vol. 13. — P. 323-340.

272. Arnhold J., Sonntag K., Sauer H. et al. Increased native chemiluminescence in granulocytes isolated from synovial fluid and peripheral blood of patients with rheumatoid arthritis // J. Biolumin. Chemi- lumin. — 1994. — Vol. 9. — P. 79-86.

273. Arulselvan P., Subramanian S. P. Beneficial effects of Murraya koenigii leaves on antioxidant defense system and ultra structural changes of pancreatic beta-cells in experimental diabetes in rats // Chem. Biol. Interact. — 2007. — Vol. 165. — P. 155-164.

274. Asano Т., Iohshita H., Matsui Т., Sano K. Status of ebselen development in stroke // 7th Biennial Sci. Meet. — Sydney, 1994. — DAIICHI 3.

275. Aslund F., Zheng M., Beckwith J., Storz G. Regulation of the OxyR transcription factor by hydrogen peroxide and the cellular thiol—disulfide status // Proc. Natl. Acad. Sci. USA. — 1999. — Vol. 96. — P. 6161-6165.

276. Asselbergs F. W., Reynolds W. F., Cohen-Tervaert J. W. et al. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease // Am. J. Med. — 2004. — Vol. 116. — P. 429-430.

277. Assmann G., Funke H. HDL metabolism and atherosclerosis // J. Cardiovasc. Pharmacol. — 1990. — Vol. 16, Suppl. 9. — P. S15-S20.

278. Astley S., Langrish-Smith A., Southon S., Sampson M. Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes // Diabetes Care. — 1999. — Vol. 22. — P. 1626-1631.

279. Atalay M., Laaksonen D. E., Niskanen L. et al. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress // Acta Physiol. Scand. — 1997. — Vol. 161. — P. 195-201.

280. Austin M. A., Krauss R. M. Genetic control of low density lipoprotein subclasses // Lancet. — 1986. — Vol. 2. — P. 592-595.

281. Aviram M. LDL modifications by phospholipases increase macrophage cholesterol accumulation // Advances in Lipoprotein and Atherosclerosis Research, Diagnostics and Treatment. — Jena: Gustav Fisher, 1995. — P. 28-33.

282. Aviram M. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells // J. Biol. Chem. — 1989. — Vol. 267. — P. 218-225.

283. Aviram M. Oxidative modification of low density lipoprotein and its relation atherosclerosis // Israel J. Med. Sci. — 1995. — Vol. 31. — P. 241-249.

284. Aviram M., Kent U. M., Hollenberg P. F. Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein // Atherosclerosis. — 1999. — Vol. 143. — P. 253-260.

285. Aviram M., Rosenblat M. Macrophage-mediated oxidation of low density lipoprotein required the binding of the lipoprotein to its receptor // J. Lipid Res. — 1994. — Vol. 35. — P. 385-394.

286. Avogaro P., Bon G. B., Cazzolato G. Presence of a modified low density lipoprotein in humans // Arteriosclerosis. — 1988. — Vol. 8. — P. 79-87.

287. Aydin A., Orhan H., Sayal A. et al. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control // Clin. Biochem. — 2001. — Vol. 34. — P. 65-70.

288. Babior B. M., Takeuchi C., Ruedi J. et al. Investigating antibody-catalyzed ozone generation by human neutrophils // Proc. Natl. Acad. Sci. USA. — 2003. — Vol. 100. — P. 3031-3034.

289. Bachetti T., Comini L., Francolini G. et al. Arginase pathway in human endothelial cells in pathophysiological conditions // J. Mol. Cell Cardiol. — 2004. — Vol. 37. — P. 515-523.

290. Bai T. R., Bramley A. M., Schellenberg R. R., Pare P. D. Nitric oxide mediates nonadrenergic, noncholinergic inhibitory neural responses in human bronchial smooth muscle // Am. Rev. Respir. Dis. — 1992. — Vol. 145. — P. A383.

291. Bajaj M. S., Kew R. R., Webster R. O., Hyers T. M. Priming of human neutrophil functions by tumor necrosis factor: Enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and FMLP // Inflammation. — 1992. — Vol. 16. — P. 241-250.

292. Baker M. S., Feigan J., Lowther D. A. The mechanism of chondrocyte hydrogen peroxide damage. Depletion of intracellular ATP due to suppression of glycolysis caused by oxidation of glyceralde- hyde-3-phosphate dehydrogenase // J. Rheumatol. — 1989. — Vol. 16. — P. 7-14.

293. Balazovich K. J., Almeida H. I., Boxer L. A. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms // J. Lab. Clin. Med. — 1991. — Vol. 118. — P. 576-584.

294. Baldus S., Heeschen C., Meinertz T. et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes // Circulation. — 2003. — Vol. 108. — P. 1440-1445.

295. Balla G., Jacob H. S., Eaton J. W. et al. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury // Arterioscler. Thromb. — 1991. — Vol. 11. — P. 1700-1711.

296. Barbagallo M., Dominguez L. J., Tagliamonte M. R. et al. Effects of vitamin E and glutathione on glucose metabolism: role of magnesium // Hypertension. — 1999. — Vol. 34. — P. 1002-1006.

297. Baritussio A. Antioxidant defenses of rabbit alveolar lining fluid // Lung Respir. — 1988. — Vol. 5. — P. 11-12.

298. Barksdale A. R., Bernard A. C., Maley M. E. et al. Regulation of arginase expression by T-helper II cytokines and isoproterenol // Surgery. — 2004. — Vol. 135. — P. 527-535.

299. Barnes P. Reactive oxygen species and airway inflammation // Free Radic. Biol. Med. — 1990. — Vol. 9. — P. 235-243.

300. Barnett Y. A., King C. M. Investigation of antioxidant status. DNA-repair capacity and mutation as a function of age in humans // Mutat. Res. — 1995. — Vol. 338. — P. 115-128.

301. Barrett E. G., Johnston C., Oberdorster G., Finkelstein J. N. Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure // Toxicol. Appl. Pharmacol. — 1999. — Vol. 158. — P. 211-220.

302. Barrington P. L. EfTects of free radicals on the electrophysiological functions of cardiac membranes // Free Radic. Biol. Med. — 1990. — Vol. 9. — P. 355—365.

303. Barrios R., Shi Z.-Z., Kala S. V. et al. Oxygen-induced pulmonary injury in γ-glutamyl transpeptidase-deficient mice // Lung. — 2001. — Vol. 179. — P. 319—330.

304. Barth J., Entzian P., Petermann W. Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-de- pendent chemiluminescence // Klin. Wochenschr. — 1988. — Vol. 65. — P. 292—297.

305. Basaga H. S. Biochemical aspects of free radicals // Biochem. Cell Biol. — 1990. — Vol. 68. — P. 989-998.

306. Baskaran S., Balasubramanian K. A. Effect of methylglyoxal on protein thiol and amino groups in isolated rat enterocytes and activity of various brush border enzymes // Indian J. Biochem. Bio- phys. — 1990. — Vol. 27. — P. 13-17.

307. Basta G., Schmidt A. M., De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes // Cardiovasc. Res. — 2004. — Vol. 63. — P. 582-592.

308. Basu S. K., Kumar D., Singh D. K. et al. Mycobacterium tuberculosis secreted antigen (MTSA-10) modulates macrophage functionby redox regulation ofphosphatases // FEBS J. — 2006. — Vol. 273. — P. 5517-5534.

309. Bates T. E., Loesch A., Burnstock G., Clark J. B. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? // Biochem. Biophys. Res. Commun. — 1996. — Vol. 218. — P. 40-44.

310. Bautista A. P., Spitzer J. J. Platelet activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion // Free Radic. Res. Commun. — 1992. — Vol. 17. — P. 195-209.

311. Baydoun A. R., Bogle R. G., Pearson J. D. Mann G. E. Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of L-arginine transport, in activated murine macrophage J774 cells // Br. J. Pharmacol. — 1993. — Vol. 110. — P. 1401-1406.

312. Baynes J. W., Thorpe S. R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm // Diabetes. — 1999. — Vol. 48. — P. 1-9.

313. Becker L. B., Van den Hoek T. L., Shao Z. H. et al. Generation of superoxide in cardiomyocytes during ischemia before reperfusion // Am. J. Physiol. — 1999. — Vol. 277. — P. H2240-H2246.

314. Beckman J. S., Minor R. L., White C. W. et al. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance // J. Biol. Chem. — 1988. — Vol. 263. — P. 6884-6892.

315. Beckmann J. S., Ye Y. Z., Anderson P. G. et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry // Biol. Chem. — 1994. — Vol. 375. — P. 81-88.

316. Behr J., Maier K., Krombach F., Adelmann-Grill B. C. Pathogenetic significance ofreactive oxygen species in diffuse fibrosing alveolitis // Am. Rev. Respir. Dis. — 1991. — Vol. 144. — P. 146-150.

317. Behrens W. A., Thompson J. N., Madere R. Distribution of alpha-tocopherol in human plasma lipoproteins // Am. J. Clin. Nutr. — 1982. — Vol. 35. — P. 691-596.

318. Belvisi M. G., Stretton D., Yacoub M., Barnes P. J. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans // Eur. J. Pharmacol. — 1992. — Vol. 210. — P. 221-222.

319. Bendtzen K., Mandrup-Poulsen T., Nerup J. et al. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans // Science. — 1996. — Vol. 232. — P. 1545-1547.

320. Berg J. T., Smith R. M. Endotoxin protection of rats from O₂ toxicity: chemiluminescence of lung neutrophils // Res. Commun. Chem. Pathol. Pharmacol. — 1984. — Vol. 44. — P. 461-476.

321. Berger M. M. Can oxidative damage be treated nutritionally? // Clin. Nutr. — 2005. — Vol. 24. — P. 172-183.

322. Bergman R. N., Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus // Trends Endocrinol. Metab. — 2000. — Vol. 11. — P. 351-356.

323. Berlett B. S., Stadtman E. R. Protein oxidation in aging, disease, and oxidative stress // J. Biol. Chem. — 1997. — Vol. 272. — P. 20313-20316.

324. Berliner J. A., Territo M. C., Sevanian A. et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions // J. Clin. Invest. — 1990. — Vol. 85. — P. 1260-1266.

325. Berry C. E., Hare J. M. Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications // J. Physiol. — 2004. — Vol. 555. — P. 589-606.

326. Bey E. A., Cathcart M. K. In vitro knockout ofhuman p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes // J. Lipid. Res. — 2000. — Vol. 41. — P. 489-495.

327. Beyer R. E. The participation of coenzyme Q in free radical production and antioxidation // Free Radic. Biol. Med. — 1990. — Vol. 8. — P. 545-565.

328. Bhadra S., Arshad M. A. Q., Rymaszewski Z. et al. Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu²+ ions: identification of major products and their effects // Biochem. Biophys. Res. Commun. — 1991. — Vol. 176. — P. 431—440.

329. Bhandari U., Kanojia R., Pillai K. K. Effect of ethanolic extract of Zingiber officinale on dyslipidae- mia in diabetic rats // J. Ethnopharmacol. — 2005. — Vol. 97. — P. 227—230.

330. Bhuyan K. C., Bhuyan D. K. Superoxide dismutase of the eye. Relative functions of superoxide dismutase and catalase in protecting the ocular lens from oxidative damage // Biochim. Biophys. Acta. — 1978. — Vol. 542. — P. 28-38.

331. Bielski B. H. J., Arudi R. L., Sutherland M. W. A study of the reactivity of HO^/O^^- with unsaturated fatty acids // J. Biol. Chem. — 1983. — Vol. 258. — P. 4759-4761.

332. Biemond P., Swaak A. J. G., Van Eijk H. G., Koster J. F. Superoxide dependent iron release from ferritin in inflammatory diseases // Free Radic. Biol. Med. — 1988. — Vol. 4. — P. 185-198.

333. Billiar T. R., Curran R. D., Harbrecht B. G. et al. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes // Am. J. Physiol. — 1992. — Vol. 262. — P. C1077-C1082.

334. Billiau A. D., Roskams T., Van Damme-Lombaerts R. et al. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-y-producing lymphocytes and IL-6- and TNF-a-producing macrophages // Blood. — 2005. — Vol. 105. — P. 1648-1651.

335. Bitar M. S., Wahid S., Pilcher C. W. et al. Alpha-lipoic acid mitigates insulin resistance in Goto- Kakizaki rats // Horm. Metab. Res. — 2004. — Vol. 36. — P. 542-549.

336. Bitner S. B., Tucker W. F. G., Cartwright I., Bieehen S. S. A double-blind, randomized, placebo- controlled trial of fish oil in psoriasis // Lancet. — 1988. — Vol. 1. — P. 378-380.

337. Bitterman P. B., Salzman L. E., Adelberg S. et al. Alveolar macrophage replication: one mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung // J. Clin. Invest. — 1984. — Vol. 74. — P. 460-469.

338. Bize I. B., Oberley L. W., Morris H. P. Superoxide dismutase and superoxide radical in Morris hepatomas // Cancer Res. — 1980. — Vol. 40. — P. 3686-3693.

339. Bjerknes R., Aarskog D. Priming of human polymorphonuclear neutrophilic leukocytes by insulinlike growth factor I: increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst // J. Clin. Endocrinol. Metab. — 1995. — Vol. 80. — P. 1948-1955.

340. Blair A. S., Hajduch E., Litherland G. J., Hundal H. S. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress: Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways // J. Biol. Chem. — 1999. — Vol. 274. — P. 36293-36299.

341. Blake D. R., Allen R. E., Lunec J. Free radicals in biological systems — a review orientated to inflammatory processes // Br. Med. Bull. — 1987. — Vol. 43. — P. 371-385.

342. Blanc J., Alves-Guerra M. C., Esposito B. et al. Protective role of uncoupling protein 2 in atherosclerosis // Circulation. — 2003. — Vol. 107. — P. 388-390.

343. Bliznakov E. G., Wilkins D. J. Biochemical and clinical consequences of inhibiting coenzyme Q₁₀ biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): A critical overview // Adv. Ther. — 1998. — Vol. 15. — P. 218-228.

344. Blom M., Tool A. T. J., Roos D., Verhoeven A. J. Priming of human eosinophils by platelet-activating factor enhances the number of cells able to bind and respond to opsonized particles // J. Immunol. — 1992. — Vol. 149. — P. 3672-3677.

345. Blomqvist H., Wickerts C. J., Andreen M. et al. Enhanced pneumonia resolution by inhalation of nitric oxide // Acta Anaesthesiol. Scand. — 1993. — Vol. 37. — P. 110-114.

346. Boaz M., Smetana S., Weinstein T. et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial // Lancet. — 2000. — Vol. 356. — P. 1213-1218.

347. Bogdan C., Thuring H., Dlaska M. et al. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population // J. Immunol. — 1997. — Vol. 159. — P. 4506-4513.

348. Boggs S. E., McCormick T. S., Lapetina E. G. Glutathione levels determine apoptosis in macrophages // Biochem. Biophys. Res. Commun. — 1998. — Vol. 247. — P. 229-233.

349. Boland M. P., O’Neil L. A. Ceramide activates NF-kB by inducing the processing of pl05 // J. Biol. Chem. — 1998. — Vol. 273. — P. 15494-15495.

350. Bollheimer L. C., Skelly R. H., Chester M. W. et al. Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation // J. Clin. Invest. — 1998. — Vol. 101. — P. 1094-1101.

351. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview // Cardiovasc. Drugs Ther. — 1991. — Vol. 5. — P. 249-268.

352. Bonanome A., Pagnan A., Biffanti S. et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification // Arte- rioscler. Thromb. — 1992. — Vol. 12. — P. 529-533.

353. Bonet B., Hauge-Gillenwater H., Zhu X. D., Knopp R. H. LDL oxidation and human placental trophoblast and macrophage cytotoxicity // Proc. Soc. Exp. Biol. Med. — 1998. — Vol. — 217. — P. 203-211.

354. Bonneau C., Couderc R., Roch-Arveiller M. et al. Effects of low-density lipoproteins on polymorphonuclear leukocyte functions in vitro // J. Lipid Mediat. Cell Signal. — 1994. — Vol. 10. — P. 203-212.

355. Bono A., Caimi G., Catania A. et al. Red cell peroxide metabolism in diabetes mellitus // Horm. Metab. Res. — 1987. — Vol. 19. — P. 264-266.

356. Borish L., Rosenbaum R., Albury L., Clark S. Activation of neutrophils by recombinant interleukin 6 // Cell. Immunol. — 1989. — Vol. 121. — P. 281-289.

357. Bose M., Farnia P. Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process // Immunol. Lett. — 1995. — Vol. 48. — P. 59-64.

358. Boucher F., Coudray C., Favier A., Deleiris J. Stimulation of peroxidative reactions by a high dose of allopurinol in the rat myocardium // Cardiovasc. Drugs Ther. — 1992. — Vol. 6. — P. 541-542.

359. Boulton T. G., Nye S. H., Robbins D. J. et al. ERKs: a family ofprotein-serine/treonine kinasesthat are activated and tyrosine phosphorylated in response to insulin and NGF // Cell. — 1991. — Vol. 65. — P. 663-675.

360. Bourre J. M., Bonneil M., Clement M. et al. Function of dietary polyunsaturated fatty acids in the nervous system // Prostaglandins Leukot. Essent. Fatty Acids. — 1993. — Vol. 48. — P. 5-15.

361. Bowman C. M., Butler E. N., Repine J. E. Hyperoxia damages cultured endothelial cells causing increased neutrophil adherence // Am. Rev. Respir. Dis. — 1983. — Vol. 128. — P. 469-472.

362. Bowry V. W., Ingold K. U. Extraordinary kinetic behavior of the α-tocopheroxyl (vitamin E) radical // J. Org. Chem. — 1995. — Vol. 60. — P. 5456-5467.

363. Brett J., Schmidt A. M., Yan S. D. et al. Survey ofthe distribution ofa newly characterized receptor for advanced glycation end products in tissues // Am. J. Pathol. — 1993. — Vol. 143. — P. 1699-1712.

364. Breugnot C., Iliou J. P., Privat S. et al. Invitro and exvivo inhibition of the modification of low-density lipoprotein by indapamide // J. Cardiovasc. Pharmacol. — 1992. — Vol. 20. — P. 340-347.

365. Briaud I., Kelpe C. L., Johnson L. M. et al. Differential effects of hyperlipidemia on insulin secretion in islets of Langerhans from hyperglycemic versus normoglycemic rats // Diabetes. — 2002. — Vol. 51. — P. 662-668.

366. Brieland J. K., Kunkel R. G., Fantone J. C. Pulmonary alveolar macrophage function during acute inflammatory lung injury // Am. Rev. Respir. Dis. — 1987. — Vol. 135. — P. 1300-1306.

367. Brigham K. L. Role of free radicals in lung injury // Chest. — 1986. — Vol. 89. — P. 859-863.

368. Brigham K. L., Meyrick B., Berry L. C., Repine J. E. Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin // J. Appl. Physiol. — 1987. — Vol. 63. — P. 840-850.

369. Bromme H. J., Ebelt H., Peschke D., Peschke E. Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin // Cell Mol. Life Sci. — 1999. — Vol. 55. — P. 487-493.

370. Brooks M. M. Activation ofeggs by oxidation-reduction indicators // Science. — 1947. — Vol. 106. — P. 320.

371. Broun S., Vonbruchhausen F. Vitamin E or probucol as donors for oxidation of human low-density lipoprotein by peroxidases/H₂0₂ // Pharmacology. — 1994. — Vol. 49. — P. 325-335.

372. Brown K. A. The polymorphonuclear cell in rheumatoid arthritis // Br. J. Rheumatol. — 1988. — Vol. 27. — P. 150-155.

373. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol depositions in atherosclerosis // Ann. Rev. Biochem. — 1983. — Vol. 52. — P. 223-261.

374. Brownlee M. A radical explanation for glucose-induced β cell dysfunction // J. Clin. Invest. —

2003. — Vol. 112. — P. 1788-1790.

375. Brownlee M. Biochemistry and molecular cell biology of diabetic complications // Nature. — 2001. — Vol. 414. — P. 813-820.

376. Brownlee M. Negative consequence of glycation // Metabolism. — 2000. — Vol. 49, Suppl. 1. — P. 9-13.

377. Brunauer L. S., Moxness M. S., Huestis W. H. Hydrogen peroxide oxidation induces the transfer of phospholipids from the membrane into the cytosol of human erythrocytes // Biochemistry. — 1994. — Vol. 334. — P. 4527-4532.

378. Brunet-Rossinni A. K. Reduced free-radical production and extreme longevity in the little brown bat (Myotis lucifugus) versus two non-flying mammals // Ageing Dev. — 2004. — Vol. 125. — P. 11-20.

379. Brunet-Rossinni A. K. Testing the free radical theory of aging in bats // Ann. N.Y. Acad. Sci. —

2004. — Vol. 1019. — P. 506-508.

380. Bryan C. L., Campbell G. D., Lawrence R. A., Jenkinson S. G. Diphosphoryl lipid A protects rats from lethal hyperoxia // J. Lab. Clin. Med. — 1992. — Vol. 120. — P. 444-452.

381. Bryk R., Griffin P., Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins // Nature. — 2000. — Vol. 407. — P. 211-215.

382. Bryszewska M., Zavodnik I. B., Niekurzak A., Szosland K. Oxidative processes in red blood cells from normal and diabetic individuals // Biochem. Mol. Biol. Int. — 1995. — Vol. 37. — P. 345-354.

383. Buard A., Clement M., Bourre J. M. Developmental changes in enzymatic systems involved in protection against peroxidation in isolated rat brain microvessels // Neurosci. Lett. — 1992. — Vol. 141. — P. 72-74.

384. Bubici C., Papa S., Pham C. G. et al. The NF-KB-mediated control of ROS and JNK signaling // Histol. Histopathol. — 2006. — Vol. 21. — P. 69-80.

385. Bucala R., Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging // Adv. Pharmacol. — 1992. — Vol. 23. — P. 1-34.

386. Bucala R., Makita Z., Koschinsky T. et al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90. — P. 6434-6438.

387. Bucala R., Makita Z., Vega G. et al. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency // Proc. Natl. Acad. Sci. USA. — 1994. — Vol. 91. — P. 9441-9445.

388. Buchmuller-Rouiller Y., Corradin S., Smith J. et al. Role of glutathione in macrophage activation: effect of cellular gluthatione depletion on nitrite production and leishmanicidal activity // Cell. Immunol. — 1995. — Vol. 164. — P. 73-80.

389. Buckley B. J., Tanswell A. K., Freeman B. A. Liposome-mediated augmentation ofcatalase in alveolar type II cells protects against H₂O₂ injury // J. Appl. Physiol. — 1987. — Vol. 63. — P. 359-367.

390. Buerke M., Weyrich A. S., Lefer A. M. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators // Am. J. Physiol. — 1994. — Vol. 266. — P. H128-H136.

391. Bulatovic V. M., Wengenack N. L., Uhl J. R. et al. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid // Antimicrob. Agents Chemother. — 2002. — Vol. 46. — P. 2765-2771.

392. Bulkley G. B. Evaluating oxidant or antioxidant status: an editorial comment // Shock. — 1994. — Vol. 1. — P. 313-314.

393. Bulkley G. B. Free radicals and other reactive oxygen metabolites: Clinical relevance and the therapeutic efficacy of antioxidant therapy // Surgery. — 1993. — Vol. 113. — P. 479-483.

394. Burkart V., Grob-Eick A., Bellmann K. et al. Suppression of nitric oxide toxicity in islet cells by α-tocopherol // FEBS Lett. — 1995. — Vol. 364. — P. 259-263.

395. Burke S. E., Wright C. D., Potoczak R. E. et al. Reduction of canine myocardial infarct size by CI- 959, an inhibitor of inflammatory cell activation // J. Cardiovasc. Pharmacol. — 1992. — Vol. 20. — P. 619-629.

396. Burnett D., Path M. R. C., Chamba A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis // Lancet. — 1987. — Vol. 11 (L,C). — P. 1043-1047.

397. Bursell S. E., Clermont A. C., Aiello L. P. et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes // Diabetes Care. — 1999. — Vol. 22. — P. 1245-1251.

398. Burton G. W., Ingold K. U. β-Carotene: an unusual type of lipid antioxidant // Science. — 1984. — Vol. 224. — P. 569-573.

399. Butler A. E., Janson J., Bonner-Weir S. et al. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes // Diabetes. — 2003. — Vol. 52. — P. 102-110.

400. Cahill G. F., Etzwiler D. D., Freinkel N. Blood glucose control in diabetes // New Engl. J. Med. — 1976. — Vol. 294. — P. 1004-1005.

401. Calhoun W. J., Bush R. K. Enhanced reactive oxygen species metabolism of airspace cells and airway inflammation follow antigen challenge in human asthma // J. Allergy Clin. Immunol. — 1990. — Vol. 87. — P. 306-314.

402. Cameron N. E., Cotter M. A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes // Diabetes Res. Clin. Pract. — 1999. — Vol. 45. — P. 137—146.

403. Campo G. M., Squadrito F., Altavilla D. et al. Protection of ischemic and reperfused rat myocardium by the nonglucocorticoid 21-aminosteroid U-74389G, a new inhibitor of lipid peroxidation // J. Pharmacol. Exp. Ther. — 1996. — Vol. 277. — P. 333-340.

404. Campos K. E., Diniz Y. S., Cataneo A. C. et al. Hypoglycaemic and antioxidant effects of onion, Allium cepa: dietary onion addition, antioxidant activity and hypoglycaemic effects on diabetic rats // Int. J. Food Sci. Nutr. — 2003. — Vol. 54. — P. 241-246.

405. Can A., Akev N., Ozsoy N. et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models // Biol. Pharm. Bull. — 2004. — Vol. 27. — P. 694-698.

406. Candido A., Rossi P. L., Lippa S. et al. Granulocyte activity in leukemias and other hemopathies // Acta Med. Rom. — 1984. — Vol. 22. — P. 217-224.

407. Candiloros H., Zeghari N., Zeigler O. et al. Hyperinsulinemia is related to phospholipid composition and membrane fluidity changes in obese nondiabetic women // J. Clin. Endocrinol. Metab. — 1996. — Vol. 81. — P. P2912-P2918.

408. Cantin A. M., North S. L., Hubbard R. C., Crystal R. G. Normal alveolar epithelial lining fluid contains high levels of glutathione // J. Appl. Physiol. — 1987. — Vol. 63. — P. 152-157.

409. Cardillo C., De Sole P., Savi L., Mores N. Effects of induced hypercholesterolemia on circulating rabbit polymorphonuclear leukocyte activation studied by chemiluminescence // Acta Med. Ro- mana. — 1987. — Vol. 25. — P. 447-454.

410. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hy- pocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit // Proc. Natl. Acad. Sci. USA. — 1987. — Vol. 84. — P. 7725-7729.

411. Carlsson C., Borg L. A., Welsh N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro // Endocrinology. — 1999. — Vol. 140. — P. 3422-3428.

412. Carlsson L. M. Jonsson J., Edlund T., Marklund S. L. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia // Proc. Natl. Acad. Sci. USA. — 1995. — Vol. 92. — P. 6264-6268.

413. Carpenter K. L., Cheeseman K. H., van der Veen C. et al. Depletion of α-tocopherol in human atherosclerotic lesions // Free Radic. Res. — 1995. — Vol. 23. — P. 549-558.

414. Carre P. C., Didier A. P., Pipy B. R. et al. The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages // Am. Rev. Respir. Dis. — 1990. — Vol. 142. — P. 1068-1072.

415. Casas J. P., Hingorani A. D., Humphries S. E. et al. Do metaanalyses of association studies of endothelial nitric oxide synthase variants and ischemic heart disease provide conclusive answers? // Circulation. — 2004. — Vol. 110. — P. e305-e306.

416. Cathcart M. K., Li Q., Chisolm G. M. Lipoprotein receptor interactions are not required for monocyte oxidation of LDL // J. Lipid Res. — 1995. — Vol. 36. — P. 1857-1865.

417. Cathcart M. K., McNally A. K., Morel D. W., Chisolm G. M. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin // J. Immunol. — 1989. — Vol. 142. — P. 1963-1969.

418. Cattaruzza M., Guzik T. J., Slodowski W. et al. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease // Circ. Res. — 2004. — Vol. 95. — P. 841-847.

419. Caye-Vaugien C., Krempf M., Lamarche P. et al. Determination of alpha-tocopherol in plasma, platelets and erythrocytes of type I and type II diabetic patients by high-performance liquid chromatography // Int. J. Vitam. Nutr. Res. — 1990. — Vol. 60. — P. 324-330.

420. Cenci E., Romani L., Mencacci A. et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans // Eur. J. Immunol. — 1993. — Vol. 23. — P. 1034-1038.

421. Ceriello A. Acute hyperglycaemia and oxidative stress generation // Diabet. Med. — 1997. — Vol. 14, Suppl. 3. — P. S45-S49.

422. Ceriello A Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications // Diabetes Nutr. Metab. — 1999. — Vol. 12. — P. 42-46.

423. Ceriello A., Bortolotti N., Motz E. et al. Meal-generated oxidative stress in type 2 diabetic patients // Diabetes Care. — 1998. — Vol. 21. — P. 1529-1533.

424. Ceriello A., Giugliano D., Quatraro A. et al. Metabolic control may influence the increased superoxide anion generation in diabetic serum // Diabetic Med. — 1991. — Vol. 8. — P. 540—542.

425. Ceriello A., Giugliano D., Quatraro A. et al. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? // Diabetes Care. — 1991. — Vol. 14. — P. 68-72.

426. Ceriello A., Morocutti A., Mercuri F. et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy // Diabetes. — 2000. — Vol. 49. — P. 2170-2177.

427. Ceriello A., Quatraro A., Caretta F. et al. Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin dependent diabetes // Diabetes Metab. — 1990. — Vol. 16. — P. 318-322.

428. Ceriello A., Quatraro A., Giugliano D. Diabetes mellitus hypertension: the possible role of hyperg- lycaemia through oxidative stress // Diabetologia. — 1993. — Vol. 36. — P. 265-266.

429. Cerutti P. A., Trump B. F. Inflammation and oxidative stress in carcinogenesis // Cancer Cells. —

1991. — Vol. 3. — P. 1-7.

430. Chait A., Brazg R. L., Tribble D. L. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B // Am. J. Med. — 1993. — Vol. 94. — P. 350-356.

431. Chakraborti S., Gurtner G. H., Michael J. R. Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium // Am. J. Physiol. — 1989. — Vol. 257. — P. L430-L437.

432. Chakravarthy U., Hayes R., Stitt A. et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end-products // Diabetes. — 1998. — Vol. 47. — P. 945-952.

433. Chan C. B., Saleh M. C., Koshkin V., Wheeler M. B. Uncoupling protein 2 and islet function // Diabetes. — 2004. — Vol. 53, Suppl. 1. — P. S136-S142.

434. Chan E. D., Chan J., Schluger N. W. What is the role of nitric oxide in murine and human host defense against tuberculosis? // Am. J. Respir. Cell Mol. Biol. — 2001. — Vol. 25. — P. 606-612.

435. Chan J., Flynn J. The immunological aspects oflatency in tuberculosis // Clin. Immunol. — 2004. — Vol. 110. — P. 2-12.

436. Chan K., Lu R., Chang J. C., Kan Y. W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development // Proc. Natl. Acad. Sci. USA. — 1996. — Vol. 93. — P. 13943-13948.

437. Chan W. Cellular interactions of vitamin E, cytokines and growth factors // Nutr. Res. — 1996. — Vol. 16. — P. 427-434.

438. Chandel N. S., Trzyna W. C., McClintock D. S., Schumacker P. T. Role of oxidants in NF-kB activation and TNF-α gene transcription induced by hypoxia and endotoxin // J. Immunol. — 2000. — Vol. 165. — P. 1013-1021.

439. Chanez P., Dent G., Yukawa T. et al. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF of phorbol esters // Eur. Respir. Dis. — 1990. — Vol. 3. — P. 1002-1007.

440. Chang G. J., Woo P., Honda H. M. et al. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide — dependence on pH and oxygen // Arterioscler. Thromb. — 1994. — Vol. 14. — P. 1808-1814.

441. Chang J. D., Xu Y., Raychowdhury M. K., Ware J. A. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets // J. Biol. Chem. — 1993. — Vol. 268. — P. 14208-14214.

442. Chang J. M., Kuo M. C., Kuo H. T. et al. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy // J. Lab. Clin. Med. — 2005. — Vol. 146. — P. 210-215.

443. Charies I. G., Palmer R. M. J., Hickery M. S. et al. Cloning, characterization and expression of cDNA encoding an inducible nitric oxide synthase from the human chondrocyte // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90. — P. 11419-11423.

444. Chauhan R., Mande S. C. Site-directed mutagenesis reveals a novel catalytic mechanism of Mycobacterium tuberculosis alkylhydroperoxidase C // Biochem. J. — 2002. — Vol. 367. — P. 255-261.

445. Chawla A., Barak Y., Nagy L. et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation // Nat. Med. — 2001. — Vol. 7. — P. 48-52.

446. Che W., Asahi M., Takahashi M. et al. Selective induction ofheparin-binding epidermal growth factor by methylflyoxal and 3-deoxyglucosone in rat smooth muscle cells: the involvement of reactive oxigen species formation methylglyoxal and a possible implication for atherogenesis in diabetes // J. Biol. Chem. - 1997. - Vol. 272. - P. 18453-18459.

447. Chen Q., Espey M. G., Krishna M. C. et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues // Proc. Natl. Acad. Sci. USA. - 2005. - Vol. 102. - P. 13604-13609.

448. Chen Q., Espey M. G., Sun A. Y. et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo// Proc. Natl. Acad. Sci. USA. - 2007. - Vol. 104. - P. 8749-8754.

449. Chen R., Kim O., Yang J. et al. Regulation of Akt/PKB activation by tyrosine phosphorylation // J. Biol. Chem. - 2001. - Vol. 276. - P. 31858-31862.

450. Cheung K., Archibald A., Robinson F. Luminol-dependent chemiluminescence produced by neutrophils stimulated by immune complexes // Austr. J. Exp. Biol. Med. Sci. - 1984. - Vol. 62, Pt. 4. - P. 403-419.

451. Chevion M., Jiang Y. D., Harel R. et al. Copper and iron are mobilized following myocardial ischemia- Possible predictive criteria for tissue injury // Proc. Natl. Acad. Sci. USA. - 1993. - Vol. 90. - P. 1102-1106.

452. Chevrier I., Tregouet D. A., Massonnet-Castel S. et al. Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis? // Atherosclerosis. - 2006. - Vol. 188. - P. 150-154.

453. Chew G. T., Watts G. F. Coenzyme Q₁₀ and diabetic endotheliopathy: oxidative stress and the «recoupling hypothesis» // Q. J. Med. - 2004. - Vol. 97. - P. 537-548.

454. Chiarelli F., Spagnoli A., Basciani F. et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications // Diabet. Med. - 2000 . - Vol. 17. - P. 650-656.

455. Chin J. H., Azhar S., Hoffman B. B. Inactivation of endothelial-derived relaxing factor by oxidized lipoproteins // J. Clin. Invest. - 1992. - Vol. 89. - P. 10-18.

456. Chisolm G. M., Ma G. P., Irwin K. C. et al. 7p-hydroperoxycholest-5-en-3p-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein // Proc. Natl. Acad. Sci. USA. - 1994. - Vol. 91. - P. 11452-11456.

457. Chistiakov D. A., Zotova E. V., Savost’anov K. V. et al. The 262T>C promoter polymorphism ofthe catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients // Diabetes Metab. - 2006. - Vol. 32. - P. 63-68.

458. Cho E. J., Lee Y. A., Yoo H. H., Yokozawa T. Protective effects ofbroccoli (Brassica oleracea) against oxidative damage in vitro and in vivo // J. Nutr. Sci. Vitaminol. - 2006. - Vol. 52. - P. 437-444.

459. Cho E. J., Yokozawa T., Kim H. Y. et al. Rosa rugosa attenuates diabetic oxidative stress in rats with streptozotocin-induced diabetes // Am. J. Chin. Med. - 2004. - Vol. 32. - P. 487-496.

460. Cho H. Y., Jedlicka A. E., Reddy S. P. et al. Role of NRF2 in protection against hyperoxic lung injury in mice // Am. J. Respir. Cell Mol. Biol. - 2002. - Vol. 26. - P. 175-182.

461. Cholletmartin S., Gatecel C., Kermarrec N. et al. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation // Am. J. Respir. Crit. Care Med. - 1996. - Vol. 153. - P. 985-990.

462. Chomarat P., Dantin C., Bennett L. et al. TNF skews monocyte differentiation from macrophages to dendritic cells // J. Immunol. - 2003. - Vol. 171. - P. 2262-2269.

463. Choudhury T. D., Das N., Chattopadhyay A., Datta A. G. Effect of oxidative stress and erythropoietin on cytoskeletal protein and lipid organization in human erythrocytes // Pol. J. Pharmacol. - 1999. - Vol. 51. - P. 341-350.

464. Chung C. P., Avalos I., Raggi P., Stein C. M. Atherosclerosis and inflammation: insights from rheumatoid arthritis // Clin. Rheumatol. - 2007. - Vol. 26. - P. 1228-1233.

465. Chung H. Y., Sung B., Jung K. J. et al. The molecular inflammatory process in aging // Antioxid. Redox Signal. - 2006. - Vol. 8. - P. 572-581.

466. Chung Y. S., Choi Y. H., Lee S. J. et al. Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo // J. Ethnopharmacol. - 2005. - Vol. 101. - P. 49-54.

467. Church D. F., Pryor W. A. Free-radical chemistry of cigarette smoke and its toxicological implications // Environ. Health Perspect. - 1985. - Vol. 64. - P. 111-126.

468. Churg A., Cherukupalli K. Cigarette smoke causes lipid peroxidation of rat tracheal epithelium // Int. J. Exp. Pathol. - 1993. - Vol. 74. - P. 127-132.

469. Ciaramella A., Cavone A., Santucci M. B. et al. Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages // J. Infect. Dis. - 2002. - Vol. 186. - P. 1277-1282.

470. Ciechanowski K., Kedzierska K., Golembiewska E. et al. Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes // Arch. Med. Res. - 2005. - Vol. 36. - P. 148-153.

471. Cifone M. G., Cironi L., Meccia M. A. et al. Role of nitric oxide in cell-mediated tumor cytotoxicity // Adv. Neuroimmunol. — 1995. — Vol. 5. — P. 443-461.

472. Cinaz P., Hasanoglu A., Bideci A., Biberoglu G. Plasma and erythrocyte vitamin E levels in children with insulin dependent diabetes mellitus // J. Pediatr. Endocrinol. Metab. — 1999. — Vol. 12. — P. 193-196.

473. Clark A., Wells C. A. Bulley I. D. et al. Islet amiloid, increased β-cells, reduced β-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes // Diabetes Res. — 1988. — Vol. 9. — P. 151-159.

474. Clark J. A., Cowden W. B., Hunt N. H. Free radical-induced pathology // Med. Res. Rev. — 1985. — Vol. 5. — P. 297-332.

475. Cleary J., Mohr D., Adams M. R. et al. Plasma and LDL levels of major lipophilic antioxidants are similar in patients with advanced atherosclerosis and age-matched controls // Free Radic. Res. — 1997. — Vol. 26. — P. 175-182.

476. Clement M., Bourre J. M. Alteration of α-tocopherol content in the developing and aging peripheral nervous system: Persistence of high correlations with total and specific (n-6) polyunsaturated fatty acids // J. Neurochem. — 1990. — Vol. 54. — P. 2110-2117.

477. Cluzel M. M., Damon P., Chanez J. et al. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma // J. Allergy Clin. Immunol. — 1987. — Vol. 80. — P. 195-201.

478. Cohen A. B., Rossi M., Gescy D., Knight L. Neutrophil turnover in normal rabbit lungs // J. Clin. Invest. — 1982. — Vol. 69. — P. 794-798.

479. Comhair S. A., Erzurum S. C. The regulation and role of extracellular glutathione peroxidase // Antioxid. Redox Signal. — 2005. — Vol. 7. — P. 72-79.

480. Conde M., Chiara M. D., Marquez M. G. et al. Respiratory burst is decreased by human hyperlipe- mic serum in rat peritoneal macrophages // Free Radic. Res. — 1996. — Vol. 24. — P. 107-114.

481. Conrad M., Jakupoglu C., Moreno S. G. et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function // Mol. Cell. Biol. — 2004. — Vol. 24. — P. 9414-9423.

482. Constantin A., Constantinescu E., Dumitrescu M. et al. Effects of ageing on carbonyl stress and antioxidant defense in RBCs of obese Type 2 diabetic patients // J. Cell. Mol. Med. — 2005. — Vol. 9. — P. 683-691.

483. Conti B., Sanchez-Alavez M., Winsky-Sommerer R. et al. Transgenic mice with a reduced core body temperature have an increased life span // Science. — 2006. — Vol. 314. — P. 825-828.

484. Cooke J. P., Singer A. H., Tsao P. et al. Antiatherogenic effects of L-arginine in the hyperchole- sterolemic rabbit // J. Clin. Invest. — 1992. — Vol. 90. — P. 1168-1172.

485. Cooke J. P., Tsao P. S. Cytoprotective effects of nitric oxide // Circulation. — 1993. — Vol. 88. — P. 2451-2454.

486. Cooney R. V., Harwood P. J., Franke A. A. et al. Products of γ-tocopherol reaction with NO· and their formation in rat insulinoma (RINm5F) cells // Free Radic. Biol. Med. — 1995. — Vol. 19. — P. 259-269.

487. Cooper A. M., Segal B. H., Frank A. A. et al. Transient loss of resistance to pulmonary tuberculosis in p47^phox-/- mice // Infect. Immun. — 2000. — Vol. 68. — P. 1231-1234.

488. Corbett J. A., Kwon G., Hill J. R., McDaniel M. L. Role of nitric oxide in β-cell destruction associated with the development of autoimmune diabetes // Diabetes Ann. — 1995. — Vol. 9. — P. 265-294.

489. Corbett J. A., Tilton R. G., Chang K. et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction // Diabetes. — 1992. — Vol. 41. — P. 552-556.

490. Corbett J. A., McDaniel M. L. Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase // J. Exp. Med. — 1995. — Vol. 181. — P. 559-568.

491. Corradi M., Majori M., Cacciani G. C. et al. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. // Thorax. — 1999. — Vol. 54. — P. 572-575.

492. Corradin S. B., Fasel N., Buchmuller-Rouiller Y. et al. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10 // Eur. J. Immunol. — 1993. — Vol. 23. — P. 2045-2048.

493. Coudray C., Boucher F., Pucheu S. et al. Relationship between severity of ischemia and antioxidant scavenger enzyme activities in the isolated rat heart // Int. J. Biochem. Cell Biol. — 1995. — Vol. 27. — P. 61-69.

494. Coudronniere N., Villalba M., Englund N., Altman A. NF-κΒ activation induced by T cell recep- tor/CD28 costimulation is mediated by protein kinase C-θ // Proc. Natl. Acad. Sci. USA. — 2000. — Vol. 97. — P. 3394-3399.

495. Crabtree D. V., Adler A. J. Is β-carotene an antioxidant? // Med. Hypotheses. — 1997. — Vol. 48. — P. 183-187.

496. Craig W. Y., Poulin S. E., Palomaki G. E. et al. Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects // Arterioscler. Thromb. Vasc. Biol. — 1995. — Vol. 15. — P. 733-739.

497. Crapo J. D., Barry B. E., Foscue H. A., Shelburne J. Structural and biochemical changes in rat lungs occurring during exposure to lethal and adaptive doses of oxygen // Am. Rev. Respir. Dis. — 1980. — Vol. 122. — P. 123-143.

498. Craven P. A., DeRubertis F. R., Kagan V. E. et al. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-β, and glomerular size in diabetes // J. Am. Soc. Nephrol. — 1997. — Vol. 8. — P. 1405-1414.

499. Craven P. A., Studer R. K., DeRubertis F. R. Impaired nitric oxide release by glomeruli from diabetic rats // Metabolism. — 1995. — Vol. 44. — P. 695-698.

500. Crino A., Schiaffini R., Manfrini S. et al. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX) // Eur. J. Endocrinol. — 2004. — Vol. 150. — P. 719-724.

501. Cronstein B. N., Weissmann G. Current comment — the adhesion molecules of inflammation // Arthritis Rheum. — 1993. — Vol. 36. — P. 147-157.

502. Cross C. E., Van der Vliet A., O’Neill C. A. et al. Oxidants, antioxidants, and respiratory tract lining fluids // Environ. Health Perspect. — 1994. — Vol. 102, Suppl. 10. — P. 185-191.

503. Cunha F. Q., Moncada S., Liew F. Y. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages // Biochem. Biophys. Res. Commun. — 1992. — Vol. 186. — P. 1155-1159.

504. Curran R. D., Billiar T. R., Stuehr D. J., Simmons R. L. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells // J. Exp. Med. — 1989. — Vol. 170. — P. 1796-1774.

505. Curzio M. Interaction between neutrophils and 4-hydroxyalkenals and consequences on neutrophil motility // Free Radic. Res. Commun. — 1988. — Vol. 5. — P. 55-66.

506. Curzio M., Esterbauer H., Di Mauro C. et al. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals // Biol. Chem. Hoppe-Seyler. — 1986. — Vol. 367. — P. 321-329.

507. Curzio M., Esterbauer H., Poli G. et al. Possible role of aldehydic lipid peroxidation products as chemoattractants // Int. J. Tissue React. — 1987. — Vol. 9. — P. 295-306.

508. Cushing S. D., Berliner J. A., Valente A. J. et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 5134-5138.

509. Cutler R. G. Genetic stability and oxidative stress: Common mechanisms in aging and cancer // Free Radicals and Aging. — Basel: Birkhauser Verlag, 1992. — P. 31-46.

510. Cutler R. G. Oxidative stress and aging: catalase is a longevity determinant enzyme // Rejuvenation. Res. — 2005. — Vol. 8. — P. 138-140.

511. Dalton T. P., Dieter M. Z., Yang Y. et al. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous // Biochem. Biophys. Res. Commun. — 2000. — Vol. 279. — P. 324-329.

512. Damon M., Cluzel M., Chanez P., Godard Ph. Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma // J. Biolumin. Chemilumin. — 1989. — Vol. 4. — P. 279-286.

513. Darius H., Grodzinska L., Meyer J. The effects of the nitric oxide donors moldisomine and SIN-1 on human polymorphonuclear leucocyte function invitro and exvivo // Eur. J. Clin. Pharmacol. —

1992. — Vol. 43. — P. 629-633.

514. Darley-Usmar V. M., Hogg N., Oleary V. J. et al. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein // Free Radic. Res. Commun. — 1992. — Vol. 17. — P. 9-20.

515. Darley-Usmar V. M, Stone D., Smith D., Martin J. F. Mitochondria, oxygen, and reperfusion damage // Ann. Med. — 1991. — Vol. 23. — P. 583-588.

516. Darley-Usmar V. M., Hogg N., O’Leary V. J. et al. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein // Free Radic. Res. Commun. - 1992. - Vol. 17. - P. 9-20.

517. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance // FEBS Lett. - 1995. - Vol. 369. - P. 131-135.

518. Das D. K., Engelman R. M. Mechanism of free radical generation during reperfusion of ischemic myocardium // Oxygen Radicals: Systemic Events and Disease Processes. - Basel: Karger, 1990. - P. 97-128.

519. Das D. K., Engelman R. M., Otani H et al. Effect of superoxide dismutase and catalase on myocardial energy metabolism during ischemia and reperfusion // Clin. Physiol. Biochem. - 1986. - Vol. 9. - P. 187-198.

520. Das D. K., Engelman R. M., Rousou J. A. et al. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion // Am. J. Physiol. - 1986. - Vol. 251. - P. 471-479.

521. Das K. C., Misra H. P. Lidokaine - a hydroxyl radical scavenger and singlet oxygen quencher // Mol. Cell. Biochem. - 1992. - Vol. 115. - P. 179-185.

522. Das S., Ray R., Snehlata et al. Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis // Mol. Cell. Biochem. - 2006. - Vol. 285. - P. 143-147.

523. Daugherty A., Dunn J. L., Rateri D. L., Heinecke J. W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions // J. Clin. Invest. - 1994. - Vol. 94. - P. 437-444.

524. Daugherty A., Webb N. R., Rateri D. L., King V. L. Cytokine regulation of macrophage functions in atherogenesis // J. Lipid Res. - 2005. - Vol. 46. - P. 1812-1822.

525. Daugherty A., Zweifel B. S., Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits // Br. J. Pharmacol. - 1989. - Vol. 98. - P. 612-618.

526. Daugherty A., Zweifel B. S., Schonfeld G. The effect of probucol on the progression of atherosclerosis in Watanabe heritable hyperlipidaemic rabbits // Br. J. Pharmacol. - 1991. - Vol. 103. - P. 1013-1018.

527. Davi G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus // Antioxid. Redox Signal. - 2005. - Vol. 7. - P. 256-268.

528. Davies E. V., Willidams B. D., Campbell A. K. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO- and NADPH-oxidase activity // Br. J. Rheumatol. - 1990. - Vol. 29. - P. 415-421.

529. Davis S. R., Cousins R. J. Metallothionein expression in animals: A physiological perspective on function // J. Nutr. - 2000. - Vol. 130. - P. 1085-1088.

530. De Cristofaro R., Rocca B., Vitacolonna E. et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus // J. Thromb. Haemost. - 2003. - Vol. 1. - P. 250-256.

531. DeFronzo R. A. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes // Diabetes Rev. - 1997. - Vol. 5. - P. 177-269.

532. Degenhardt T. P., Brinkmann-Frye E., Thorpe S. R., Baynes J. W. Role of carbonyl stress in aging and age-related diseases // Maillard Reaction in Foods and Medicine. - London: Royal Soc. Chem, 1998. - P. 3-10.

533. De Haan J. B., Bladier C., Griffiths P. et al. Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide // J. Biol. Chem. - 1998. - Vol. 273. - P. 2252822536.

534. De la Fuente M. Effects of antioxidants on immune system ageing // Eur. J. Clin. Nutr. - 2002. - Vol. 56, Suppl. 3. - P. S5-S8.

535. Delport R., Ubbink J. B., Human J. A. et al. Antioxidant vitamins and coronary artery disease risk in South African males // Clin. Chim. Acta. - 1998. - Vol. 278. - P. 55-60.

536. Denu J. M., Tanner K. G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation // Biochemistry. - 1998. - Vol. 37. - P. 5633-5642.

537. De Quiroga G. B. Brown fat thermogenesis and exercise: two examples of physiological oxidative stress? // Free Radic. Biol. Med. - 1992. - Vol. 13. - P. 325-340.

538. Derian C. K., Lewis D. F. Activation of15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein // Prostaglandins Leukot. Essent. Fatty Acids. - 1992. - Vol. 45. - P. 49-57.

539. De Sole P., Savi L., Cardillo C., Lippa S. Polymorphonuclear leukocyte activation in vasculopatic subjects: A chemiluminescence study // Acta Med. Rom. — 1985. — Vol. 23. — P. 170—175.

540. De Sole P. Polymorphonuclear chemiluminescence. Some clinical applications // J. Biolumin. Chemilumin. — 1989. — Vol. 4. — P. 251-262.

541. Devaraj S., Glaser N., Griffen S. et al. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes // Diabetes. — 2006. — Vol. 55. — P. 774-779.

542. Devaraj S., Jialal I. Low-density lipoprotein postsecretory modification, monocyte function and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of α-tocopherol supplementation // Circulation. — 2000. — Vol. 102. — P. 191-196.

543. Dhamrait S. S., Stephens J. W., Cooper J. A. et al. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2 // Eur. Heart J. — 2004. — Vol. 25. — P. 468-475.

544. Dianzani C., Parrini M., Ferrara C., Fantozzi R. Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils // Cell Biochem. Func. — 1996. — Vol. 14. — P. 193-200.

545. Dierckx N., Horvath G., van Gils C. et al. Oxidative stress status in patients with diabetes mellitus: relationship to diet // Eur. J. Clin. Nutr. — 2003. — Vol. 57. — P. 999-1008.

546. Di Marino L. Is the erythrocyte membrane fatty acid composition a valid index of skeletal muscle membrane fatty acid composition? // Metabolism. — 2000. — Vol. 49. — P. 1164-1166.

547. Di Mauro C., Cavalli G., Amprimo M. C. et al. Influence of 4-hydroxynonenal on chemiluminescence production by unstimulated and opsonized zymosan-stimulated human neutrophils // Cell Biochem. Funct. — 1990. — Vol. 8. — P. 147-155.

548. Ding A., Nathan C. F., Graycar J. et al. Macrophage deactivating factor and transforming growth factors-p1, β2 and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ // J. Immunol. — 1990. — Vol. 145. — P. 940-944.

549. Dinh-Xuan A. T., Higenbottam T. W., Clelland C. A. et al. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease // New Engl. J. Med. — 1991. — Vol. 324. — P. 1539-1547.

550. Donaldson K., Slight J., Bolton R. E. The effect of products from bronchoalveolar-derived neutrophils on oxidant production and phagocytic activity of alveolar macrophages // Clin. Exp. Immunol. — 1988. — Vol. 74. — P. 477-482.

551. Donati G., Pournaras C. J., Tsacopoulos M. Effect of nitroprusside on arteriolar constriction after retinal branch vein occlusion // Invest. Ophthalmol. Vis. Sci. — 1998. — Vol. 39. — P. 1910-1917.

552. Donati G., Pournaras C. J., Tsacopoulos M. Endogenous deficiency of nitric oxide is an aggravating factor in retinal vein occlusion // Klin. Monatsbl. Augenheilkd. — 1998. — Vol. 212. — P. 324-325.

553. Dorward A., Sweet S., Moorehead R., Singh G. Mitochondrial contributions to cancer cell physiology: Redox balance, cell cycle, and drug resistance // J. Bioenerg. Biomembr. — 1997. — Vol. 29. — P. 385-392.

554. Drapier J.-C., Wietzerbin J., Hibbs J. B. Jr. Interferon-γ and tumor necrosis factor induce the L-ar- ginine-dependent cytotoxic effector mechanism in murine macrophages // J. Immunol. — 1988. — Vol. 18. — P. 1587-1592.

555. Dresner A., Laurent D., Marcucci M. et al. Effects of free fatty acids on glucose transport and IRS-1- associated phosphatidylinositol 3-kinase activity // J. Clin. Invest. — 1999. — Vol. 103. — P. 253-59.

556. Drew B., Leeuwenburgh C. Aging and the role of reactive nitrogen species // Ann. N.Y. Acad. Sci. — 2002. — Vol. 959. — P. 66-81.

557. Droge W. Free radicals in the physiological control of cell function // Physiol. Rev. — 2002. — Vol. 82. — P. 47-95.

558. Du X., Matsumura T., Edelstein D. et al. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells // J. Clin. Invest. — 2003. — Vol. 112. — P. 1049-1057.

559. Duan L., Gan H., Golan D. E., Remold H. G. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis // J. Immunol. — 2002. — Vol. 169. — P. 5181-5187.

560. Duan X., Pinkerton K., Plopper C. Increase of antioxidant enzymes in target sites within the lung following long-term ozone exposure // Am. Rev. Respir. Dis. — 1993. — Vol. 147. — P. A441.

561. Duckles S. P., Krause D. N., Stirone C., Procaccio V. Estrogen and mitochondria: a new paradigm for vascular protection? // Mol. Interv. — 2006. — Vol. 6. — P. 26-35.

562. Duilio C., Ambrosio G., Kuppusamy P. et al. Neutrophils are primary source of O₂ radicals during reperfusion after prolonged myocardial ischemia // Am. J. Physiol. — 2001. — Vol. 280. — P. H2649-H2657.

563. Dunger A., Schroder D., Augstein P. et al. Impact ofmetabolic activity ofbeta cells on cytokine-induced damage and recovery of rat pancreatic islets // Acta Diabetol. — 1995. — Vol. 32. — P. 217—224.

564. Durrbaum-Laudmann J., Gercken J., Flad H. D., Ernst M. Effect of in vitro infection of human monocyte with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis // Infect. Immun. — 1996. — Vol. 64. — P. 5384-5389.

565. Dushkin M. I., Zenkov N. K., Menshikova E. B. et al. Ketoconazole inhibits oxidative modification oflow density lipoprotein // Atherosclerosis. — 1995. — Vol. 114. — P. 9-18.

566. Dussurget O., Stewart G., Neyrolles O. et al. Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase // Infect. Immun. — 2001. — Vol. 69. — P. 529-533.

567. Duval D. L., Miller D. R., Collier J., Billings R. E. Characterization of hepatic nitric oxide synthase: Identification as the cytokine-inducible form primarily regulated by oxidants // Mol. Pharmacol. — 1996. — Vol. 50. — P. 277-284.

568. Dwenger A., Regel G., Schweitzer G. et al. Cellular and humoral reactions of the nonspecific immune system of polytraumatized patients with and without the adult respiratory distress syndrome // Immune Consequences of Trauma, Shock and Sepsis. — Berlin: Springer-Verlag, 1989. — P. 241-246.

569. Eddy L. J., Stewart J. R., Jones H. P. et al. Free-radical producing enzyme, xanthine oxidase, is undetectable in human hearts // Am. J. Physiol. — 1987. — Vol. 253. — P. H709-H711.

570. Edwards S. W., Hallett M. B., Campbell A. K. Oxygen-radical production during inflammation may be limited by oxygen concentration // Biochem. J. — 1984. — Vol. 217. — P. 851-854.

571. Ehrenwald E., Chisolm G. M., Fox P. L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein // J. Clin. Invest. — 1994. — Vol. 93. — P. 1493-1501.

572. Eisenberg S., Sehayek E., Olivecrona T., Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix // J. Clin. Invest. — 1992. — Vol. 90. — P. 2013-2021.

573. Eizirik D. L., Cagliero E., Bjorklund A., Welsh N. Interleukin-1p induces the expression of an isoform of nitric oxide synthase in insulin-producing cells, which is similar to that observed in activated macrophages // FEBS Lett. — 1992. — Vol. 308. — P. 249-252.

574. Elchuri S., Oberley T. D., Qi W. et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life // Oncogene. — 2005. — Vol. 24. — P. 367-380.

575. El-Demerdash F. M., Yousef M. I., El-Naga N. I. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats // Food Chem. Toxicol. — 2005. — Vol. 43. — P. 57-63.

576. Elliott R. B., Chase H. P. Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide // Diabetologia. — 1991. — Vol. 34. — P. 362-365.

577. Emerit I., Fabiani J. N., Levy A. et al. Plasma from patient exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes // Free Radic. Biol. Med. — 1995. — Vol. 19. — P. 405-415.

578. Engler R., Gilpin E. Can superoxide dismutase alter infarct size? // Circulation. — 1989. — Vol. 79. — P. 277-285.

579. Engstrom P., Easterling L., Baker R., Matalon S. Mechanisms of extracellular hydrogen peroxide clearance by alveolar type II pneumocytes // J. Appl. Physiol. — 1990. — Vol. 69. — P. 2078-2084.

580. Erdei N., Bagi Z., Edes I. et al. H₂O₂ increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice // Am. J. Physiol. Heart Circ. Physiol. — 2007. — Vol. 292. — P. H649-H656.

581. Erickson J. C., Hollopeter G., Thomas S. A. et al. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures // J. Neurosci. — 1997. — Vol. 17. — P. 1271-1281.

582. Essman W. B., Wollman S. B. Free radicals, central nervous system processes and brain functions // Oxygen Radicals: Systemic Events and Disease Processes. — Basel: Karger, 1990. — P. 172-192.

583. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products // Am. J. Clin. Nutr. —

1993. — Vol. 57, Suppl. — P. 779S—786S.

584. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL // Free Radic. Biol. Med. — 1992. — Vol. 13. — P. 341-390.

585. Esterbauer H., Jurgens G. Mechanistic and genetic aspects of susceptibility of LDL to oxidation // Curr. Opin. Lipidol. — 1993. — Vol. 4. — P. 114-124.

586. Esterbauer H., Puhl H., Dieberrotheneder M. et al. Effect of antioxidants on oxidative modification of LDL // Ann. Med. — 1991. — Vol. 23. — P. 573-581.

587. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malon- aldehyde and related aldehydes // Free Radic. Biol. Med. — 1991. — Vol. 11. — P. 81—128.

588. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein // Free Radic. Res. Commun. — 1989. — Vol. 6. — P. 67—75.

589. Esterbauer H., Wag G., Puhl H. Lipid peroxidation and its role in atherosclerosis // Br. Med. Bull. — 1993. — Vol. 49. — P. 566-576.

590. Esterline R., Trush M. A. Lucigenin chemiluminescence and its relationship to mitochondrial respiration in phagocytic cells // Biochem. Biophys. Res. Commun. — 1989. — Vol. 159. — P. 584

591.

591. Esworthy R. S., Aranda R., Martin M. G. et al. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis // Am. J. Physiol. Gastrointest. Liver Physiol. — 2001. — Vol. 281. — P. G848- G855.

592. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes // Endocr. Rev. — 2002. — Vol. 23. — P. 599-622.

593. Farrell A. J., Blake D. R., Palmer R. M. J., Moncada S. Elevated synovial and serum nitrite suggest increased nitric oxide synthesis in rheumatic diseases // Ann. Rheum. Dis. — 1992. — Vol. 51. — P. 1219-1222.

594. Farvid M. S., Jalali M., Siassi F., Hosseini M. Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes // Diabetes Care. — 2005. — Vol. 28. — P. 2458-2464.

595. Federici M., Hribal M., Perego L. et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program // Diabetes. — 2001. — Vol. 50. — P. 1290-1301.

596. Fedyk E. R., Phipps R. P. Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation // Int. J. Immunopharmacol. — 1994. — Vol. 16. — P. 533-546.

597. Feinmark S. J., Cornicelli J. A. Is there a role for 15-lipoxygenase in atherogenesis? // Biochem. Pharmacol. — 1997. — Vol. 54. — P. 953-959.

598. Fels A. O. S., Cohn Z. A. The alveolar macrophage // J. Appl. Physiol. — 1986. — Vol. 60. — P. 353-369.

599. Feng J., Han J., Pearce S. F. et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ // J. Lipid. Res. — 2000. — Vol. 41. — P. 688-696.

600. Fernandes A. C., Filipe P. M., Manso C. F. pH Dependence of lipid peroxidation and albumin oxidative modification: possible implications to the pH paradox // Redox Rep. — 1995. — Vol. 1. — P. 139-144.

601. Ferrante A. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors // Immunol. Ser. — 1992. — Vol. 57. — P. 417-436.

602. Ferret P. J., Soum E., Negre O., Fradelizi D. Auto-protective redox buffering systems in stimulated macrophages // BMC Immunol. — 2002. — Vol. 3. — P. 1-13.

603. Ferretti G., Bacchetti T., Busni D. et al. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 2957-2962.

604. Firmani M. A., Riley L. W. Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro // Infect. Immun. — 2002. — Vol. 70. — P. 3965-3968.

605. Firmani M. A., Riley L. W. Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro // J. Clin. Microbiol. — 2002. — Vol. 40. — P. 3162-3166.

606. Firoozrai M., Nourbakhsh M., Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes // Diabetes Res. Clin. Pract. — 2007. — Vol. 77. — P. 427-432.

607. Flaherty J. T. Myocardial injury mediated by oxygen free radicals // Am. J. Med. — 1991. — Vol. 91. — P. 79-85.

608. Fleming R. E., Whitman I. P., Gitlin J. D. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia // Am. J. Physiol. — 1991. — Vol. 260. — P. L68-L74.

609. Fliss H., Menard M., Desai M. Hypochlorous acid mobilizes cellular zinc // Can. J. Physiol. Pharmacol. — 1991. — Vol. 69. — P. 1686-1691.

610. Floyd R. A. Role of oxygen free radicals in carcinogenesis and brain ischemia // FASEB J. — 1990. — Vol. 4. — P. 2587-2597.

611. Floyd R. A. Antioxidants, oxidative stress, and degenerative neurological disorders // Proc. Soc. Exp. Biol. Med. - 1999. - Vol. 222. - P. 236-245.

612. Folcik V. A., Aamir R., Cathcart M. K. Cytokine modulation of LDL oxidation by activated human monocytes // Arterioscler. Thromb. Vasc. Biol. — 1997. — Vol. 17. — P. 1954-1961.

613. Folcik V. A., Cathcart M. K. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation // J. Lipid Res. — 1993. — Vol. 34. — P. 69-79.

614. Forman H. J. Oxidant radical production and lung injury // Oxygen Radicals: Systemic Events and Disease Processes. — Basel: Karger, 1990. — P. 71-96.

615. Forslid J., Bjorksten B., Hagersten K., Hed J. Erythrocyte-mediated scavenging of reactive oxygen metabolites generated by human polymorphonuclear leukocytes during phagocytosis: Comparison between normal and Down’s syndrome blood cells // Inflammation. — 1989. — Vol. 13. — P. 543-551.

616. Fox R. B. Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea // J. Clin. Invest. — 1984. — Vol. 74. — P. 1456-1464.

617. Francia P., delli Gatti C., Bachschmid M. et al. Deletion of p66^Shc gene protects against age-related endothelial dysfunction // Circulation. — 2004. — Vol. 110. — P. 2889-2895.

618. Frank S., Zacharowski K., Wray G. M. et al. Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats // FASEB J. — 1999. — Vol. 13. — P. 869-882.

619. Fratazzi C., Arbeit R. D., Carini C. et al. Macrophage apoptosis in mycobacterial infections // J. Leukoc. Biol. — 1999. — Vol. 66. — P. 763-764.

620. Frayn K. N. Insulin resistance and lipid metabolism // Curr. Opin. Lipidol. — 1993. — Vol. 4. — P. 197-204.

621. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage // Am. J. Clin. Nutr. — 1991. — Vol. 54. — P. S1113-S1118.

622. Friebe A., Mergia E., Dangel O. et al. Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase // Proc. Natl. Acad. Sci. USA. — 2007. — Vol. 104. — P. 7699-7704.

623. Friedman C. R., Quinn G. C., Kreiswirth B. N. et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis // J. Infect. Dis. — 1997. — Vol. 176. — P. 478-484.

624. Froguel P., Velho G. Genetic determinants oftype 2 diabetes // Recent Prog. Horm. Res. — 2001. — Vol. 56. — P. 91-105.

625. Fruebis J., Steinberg D., Dresel H. A., Carew T. E. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits // J. Clin. Invest. — 1994. — Vol. 94. — P. 392-398.

626. Fuhrman B., Oiknine J., Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties // Atherosclerosis. — 1994. — Vol. 111. — P. 65-78.

627. Fukuda T., Ito H., Yoshida T. Effect of walnut polyphenol fraction on oxidative stress in type 2 diabetes mice // Biofactors. — 2004. — Vol. 21. — P. 251-253.

628. Fujimoto S., Kawakami N., Ohara A. Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production // Biol. Pharm. Bull. — 1995. — Vol. 3. — P. 396-400.

629. Fukai T., Galis Z. S., Meng X. P. et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis // J. Clin. Invest. — 1998. — Vol. 101. — P. 2101-2111.

630. Fukuda H., Sawa Y., Kadoba K. et al. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury // Circulation. — 1995. — Vol. 92. — P. 413-416.

631. Fuller C. J., Chandalia M., Garg A. et al. RRR-a-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus // Am. J. Clin. Nutr. — 1996. — Vol. 63. — P. 753-759.

632. Gaboury J. P., Niu X. F., Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation // Circulation. — 1996. — Vol. 93. — P. 318-326.

633. Gaede P., Poulsen H. E., Parving H. H., Pedersen O. Double-blind, randomized study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients // Diabet. Med. — 2001. — Vol. 18. — P. 756-760.

634. Gale E. A. M. Molecular mechanisms of β-cell destruction in IDDM: the role of nicotinamide // Horm. Res. — 1996. — Vol. 45, Suppl. 1. — P. 40-43.

635. Gale E. A. M., Bingley P. J., Emmett C. L., Collier T. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes // Lancet. - 2004. - Vol. 363. - P. 925-931.

636. Galeotti T., Borrello S., Masotti L. Oxy-radical sources, scavenger systems and membrane damage in cancer cells // Oxygen Radicals: Systemic Events and Disease Processes. — Basel: Karger, 1990. — P. 129-148.

637. Galeotti T., Masotti L., Borrello S., Casali E. Oxy-radical metabolism and control of tumour growth // Xenobiotica. — 1991. — Vol. 21. — P. 1041-1051.

638. Galinanes M., Ferrari R., Qiu Y. M. et al. PEG-SOD and myocardial antioxidant status during ischaemia and reperfusion — Dose-response studies in the isolated blood perfused rabbit heart // J. Mol. Cell. Cardiol. — 1992. — Vol. 24. — P. 1021-1030.

639. Galle J., Schneider R., Heinloth A. et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress // Kidney Int. — 1999. — Vol. 55. — P. 1450-1461.

640. Gardemann A., Mages P., Katz N. et al. The p22^phox gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals // Atherosclerosis. — 1999. — Vol. — 145. — P. 315-323.

641. Garner B., Jessup W. Cell-mediated oxidation oflow-density lipoprotein: the elusive mechanism(s) // Redox Rep. — 1996. — Vol. 2. — P. 97-104.

642. Garthwaite J. Glutamate, nitric oxide, and cell-cell signalling in the nervous system // Trends Neu- rosci. — 1991. — Vol. 14. — P. 60-67.

643. Gasale A. S., Bulkley G. B., Bulkley B. H. et al. Oxygen free-radical scavengers protect the arrested, globally ischemic heart upon reperfusion // Surg. Forum. — 1983. — Vol. 34. — P. 313-318.

644. Gazis A., White D. J., Page S. R., Cockcroft J. R. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus // Diabet Med. — 1999. — Vol. 16. — P. 304-311.

645. Geertsma M. F., Broos H. R., Van den Barselaar M. T. et al. Lung surfactant suppresses oxygen-dependent bactericidal functions ofhuman blood monocytes by inhibiting the assembly of the NADPH oxidase // J. Immunol. — 1993. — Vol. 150. — P. 2391-2400.

646. Geffner J. R., Giordano M., Palermo M. S. et al. Neutrophil-mediated cytotoxicity triggered by immune complexes: the role ofreactive oxygen metabolites // Clin. Exp. Immunol. — 1987. — Vol. 69. — P. 668-675.

647. Geiszt M., Leto T. L. The Nox family of NAD(P)H oxidases: Host defense and beyond // J. Biol. Chem. — 2004. — Vol. 279. — P. 51715-51718.

648. Geller D. A., Di Silvio M., Nussler A. K. et al. Nitric oxide synthase expression is induced in hepa- tocytes in vivo during hepatic inflammation // J. Surg. Res. — 1993. — Vol. 55. — P. 427-432.

649. Geng Y. J., Hansson G. K. Interferon-γ inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages // J. Clin. Invest. — 1992. — Vol. 89. — P. 1322-1330.

650. Genova M. L., Pich M. M., Bernacchia A. et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology // Ann. N. Y. Acad. Sci. — 2004. — Vol. 1011. — P. 86-100.

651. Gerlach H., Rossaint R., Pappert D., Falke K. J. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome // Eur. J. Clin. Invest. — 1993. — Vol. 20. — P. 499-505.

652. Gey K. F., Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology // Ann. N. Y. Acad. Sci. — 1989. — Vol. 570. — P. 268282.

653. Gey K. F., Puska P., Jordan P., Moser U. K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology // Am. J. Clin. Nutr. — 1991. — Vol. 53. — P. 326S—334S.

654. Gey K. F., Stahelin H. B., Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study // Clin. Invest. — 1993. — Vol. 71. — P. 3-6.

655. Ghiselli G., Giorgini L., Gelati M., Musanti R. Oxidatively modified HDLs are potent inhibitors of cholesterol biosynthesis in human skin fibroblasts // Arterioscler. Thromb. — 1992. — Vol. 8. — P. 929-935.

656. Giardina B., Penco M., Lazzarino G. et al. Effectiveness of thrombolysis is associated with a time- dependent increase of malondialdehyde in peripheral blood of patients with acute myocardial infarction // Am. J. Cardiol. — 1993. — Vol. 71. — P. 788-793.

657. Gille G., Sigler K. Oxidative stress and living cells // Folia Microbiol. — 1995. — Vol. 40. — P. 131-152.

658. Ginsburg I., Kohen R. Cell damage in inflammatory and infectious sites might involve a coordinated «cross-talk» among oxidants, microbial haemolysins and amphyphiles, cationic proteins, phospholipases, fatty acids, proteinases and cytokines // Free Radic. Res. — 1995. — Vol. 22. — P. 489-517.

659. Ginsburg I., Kohen R. Synergistic effects among oxidants, membrane-damaging agents, fatty acids, proteinases and xenobiotics: Killing of epithelial cells and the release of arachidonic acid // Inflammation. — 1994. — Vol. 19. — P. 101-118.

660. Ginsburg I., Misgav R., Pinson A. et al. Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, proteinases and cytokines // Inflammation. — 1992. — Vol. 16. — P. 519-538.

661. Ginsburg I., Varani J. Interaction of viable group A streptococci and hydrogen peroxide in killing of vascular endothelial cells // Free Radic. Biol. Med. — 1993. — Vol. 14. — P. 495-500.

662. Giorgio M., Trinei M., Migliaccio E., Pelicci P. G. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? // Nat. Rev. Mol. Cell Biol. — 2007. — Vol. 8. — P. 722-728.

663. Gisinger C., Jeremy J., Speiser P. et al. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial // Diabetes. — 1988. — Vol. 37. — P. 1260-1264.

664. Glatz J. F. C., Paulssen R. J. A., Veerkamp J. H. Fatty acid binding protein from heart // Chem. Phys. Lipids. — 1985. — Vol. 38. — P. 115-129.

665. Gloire G., Legrand-Poels S., Piette J. NF-κΒ activation by reactive oxygen species: Fifteen years later // Biochem. Pharmacol. — 2006. — Vol. 72. — P. 1493-1505.

666. Go Y. M., Halvey P. J., Hansen J. M. et al. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion // Am. J. Pathol. — 2007. — Vol. 171. — P. 1670-1681.

667. Goldmann O., Kockritz-Blickwede M. V., Holtje C. et al. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program // Infect. Immun. — 2007. — Vol. 75. — P. 4148-4157.

668. Goldstein B. J. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity, and related states of insulin resistance // Curr. Drug Targets. — 2001. — Vol. 1. — P. 265-275.

669. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition // Proc. Natl. Acad. Sci. USA. — 1979. — Vol. 76. — P. 333-337.

670. Gomes M. S., Florido M., Pais T. F., Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene // J. Immunol. — 1999. — Vol. 162. — P. 6734-6739.

671. Gong J., Chen S. S. Polyphenolic antioxidants inhibit peptide presentation by antigen-presenting cells // Int. Immunopharmacol. — 2003. — Vol. 3. — P. 1841-1852.

672. Gonzalez-Correa J. A., Arrebola M. M., Guerrero A. et al. Antioxidant and antiplatelet effects ofthe alpha-tocopherol-aspirin combination in type 1-like diabetic rats // Life Sci. — 2006. — Vol. 79. — P. 1405-1412.

673. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis // Semin. Arthritis Rheum. — 2005. — Vol. 35. — P. 8-17.

674. Gordon S. Alternative activation of macrophages // Nat. Rev. Immunol. — 2003. — Vol. 3. — P. 23-35.

675. Gorogawa S., Kajimoto Y., Umayahara Y. et al. Probucol preserves pancreanic β-cell function through reduction of oxidative stress in type 2 diabetes // Diab. Res. Clin. Pract. — 2002. — Vol. 57. — P. 1-10.

676. Gote G., Tardif J.-C., Lesperance J. et al. Effect of probucol on vascular remodeling after coronary angioplasty // Circulation. — 1999. — Vol. 99. — P. 30-35.

677. Goth L. Reactive oxygen species, hydrogen peroxide, catalase and diabetes mellitus // Redox Rep. — 2006. — Vol. 11. — P. 281-282.

678. Gratchev A., Kzhyshkowska J., Utikal J., Goerdt S. Interleukin-4 and dexamethasone counterregu- late extracellular matrix remodelling and phagocytosis in type-2 macrophages // Scand. J. Immunol. — 2005. — Vol. 61. — P. 10-17.

679. Graham A., Hogg N., Kalyanaraman B. et al. Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor // FEBS Lett. — 1993. — Vol. 330. — P. 181-185.

680. Graham A., Wood J. L., Oleary V. J., Stone D. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism // Free Radic. Res. — 1994. — Vol. 21. — P. 295—308.

681. Grankvist K., Marklund S., Taljedal I. B. Superoxide dismutase is a prophylactic against alloxan diabetes // Nature. — 1981. — Vol. 294. — P. 158-160.

682. Green R. M., Seth A., Connell N. D. A peptide permease mutant of Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-nitrosoglutathione // Infect. Immun. — 2000. — Vol. 68. — P. 429-436.

683. Greening A. P., Lowric D. B. Extracellular release of hydrogen peroxide by human alveolar macrophages: The relationship to cigarette smoking and lower respiratory tract infections // Clin. Sci. — 1983. — Vol. 65. — P. 661-664.

684. Greenspan P., Ryu B. H. Mao F. W., Gutman R. L. Association of negatively-charged phospholipids with low-density lipoprotein increases its uptake and the deposition of cholesteryl esters by macrophages // Biochim. Biophys. Acta. (Lipid Metab.). — 1995. — Vol. 1257. — P. 257-264.

685. Greenwald R. A. Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment // Semin. Arthritis Rheum. — 1991. — Vol. 20. — P. 219-240.

686. Greenwald R. A., Moak S. A. Degradation of gyaluronic acid by polymorphonuclear leukocytes // Inflammation. — 1986. — Vol. 10. — P. 15-30.

687. Griffiths H. R. ROS as signalling molecules in T cells — evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis // Redox Rep. — 2005. — Vol. 10. — P. 273-280.

688. Grill H. P., Zweier J. L., Kuppusamy P. et al. Direct measurement of myocardial free radical generation in an in vivo model — Effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase // J. Am. Coll. Cardiol. — 1992. — Vol. 20. — P. 1604-1611.

689. Grisham M. B., Von Ritter C., Smith B. F. et al. Interaction between oxygen radicals and gastric mucin // Am. J. Physiol. — 1987. — Vol. 253. — P. G. 93-96.

690. Gromadzinska J., Sklodowska M., Wolkanin P. et al. Lipid peroxide levels and antioxidant enzyme activities in blood ofbreast cancer patients // J. Clin. Biochem. Nutr. — 1992. — Vol. 13. — P. 127-135.

691. Grootveld M., Halliwell B. Measurement of allantoin and uric acid in human body fluids // Bio- chem. J. — 1987. — Vol. 243. — P. 803-808.

692. Grum C. M., Gallagher K. P., Kirsh M. M., Shlafer M. Absence of detectable xanthine oxidase in human myocardium // J. Mol. Cell. Cardiol. — 1989. — Vol. 21. — P. 263-267.

693. Grundy S. M. Metabolic complications of obesity // Endocrine. — 2000. — Vol. 13. — P. 155-165.

694. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial // Lancet. — 1999. — Vol. 354. — P. 447-455.

695. Guarnieri C., Muscari C., Venture C., Mavelli I. Effect of ischemia on heart submitochondrial superoxide production // Free Radic. Res. Commun. — 1985. — Vol. 1. — P. 123-128.

696. Guo Z., Xia Z., Jiang J., McNeill J. H. Down-regulation of NADPH oxidase, antioxidant enzymes and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetylcyste- ine // Am. J. Physiol. Heart Circ. Physiol. — 2007. — Vol. 292. — P. H1728-H1736.

697. Gupta J. W., Kubin M., Hartman L. et al. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and gamma-interferon // Cancer Res. — 1992. — Vol. 52. — P. 2530-2537.

698. Gutteridge J. M. C. Antioxidant properties of caeruloplasmin towards iron- and copper-dependent oxygen radical formation // FEBS Lett. — 1983. — Vol. 157. — P. 37-40.

699. Gutteridge J. M. C. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides // FEBS Lett. — 1986. — Vol. 201. — P. 291-295.

700. Guzik T. J., Korbut R., Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation // J. Physiol. Pharmacol. — 2003. — Vol. 54. — P. 469-487.

701. Haglund U., Gerdin B. Oxygen-free radicals (OFR) and circulatory shock // Circ. Shock. — 1991. — Vol. 34. — P. 405-411.

702. Halim E. M. Lowering of blood sugar by water extract of Azadirachta indica and Abroma augusta in diabetes rats // Indian J. Exp. Biol. — 2003. — Vol. 41. — P. 636-640.

703. Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants // Am. J. Clin. Nutr. — 1995. — Vol. 61, Suppl. — P. 670S—677S.

704. Halliwell B. Reactive oxygen species in living systems — Source, biochemistry, and role in human disease // Am. J. Med. — 1991. — Vol. 91, Suppl. 3C. — P. S14-S22.

705. Halliwell B. Superoxide, iron, vascular endothelium and reperfusion injury // Free Radic. Res. Commun.— 1989. — Vol. 5. — P. 315-318.

706. Halliwell B., Grootveld M. The measurement of free radical reactions in humans: Some thoughts for future experimentation // FEBS Lett. — 1987. — Vol. 213. — P. 9—14.

707. Halliwell B., Wasil M., Grootveld M. Biologically significant scavenging ofthe myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid // FEBS Lett. — 1987. — Vol. 213. — P. 15—18.

708. Hamilton M. L., Van Remmen H., Drake J. A. et al. Does oxidative damage to DNA increase with age? // Proc. Natl. Acad. Sci. USA. — 2001. — Vol. 98. — P. 10469-10474.

709. Hammann K. P., Corradini C., Dillmann U. et al. Correlation of chemiluminescence activity of peripheral blood monocytes with CSF parameters of inflammation and the clinical course of patients with lymphocytic meningoencephalitis // Acta Neurol. Scand. — 1985. — Vol. 72. — P. 198-203.

710. Hammerschmidt D. E. Activation of the complement system and of granulocytes in lung injury: the adult respiratory distress syndrome // Adv. Inflamm. Res. — 1983. — Vol. 5. — P. 147-172.

711. Hammerschmidt D. E., Jacob H. S. The stimulated granulocyte as a source of toxic oxygen compounds in tissue injury // Pathology of Oxygen. — L.: Acad. Press, 1982. — P. 59-73.

712. Hao J. S., Shan B. E. Immune enhancement and anti-tumour activity of IL-23 // Cancer. Immunol. Immunother. — 2006. — Vol. 55. — P. 1426-1431.

713. Harada R. N., Limm W., Piette L. H., McNamara J. J. Failure of mannitol to reduce myocardial infarct size in the baboon // Cardiovasc. Res. — 1992. — Vol. 26. — P. 893-896.

714. Haramaki N., Stewart D. B., Aggarwal S. et al. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion // Free Radic. Biol. Med. — 1998. — Vol. 25. — P. 329-339.

715. Harel S., Salan M. A., Kanner J. Iron release from metmyoglobin, methaemoglobin and cytochrome c by a system generating hydrogen peroxide // Free Radic. Res. Commun. — 1988. — Vol. 5. — P. 11-19.

716. Harman D. Aging: a theory based on free radical and radiation chemistry // J. Gerontol. — 1956. — Vol. 11. — P. 298-300.

717. Harman D. Aging: Minimizing free radical damage // J. Anti-Aging Med. — 1999. — Vol. 2. — P. 15-36.

718. Harman D. Aging: Prospects for further increases in the functional life span // Age. — 1994. — Vol. 17. — P. 119-146.

719. Harman D. Free radical theory of aging: Beneficial efects of adding antioxidants to the maternal mouse diet on the life span of offspring; possible explanation of the sex difference in longevity // Age. — 1979. — Vol. 2. — P. 109-122.

720. Harman D. The biological clock: The mitochondria? // J. Amer. Geriatrics Soc. — 1972. — Vol. 20. — P. 145-147.

721. Harmon J. S., Gleason C. E., Tanaka Y. et al. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats // Diabetes. — 2001. — Vol. 50. — P. 2481-2486.

722. Harmon J. S., Gleason C. E., Tanaka Y. et al. In vivo prevention of hyperglycemia also prevents glu- cotoxic effects on PDX-1 and insulin gene expression // Diabetes. — 1999. — Vol. 48. — P. 19952000.

723. Harris L. R., Cake M. H., Macey D. J. Iron release from ferritin and its sensitivity to superoxide ions differs among vertebrates // Biochem. J. — 1994. — Vol. 301. — P. 385-389.

724. Harrison D. Cellular and molecular mechanisms of endothelial cell dysfunction // J. Clin. Invest. — 1997. — Vol. 100. — P. 2153-2157.

725. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? // Free Radic. Biol. Med. — 2002. — Vol. 33. — P. 774-797.

726. Harrison R., Benboubetra M., Bryson S. et al. Antibodies to xanthine oxidase: Elevated levels in patients with acute myocardial infarction // Cardioscience. — 1990. — Vol. 1. — P. 183-190.

727. Harth G., Horwitz M. A. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria // J. Biol. Chem. — 1999. — Vol. 274. — P. 4281-4292.

728. Hata Y., Rook S. L., Aiello L. P. Basic fibroblast growth factor induces expression ofVEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway // Diabetes. — 1999. — Vol. 48. — P. 1145-1155.

729. Hayashi К., Noguchi N., Niki E. Action of nitric oxide as an antioxidant against oxidation of soybean phosphatidylcholine liposomal membrane // FEBS Lett. — 1995. — Vol. 370. — P. 37-40.

730. Hazell L. J., Arnold L., Flowers D. et al. Presence of hypochlorite-modified proteins in human atherosclerotic lesions // J. Clin. Invest. — 1996. — Vol. 97. — P. 1535-1544.

731. Hazell L. J., Vandenberg J. J. M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation // Biochem. J. - 1994. - Vol. 302. - P. 297-304.

732. Hazen S. L., Heinecke J. W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic in- tima // J. Clin. Invest. - 1997. - Vol. 99. - P. 2075-2081.

733. He J., Qiu Y., Yan Y., Niu Y. Relationship between changes of phospholipid and lipid peroxide of erythrocyte membrane and diabetic retinopathy // Zhonghua Yan Ke Za Zhi. - 1998. - Vol. 34. - P. 202-204.

734. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial // Lancet. - 2002. - Vol. 360. - P. 23-33.

735. Heasman S. J., Giles K. M., Ward C. et al. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation // J. Endocrinol. - 2003. - Vol. 178. - P. 29-36.

736. Heberer M., Ernst M., Durig M. et al. Measurement of chemiluminescence in freshly drawn human blood // Klin. Wochenschr. - 1982. - Vol. 60. - P. 1443-1448.

737. Heemskerk J. W. M., Sage S. O. Calcium signalling in platelets and other cells // Platelets. -

1994. - Vol. 5. - P. 295-316.

738. Heinecke J. W. Free radical modification of low-density lipoprotein: Mechanism and biological consequences // Free Radic. Biol. Med. - 1987. - Vol. 3. - P. 65-73.

739. Heinecke J. W. Superoxide-mediated oxidation of low density lipoprotein by thiols // Oxy-Radicals in Molecular Biology and Pathology. - N.Y.: Liss, 1988. - P. 443-457.

740. Heinecke J. W., Kawamura M., Suzuki L., Chait A. Oxidation of low-density lipoprotein by thiols: superoxide-dependent and independent mechanisms // J. Lipid Res. - 1993. - Vol. 34. - P. 2051-2061.

741. Heinecke J. W., Li W., Mueller D. M. et al. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes // Biochemistry. - 1994. - Vol. 33. - P. 10127-10136.

742. Heinecke J. W., Rozen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture // J. Clin. Invest. - 1984. - Vol. 4. - P. 1890-1894.

743. Hemalatha S., Wahi A. K., Singh P. N., Chansouria J. P. Hypoglycemic activity of Withania co- agulans Dunal in streptozotocin induced diabetic rats // J. Ethnopharmacol. - 2004. - Vol. 93. - P. 261-264.

744. Hempel A., Maasch C., Heintze U. et al. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C-α // Circ. Res. - 1997. - Vol. 81. - P. 363-371.

745. Hennig B., Chow C. K. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Review // Free Radic. Biol. Med. - 1988. - Vol. 4. - P. 99-105.

746. Hennig B., Meerarani P., Ramadass P. et al. Fatty acid-mediated activation of vascular endothelial cells // Metabolism. - 2000. - Vol. 49. - P. 1006-1013.

747. Henriksen E. J., Holloszy J. O. Effects of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle // Am. J. Physiol. - 1990. - Vol. 258. - P. C648-C653.

748. Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation oflow density lipoprotein previously incubated with cultured endothelial cells-recognition by receptors for acetylated low density lipoproteins // Proc. Natl. Acad. Sci. USA. - 1981. - Vol. 78. - P. 6499-6503.

749. Henry T. D., Archer S. L., Nelson D. et al. Enhanced chemiluminescence as a measure of oxygen- derived free radical generation during ischemia and reperfusion // Circ. Res. - 1990. - Vol. 67. - P. 1453-1461.

750. Hesse M., Modolell M., La Flamme A. C. et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism // J. Immunol. - 2001. - Vol. 167. - P. 6533-6544.

751. Hessler J. R., Morel D. W., Lewis L. J., Chisolm G. M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity // Arteriosclerosis. - 1983. - Vol. 3. - P. 215-222.

752. Heym B., Alzari P. M., Honore N., Cole S. T. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis // Mol. Microbiol. -

1995. - Vol. 15. - P. 235-245.

753. Hibbs Jr. J. B. Cytokine induced synthesis of nitric oxide from L-arginine: a cytotoxic mechanism that targets intracellular iron // Iron in Central Nervous System Disorders. — Vienna: Springer- Verlag, 1993. — P. 155-171.

754. Hibbs Jr. J. B., Westenfelder C., Taintor R. R. et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy // J. Clin. Invest. — 1992. — Vol. 89. — P. 867-877.

755. Hicks M., Delbridge L., Yue D. K. et al. Increase in crosslinking of nonenzymatically glycosylated collagen induced by products of lipid peroxidation // Arch. Biochem. Biophys. — 1989. — Vol. 268. — P. 249-254.

756. Hillas P. J., del Alba F. S., Oyarzaba J. et al. The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis // J. Biol. Chem. — 2000. — Vol. 275. — P. 18801-18809.

757. Hiltunen T., Luoma J., Nikkari T., Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions // Circulation. — 1995. — Vol. 92. — P. 3297-3303.

758. Hiramatsu K., Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes // Diabetes. — 1988. — Vol. 37. — P. 832-837.

759. Ho Y. K., Brown M. S., Goldstein J. L. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: Stimulation by high density lipoprotein and other agents // J. Lipid. Res. — 1980. — Vol. 21. — P. 391-398.

760. Ho Y. S., Magnenat J. L., Bronson R. T. et al. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia // J. Biol. Chem. — 1997. — Vol. 272. — P. 16644-16651.

761. Ho Y. S., Vincent R., Dey M. S. et al. Transgenic models for the study of lung antioxidant defense: enhanced manganese containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia // Am. J. Respir. Cell Mol. Biol. — 1998. — Vol. 18. — P. 538-547.

762. Ho Y. S., Xiong Y., Ma W. et al. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury // J. Biol. Chem. — 2004. — Vol. 279. — P. 32804-32812.

763. Hodgkinson A. D., Bartlett T., Oates P. J. et al. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy // Diabetes. — 2003. — Vol. 52. — P.846-851.

764. Hodgson J. M., Watts G. F., Playford D. A. et al. Coenzyme Q₁₀ improves blood pressure and gly- caemic control: a controlled trial in subjects with type 2 diabetes // Eur. J. Clin. Nutr. — 2002. — Vol. 56. — P. 1137-1142.

765. Hodis H. N., Mack W. J., Labree L. et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression ofcoronary artery atherosclerosis // JAMA. — 1995. — Vol. 273. — P. 1849-1854.

766. Hoff H. F., O’Neil J. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages // Atherosclerosis. — 1988. — V. 70. — P. 29-41.

767. Hoffmeyer M. R., Jones S. P., Ross C. R. et al. Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice // Circ. Res. — 2000. — Vol. 87. — P. 812-817.

768. Hofmann M. A., Schiekofer S., Isermann B. et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB // Diabetologia. — 1999. — Vol. 42. — P. 222-232.

769. Hofmann M. A., Schiekofer S., Kanitz M. et al. Insuflicient glycemic control increases nuclear factor-KB binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes // Diabetes Care. — 1998. — Vol. 21. — P. 1310-1316.

770. Hogg N., Darley-Usmar V. M., Wilson M. T., Moncada S. The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide // FEBS Lett. — 1993. — Vol. 326. — P. 199-203.

771. Hogg N., Kalyanaraman B., Joseph J. et al. Inhibition oflow-density lipoprotein oxidation by nitric oxide: Potential role in atherogenesis // FEBS Lett. — 1993. — Vol. 334. — P. 170-174.

772. Holvoet P. Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis // FASEB J. — 1994. — Vol. 8. — P. 1279-1284.

773. Hoorens A., Pipeleers D. Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis // Diabetologia. — 1999. — Vol. 42. — P. 55-59.

774. Hotta N. New approaches for treatment in diabetes: aldose reductase inhibitors // Biomed. Pharma- cother. — 1995. — Vol. 49. — P. 232-243.

775. Houben J. M. J., Moonen H. J. J., van Schooten F. J., Hageman G. J. Telomere length assessment: biomarker of chronic oxidative stress? // Free Radic. Biol. Med. — 2008. - Vol. 44. - P. 235-246.

776. Houstis N., Rosen E. D., Lander E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance // Nature. — 2006. — Vol. 440. — P. 944—948.

777. Hovind P., Tarnow L., Oestergaard P. B., Parving H. H. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy // Kidney Int. — 2000 . — Vol. 57, Suppl. 75. — P. S56—S61.

778. Hrabak A., Bajor T., Csuka I. The effect of various inflammatory agents on the alternative metabolic pathways of arginine in mouse and rat macrophages // Inflamm. Res. — 2006. — Vol. 55. — P. 23—31.

779. Hsu R. M., Devaraj S., Jialal I. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus // Clin. Chim. Acta. — 2002. — Vol. 317. — P. 145—150.

780. Hsu W. T., Tsai L. Y., Lin S. K. et al. Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus // Ann. Clin. Lab. Sci. — 2006. — Vol. 36. — P. 174—178.

781. Huang T. T., Carlson E. J., Gillespie A. M. et al. Ubiquitous overexpression of CuZn superoxide dis- mutase does not extend life span in mice // J. Gerontol. A Biol. Sci. Med. Sci. — 2000. — Vol. 55. — P. B5—B9.

782. Hudson E. K., Hogue B. A., Souza-Pinto N. C. et al. Age-associated change in mitochondrial DNA damage // Free Radic. Res. — 1998. — Vol. 29. — P. 573—579.

783. Hunt J. V., Bottoms M. A., Mitchinson M. J. Ascorbic acid oxidation — a potential cause ofthe elevated severity of atherosclerosis in diabetes-mellitus // FEBS Lett. — 1992. — Vol. 311. — P. 161—164.

784. Hurst R. T., Lee R. W. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: Mechanisms and management // Ann. Intern. Med. — 2003. — Vol. 139. — P. 824—834.

785. Iannone A., Rota C., Bergamini S. et al. Antioxidant activity of carotenoids: an electron-spin resonance study on β-carotene and lutein interaction with free radicals generated in a chemical system // J. Biochem. Mol. Toxicol. — 1998. — Vol. 12. — P. 299-304.

786. Ido Y., Kilo C., Williamson J. R. Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus // Diabetologia. — 1997. — Vol. 40, Suppl. 2. — P. S115-S117.

787. Idris I., Gray S., Donnelly R. Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes // Diabetologia. — 2001. — Vol. 44. — P. 659-673.

788. Iliou J. P., Thollon C., Villeneuve N. et al. Monohydroperoxidized fatty acids but not 4-hydroxynon- enal induced acute cardiac cell damage // Free Radic. Biol. Med. — 1995. — Vol. 19. — P. 773-783.

789. Il’yasova D., Morrow J. D., Wagenknecht L. E. Urinary F₂-isoprostanes are not associated with increased risk of type 2 diabetes // Obes. Res. — 2005. — Vol. 13. — P. 1638-1644.

790. Ingold K. U., Bowry V. W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids — unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90. — P. 45-49.

791. Inoguchi T., Battan R., Handler E. et al. Preferential elevation of protein kinase C isoform β II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet transplantation // Proc. Natl. Acad. Sci. USA. — 1992. — Vol. 89. — P. 11059-11063.

792. Inoguchi T., Li P., Umeda F. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells // Diabetes. — 2000. — Vol. 49. — P. 1939-1945.

793. Inoue N., Kawashima S., Kanazawa K. et al. Polymorphism ofthe NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease // Circulation. — 1998. — Vol. 97. — P. 135-137.

794. Ishibashi F., Nunoi H., Endo F. et al. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency // Hum. Genet. — 2000. — Vol. 106.— P. 473-481.

795. Ishii H., Daisuke K., King G. L. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus // J. Mol. Med. — 1998. — Vol. 76. — P. 21-31.

796. Ishii T., Itoh K., Ruiz E. et al. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: Activation by oxidatively modified LDL and 4-hydroxynonenal // Circ. Res. — 2004. — Vol. 94. — P. 609-616.

797. Ishii T., Tatsuda E., Kumazawa S. et al. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phos- phate dehydrogenase // Biochemistry. — 2003. — Vol. 42. — P. 3474-3480.

798. Iwai K., Onodera A., Matsue H. Inhibitory effects of Viburnum dilatatum Thunb. (gamazumi) on oxidation and hyperglycemia in rats with streptozotocin-induced diabetes // J. Agric. Food Chem. — 2004. — Vol. 52. — P. 1002-1007.

799. Iwata K., Nishinaka T., Matsuno K., Yabe-Nishimura C. Increased gene expression of glutathione peroxidase-3 in diabetic mouse heart // Biol. Pharm. Bull. — 2006. — Vol. 29. — P. 1042-1045.

800. Iwata M., Koide T., Maekawa K. et al. Tocopherol acetate reference standart (control 001) of National Institute of Health Sciences // Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. — 2000. — Vol. 118. — P. 141-143.

801. Jackett P. S., Aber V. R., Lowrie D. B. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis // J. Gen. Microbiol. — 1978. — Vol. 104. — P. 37-45.

802. Jackett P. S., Aber V. R., Lowrie D. B. Virulence of Mycobacterium tuberculosis and susceptibility to peroxidative killing systems // J. Gen. Microbiol. — 1978. — Vol. 107. — P. 273-278.

803. Jackson R. L., Gotto A. M. Phospholipids in biology and medicine // New Engl. J. Med. — 1974. — Vol. 290. — P. 24-29.

804. Jackson R. M., Frank L. Ozone-induced tolerance to hyperoxia in rats // Am. Rev. Respir. Dis. — 1984. — Vol. 129. — P. 425-429.

805. Jacob M., Plane F., Bruckdorfer K. R. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta // Br. J. Pharmacol. — 1990. — Vol. 100. — P. 21-26.

806. Jacob S., Ruus P., Hermann R. et al. Oral administration of RAC-a-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial // Free Radic. Biol. Med. — 1999. — Vol. 27. — P. 309-314.

807. Jacobs M., Samarina A., Grivennikov S. et al. Reactivation of tuberculosis by tumor necrosis factor neutralization // Eur. Cytokine Netw. — 2007. — Vol. 18. — P. 5-13.

808. Jacqueminet S., Briaud I., Rouault C. et al. Inhibition of insulin gene expression by long-term exposure of pancreatic β cells to palmitate is dependent on the presence of a stimulatory glucose concentration // Metabolism. — 2000. — Vol. 49. — P. 532-536.

809. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury // Proc. Soc. Exp. Biol. Med. —1995. — Vol. 209. — P. 104-111.

810. Jain S. K., Krueger K. S., McVie R. et al. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients // Diabetes Care. — 1998. — Vol. 21. — P. 1511-1516.

811. Jain S. K., McVie R., Duett J., Herbst J. J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes // Diabetes. — 1989. — Vol. 38. — P. 1539-1543.

812. Jain S. K., Palmer M. The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins // Free Radic. Biol. Med. — 1997. — Vol. 22. — P. 593-596.

813. Jakupoglu C., Przemeck G. K., Schneider M. et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development // Mol. Cell. Biol. — 2005. — Vol. 25. — P. 1980-1988.

814. James S. H., Meyers A. M. Microangiopathic hemolytic anemia as a complication of diabetes mellitus // Am. J. Med. Sci. — 1998. — Vol. 315. — P. 211-215.

815. Jameson M., Dai F. X., Luster Т. et al. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension // Hypertension. — 1993. — Vol. 21. — P. 280-288.

816. Jana C. K., Das N., Sohal R. S. Specificity of age-related carbonylation of plasma proteins in the mouse and rat // Arch. Biochem. Biophys. — 2002. — Vol. 397. — P. 433-439.

817. Jang Y. Y., Song J. H., Shin Y. K. et al. Protective effect ofboldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats // Pharmacol. Res. — 2000. — Vol. 42. — P. 361-371.

818. Jaswal S., Mehta H. C., Sood A. K., Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy // Clin. Chim. Acta. — 2003. — Vol. 338. — P. 123-129.

819. Jennings P. E., Belch J. J. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide // Metabolism. — 2000. — Vol. 49. — P. 23-26.

820. Jensen S. K., Engberg R. M., Hedemann M. S. All-rac-alpha-tocopherol acetate is a better vitamin E source than all-rac-alpha-tocopherol succinate for broilers // J. Nutr. — 1999. — Vol. 129. — P. 1355-1360.

821. Jessup W., Bedwell S., Kwok K., Dean R. T. Oxidative modification of low-density lipoprotein: initiation by free radicals and protection by antioxidants // Agents Actions. — 1989. — Vol. 26, Suppl. — P. 241-246.

822. Jessup W., Darley-Usmar V., O’Leary V., Bedwell S. 5-Lipoxygenase is not essential in macrophage- mediated oxidation of low density lipoprotein // Biochem. J. — 1991. — Vol. 278. — P. 163-169.

823. Jessup W., Mohr D., Gieseg S. P. et al. The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein // Biochim. Biophys. Acta. — 1992. — Vol. 1180. — P. 73-82.

824. Jessup W., Rankin S. M., De Whalley C. V. et al. α-Tocopherol consumption during low-density- lipoprotein oxidation // Biochem. J. — 1990. — Vol. 265. — P. 399—405.

825. Jessup W., Simpson J. A., Dean R. T. Does superoxide radical have a role in macrophage-mediated oxidative midification of LDL? // Atherosclerosis. — 1993. — Vol. 99. — P. 107—120.

826. Jialal I., Devaraj S., Venugopal S. K. Oxidative stress, inflammation, and diabetic vasculopathies: the role of α-tocopherol therapy // Free Radic. Res. — 2002. — Vol. 36. — P. 1331—1336.

827. Jialal I., Fuller C. J., Huet B. A. The effect of alpha-tocopherol supplementation on LDL oxidation // Arterioscler. Thromb. Vasc. Biol. — 1995. — Vol. 15. — P. 190—198.

828. Jialal I., Traber M., Devaraj S. Is there a vitamin E paradox? // Curr. Opin. Lipidol. — 2001. — Vol. 12. — P. 49-53.

829. Jialal I., Vega G. L., Grundy S. M. Physiologic levels of ascorbate inhibit the oxidative modification oflow density lipoprotein // Atherosclerosis. — 1990. — Vol. 82. — P. 185-191.

830. Jin D. Q., Li G., Kim J. S. et al. Preventive effects of Laminaria japonica aqueous extract on the oxidative stress and xanthine oxidase activity in streptozotocin-induced diabetic rat liver // Biol. Pharm. Bull. — 2004. — Vol. 27. — P. 1037-1040.

831. Joerink M., Savelkoul H. F., Wiegertjes G. F. Evolutionary conservation of alternative activation of macrophages: structural and functional characterization of arginase 1 and 2 in carp (Cyprinus carpio L. ) // Mol. Immunol. — 2006. — Vol. 43. — P. 1116-1128.

832. Jones G. S., Amirault H. J., Andersen B. R. Killing of M. tuberculosis by neutrophils: a nonoxidative process // J. Infect. Dis. — 1990. — Vol. 162. — P. 700-704.

833. Jongejan R. C., Dejongste J. C., Raatgeep R. C. et al. Effects of zymosan-activated human granulocytes on isolated human airways // Am. Rev. Respir. Dis. — 1991. — Vol. 143. — P. 553-360.

834. Jugdutt B. I. Role of nitrates after acute myocardial infarction // Am. J. Cardiol. — 1992. — Vol. 70. — P. B82-B87.

835. Juneau C. F., Ito B. R., Delbalzo U., Engler R. L. Severe neutrophil depletion by leucocyte filters or cytotoxic drug does not improve recovery of contractile function in stunned porcine myocardium // Cardiovasc. Res. — 1993. — Vol. 27. — P. 720-727.

836. Jung C. H., Seog H. M., Choi I. W. et al. Effects of wild ginseng (Panax ginseng C. A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats // J. Ethnopharmacol. — 2005. — Vol. 98. — P. 245-250.

837. Jurgens G., Lang J., Esterbauer H. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal // Biochim. Biophys. Acta. — 1986. — Vol. 875. — P. 103-114.

838. Kahler W., Kuklinski B., Ruhlmann C., Plotz C. Diabetes mellitus — a free radical-associated disease. Results of adjuvant antioxidant supplementation // Z. Gesamte Inn. Med. — 1993. — Bd. 48. — S. 223-232.

839. Kahn C. R., Vicent D., Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus // Annu. Rev. Med. — 1996. — Vol. 47. — P. 509-531.

840. Kaji H., Kurasaki M., Ito K. et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women // Klin. Wochenschr. — 1985. — B. 63. — S. 765-768.

841. Kajikawa M., Ohta T., Takase M. et al. Lactoferrin inhibits cholesterol accumulation in macrophages mediated by acetylated or oxidized low-density lipoproteins // Biochim. Biophys. Acta. — 1994. — Vol. 1213. — P. 82-90.

842. Kakishita H., Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal // Life Sci. — 2001. — Vol. 69. — P. 689-697.

843. Kaleem M., Asif M., Ahmed Q. U., Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats // Singapore Med. J. — 2006. — Vol. 47. — P. 670-675.

844. Kaleem M., Kirmani D., Asif M. et al. Biochemical effects of Nigella sativa L. seeds in diabetic rats // Indian J. Exp. Biol. — 2006. — Vol. 44. — P. 745-748.

845. Kaleem M., Sheema, Sarmad H., Bano B. Protective effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats // Indian J. Physiol. Pharmacol. — 2005. — Vol. 49. — P. 65-71.

846. Kalofoutis A., Lekakis J. Changes of platelet phospholipids in diabetes mellitus // Diabelologia. — 1981. — Vol. 21. — P. 540-543.

847. Kalra J., Chaudhary A. K., Prasad K. Increased production of oxygen free radicals in cigarette smokers // Int. J. Exp. Pathol. — 1991. — Vol. 72. — P. 1-7.

848. Kalra V. K., Shen Y., Sultana C., Rattan V. Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes // Am. J. Physiol. — 1996. — Vol. 271. — P. H2025-H2034.

849. Kamalakkannan N., Prince P. S. Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats // J. Ethnopharmacol. — 2003. — Vol. 87. — P. 207—210.

850. Kamalakkannan N., Stanely Mainzen Prince P. Effect of Aegle marmelos Correa. (Bael) fruit extract on tissue antioxidants in streptozotocin diabetic rats // Indian J. Exp. Biol. — 2003. — Vol. 41. — P. 1285-1288.

851. Kaneko M., Suzuki H., Masuda H. et al. Effects of oxygen free radicals on Ca²+ binding to cardiac troponin // Jap. Circ. J. — 1992. — Vol. 56, Suppl. 5. — P. 1288-1290.

852. Kang J. H. Modification and inactivation of human Cu,Zn-superoxide dismutase by methylgly- oxal // Mol. Cells. — 2003. — Vol. 15. — P. 194-199.

853. Kang K. A., Chae S., Koh Y. S. et al. Protective effect of Puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin // Biol. Pharm. Bull. — 2005. — Vol. 28. — P. 1154-1160.

854. Kang K. S., Kim H. Y., Yamabe N. et al. Protective effect of sun ginseng against diabetic renal damage // Biol. Pharm. Bull. — 2006. — Vol. 29. — P. 1678-1684.

855. Kanter M., Coskun O., Korkmaz A., Oter S. Effects of Nigella sativa on oxidative stress and β-cell damage in streptozotocin-induced diabetic rats // Anat. Rec. A Discov. Mol. Cell. Evol. Biol. —

2004. — Vol. 279. — P. 685-691.

856. Karpen C. W., Cataland S., O’Dorisio T. M., Panganamala R. Intervention of platelet vitamin E and thromboxane synthesis in type 1 diabetes mellitus // Diabetes. — 1984 . — Vol. 33. — P. 239-243.

857. Kasahara Y., Iwai K., Yachie A. et al. Involvement of reactive oxygen intermediates in spontaneous and CD95(fas/APO-1)-mediated apoptosis of neutrophils // Blood. — 1997. — Vol. 89. — P. 1748-1753.

858. Kasai K., Hattori Y., Nakanishi N. et al. Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture // Endocrinology. — 1995. — Vol. 136. — P. 4261-4270.

859. Kashfi K., Rimarachin J. A., Weksler B. B. Dannenberg A. J. Differential induction of glutathione S-transferase in rat aorta versus liver // Biochem. Pharmacol. —1994. — Vol. 47. — P. 1903-1907.

860. Kashiwagi A., Shinozaki K., Nishio Y. et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats // Am. J. Physiol. — 1999. — Vol. 277. — P. E976-E983.

861. Kasiske B. L., Keane W. F. Role of lipid peroxidation in the inhibition of mononuclear cell proliferation by normal lipoproteins // J. Lipid Res. — 1991. — Vol. 32. — P. 775-781.

862. Kastrati A., Mehilli J., Dirschinder J. et al. Restenosis after coronary placement of various stent types // Am. J. Cardiol. — 2001. — Vol. 87. — P. 34-39.

863. Kasuga M., Karlsson F. A., Kahn C. R. Insulin stimulates and phosphorylation of the 95 000 dalton β-subunit of its own receptor // Science. — 1983. — Vol. 215. — P. 185-187.

864. Katoh S., Toyama J., Kodama I. et al. Protective action of iron-helating agents (catechol, mimo- sine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts // Eur. Surg. Res. — 1992. — Vol. 24. — P. 349-355.

865. Katsura M., Forster L. A., Ferns G. A. A., Anggard E. E. Oxidative modification oflow-density lipoprotein by human polymorphonuclear leucocytes to a form recognized by the lipoprotein scavenger pathway // Biocim. Biophys. Acta. — 1994. — Vol. 1213. — P. 231-237.

866. Katsura Y. Tsuru S., Noritake M. et al. Effects of macrophage colony-stimulating factor on the activities of the murine monocytes and peritoneal macrophages in vivo // Nat. Immun. — 1992. — Vol. 11. — P. 167-176.

867. Katsura Y. Tsuru S., Noritake M. et al. Granulocyte colony-stimulating factor enhances the extracellular emission of reactive oxygen from neutrophils stimulated with formylmethionylleucylphenyl- alanine // Cell. Immunol. — 1993. — Vol. 148. — P. 10-17.

868. Kaul N., Siveskiiliskovic N., Thomas T. P. et al. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy // Nutrition. — 1995. — Vol. 11. — P. 551-554.

869. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients // FEBS Lett. — 1994. — Vol. 350. — P. 9-12.

870. Kaviarasan K., Arjunan M. M., Pugalendi K. V. Lipid profile, oxidant-antioxidant status and glycoprotein components in hyperlipidemic patients with/without diabetes // Clin. Chim. Acta. —

2005. — Vol. 362. — P. 49-56.

871. Kawamura M., Heinecke J. W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway // J. Clin. Invest. — 1994. — Vol. 94. — P. 771-778.

872. Kaul N., Siveski-Iliskovic N., Hill M. et al. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy // Mol. Cell. Biochem. — 1996. — Vol. 160-161. — P. 283-288.

873. Keane J., Balcewicz-Sablinska M. K., Remold H. G. et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis // Infect. Immun. — 1997. — Vol. 65. — P. 298—304.

874. Keane J., Remold H. G., Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages // J. Immunol. — 2000. — Vol. 164. — P. 2016—2020.

875. Kedziora-Kornatowska K. Effect of angiotensin convertase inhibitors and AT1 angiotensin receptor antagonists on the development of oxidative stress in the kidney of diabetic rats // Clin. Chim. Acta. — 1999. — Vol. 287. — P. 19-27.

876. Kedziora-Kornatowska K. Z., Luciak M., Paszkowski J. Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: Effect of treatment with angiotensin convertase inhibitors // IUBMB Life. — 2000. — Vol. 49. — P. 303-307.

877. Kedziora-Kornatowska K. Z., Szram S., Kornatowski T. et al. Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney // Nephron. Exp. Nephrol. — 2003. — Vol. 95. — P. e134-e143.

878. Kehrer J. P., Smith C. V. Free radicals in biology: sources, reactivities, and roles in the etiology of human diseases // Natural Antioxidants in Human Health and Disease. — N.Y.: Acad. Press, 1994. — P. 25-62.

879. Kellerer M., Sesti G., Seffer E. et al. Altered pattern of insulin receptor isotypes in skeletal muscle membranes oftype 2 (non-insulin-dependent) diabetic subjects // Diabetologia. — 1993. — Vol. 36. — P. 628-632.

880. Kelley J. L., Suenram C. A., Rozek M. M., Schwartz C. J. Influence ofhypercholesterolemia and cholesterol accumulation on rabbit carrageenan granuloma macrophage activation // Am. J. Pathol. — 1988. — Vol. 131. — P. 539-546.

881. Kennedy L., Mehl T. D., Elder E. et al. Nonenzymatic glycosylation of serum and plasma proteins // Diabetes. — 1982. — Vol. 31. — P. 52-56.

882. Kesaniemi Y. A. Mechanisms of low density lipoprotein lowering by hypolipidemic agents // Ann. Med. — 1991. — Vol. 23. — P. 195-198.

883. Keyse S. M. The role of protein phosphatases in the regulation of mitogen and stress-activated protein kinases // Free Radic. Res. — 1999. — Vol. 31. — P. 341-349.

884. Khan J., Brennan D. M., Bradley N. et al. 3-nitrotyrosine in the proteins of human plasma determined by an ELISA method // Biochem. J. — 1998. — Vol. 330. — P. 795-801.

885. Kharazmi A., Nielsen H., Rechitzer C., Bendzen K. Interleukin 6 primes human neutrophils and monocyte oxidative burst response // Immunol. Lett. — 1989. — Vol. 21. — P. 177-184.

886. Kido Y., Nakae J., Accili D. Clinical review 125: the insulin receptor and its cellular targets // J. Clin. Endocrinol. Metab. — 2001. — Vol. 86. — P. 972-979.

887. Kilbourn R. G., Belloni P. Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor, interleukin-1, or endotoxin // J. Natl. Cancer Inst. — 1990. — Vol. 82. — P. 772-776.

888. Kim H. J., Cho E. H., Yoo J. H. et al. Proteome analysis of serum from type 2 diabetics with nephropathy // J. Proteome Res. — 2007. — Vol. 6. — P. 735-743.

889. Kim H. K., Kim M. J., Cho H. Y. et al. Antioxidative and anti-diabetic effects of amaranth (Amaran- thus esculantus) in streptozotocin-induced diabetic rats // Cell Biochem. Funct. — 2006. — Vol. 24. — P. 195-199.

890. Kim H. Y., Yokozawa T., Cho E. J. et al. In vitro and in vivo antioxidant effects of mustard leaf (Bras- sica juncea) // Phytother. Res. — 2003. — Vol. 17. — P. 465-471.

891. Kim S. H., Hyun S. H., Choung S. Y. Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice // Biofactors. — 2006. — Vol. 26. — P. 209-219.

892. King H., Aubert R. E., Herman. W. H. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections // Diabetes Care. — 1998. — Vol. 21. — P. 1414-1431.

893. Kinnula V., Chang L., Everitt J. I., Crapo J. D. Oxidants and antioxidants in alveolar epithelial type II cells: in situ, freshly isolated, and cultured cells // Am. J. Physiol. — 1992. — Vol. 262. — P. L69-L77.

894. Kinugasa Y., Ogino K., Furuse Y. et al. Allopurinol improves cardiac dysfunction after ischemia- reperfusion via reduction of oxidative stress in isolated perfused rat hearts // Circ. J. — 2003. — Vol. 67. — P. 781-787.

895. Kirstein M., Aston C., Hintz R., Vlassara H. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins // J. Clin. Invest. — 1992. — Vol. 90. — P. 439-446.

896. Kirstein M., Brett J., Radoff S. et al. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 9010-9014.

897. Kishi Y., Schmelzer J. D., Yao J. K. et al. α-Lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy // Diabetes. — 1999. — Vol. 48. — P. 2045-2051.

898. Kiss L., Szabo C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP- ribose) polymerase activation in peroxynitrite-mediated cytotoxicity // Mem. Inst. Oswaldo Cruz. — 2005. — Vol. 100. — P. 29-37.

899. Kita T., Nagano Y., Yokode M. et al. Probucol prevents the progression of atherosclerosis in Wata- nabe heritable hyperlipidemic rabbit an animal model for familial hypercholesterolemia // Proc. Natl. Acad. Sci. USA. — 1987. — Vol. 84. — P. 5928-5931.

900. Kitagawa S., Yuo A., Yagisawa M. et al. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release // Exp. Hematol. — 1996. — Vol. 24. — P. 559-567.

901. Klebanoff S. J. Oxygen metabolites from phagocytes // Inflammation: Basic Principles and Clinical Correlates. — N.Y.: Raven Press, 1992. — P. 541-588.

902. Klebanoff S. J. Reactive nitrogen intermediates and antimicrobial activity: Role of nitrite // Free Radic. Biol. Med. — 1993. — Vol. 14. — P. 351-360.

903. Kleemann R., Rothe H., Kolb-Bachofen V. et al. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats // FEBS Lett. — 1993. — Vol. 328. — P. 9-12.

904. Klein H. H., Pich S., Lindertheimberg S. et al. Failure of chronic, high-dose, oral vitamin-E treatment to protect the ischemic, reperfused porcine heart // J. Mol. Cell. Cardiol. —1993. — Vol. 25. — P. 103-112.

905. Klein R., Klein B. E., Moss S. E. et al. The Wisconsin epidemiologic study of diabetic retinopathy XIV: Ten year incidence and progression of diabetic retinopathy // Arch. Ophthalmol. — 1994. — Vol. 112. — P. 1217-1228.

906. Klein R., Klein B. E., Moss S. E. et al. The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema // Ophthalmology. — 1995. — Vol. 102. — P. 7-16.

907. Klein R. L., Laimins M., Lopes-Virella M. F. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects // Diabetes. — 1995. — Vol. 44. — P. 1093-1098.

908. Klipstein-Brobusch K., Geleijnse J. M., den Breeijen J. H. et al. Dietary antioxidants and risk of myocardial infarction in the elderly: The Rotterdam Study // Am. J. Clin. Nutr. — 1999. — Vol. 69. — P. 261-266.

909. Klockars M., Savolainen H. Tumour necrosis factor enhances the asbestos-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes (PMN) // Clin. Exp. Immunol. — 1992. — Vol. 90. — P. 68-71.

910. Kloppel G., Lohr M., Habich K. et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited // Surv. Synth. Pathol. Res. — 1985. — Vol. 4. — P. 110-125.

911. Knekt P., Reunanen A., Jarvinen R. et al. Antioxidant vitamin intake and coronary mortality in a Longitudinal Population stady // Am. J. Epidemiol. — 1994. — Vol. 139. — P. 1180-1189.

912. Knekt P., Reunanen A., Marniemi J. et al. Low vitamin E status is a potential risk factor for insulin- dependent diabetes mellitus // J. Intern. Med. — 1999. — Vol. 245. — P. 99-102.

913. Knight R. J., Kofoed K. F., Schelbert H. R., Buxton D. B. Inhibition ofglyceraldehyde-3-phosphate dehydrogenase in post-ischemic myocardium // Cardiovasc. Res. — 1996. — Vol. 32. — P. 1016-1023.

914. Koc A., Gladyshev V. N. Methionine sulfoxide reduction and the aging process // Ann. N.Y. Acad. Sci. — 2007. — Vol. 1100. — P. 383-386.

915. Kock R., Delvoux B., Sigmund M., Greiling H. A comparative study of the concentrations of hy- poxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases // Eur. J. Clin. Chem. Clin. Biochem. — 1994. — Vol. 32. — P. 837-842.

916. Koerner J. E., Anderson B. A., Dage R. C. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals — superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril // J. Cardiovasc. Pharmacol. — 1991. — Vol. 17. — P. 185-192.

917. Kolb H., Burkart V. Nicotinamide in type 1 diabetes. Mechanism of action revisited // Diabetes Care. — 1999. — Vol. 22, Suppl. 2. — P. B16-B20.

918. Komosinska-Vassev K., Olczyk K., Olczyk P., Winsz-Szczotka K. Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients // Diabetes Res. Clin. Pract. — 2005. — Vol. 68. — P. 207-216.

919. Kontush A., Hubner C., Finckh B. et al. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach // Free Radic. Res. — 1996. — Vol. 24. — P. 135-147.

920. Kontush A., Weber W., Beisiegel U. α- and β-Carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation // Atherosclerosis. — 2000. — Vol. 148. — P. 87-93.

921. Konya L., Kekesi V., Juhasznagy S., Peher J. The effect of superoxide dismutase in the myocardium during reperfusion in the dog // Free Radic. Biol. Med. — 1992. — Vol. 13. — P. 527-532.

922. Kopprasch S., Leonhardt W., Pietzsch J., Kuhne H. Hypochlorite-modified low-density lipoprotein stimulates human polymorphonuclear leukocytes for enhanced production of reactive oxygen metabolites, enzyme secretion, and adhesion to endothelial cells // Atherosclerosis. — 1998. — Vol. 136. — P. 315-324.

923. Kornfeld H., Mancino G., Colizzi V. The role of macrophage cell death in tuberculosis // Cell Death Differ. — 1999. — Vol. 6. — P. 71-78.

924. Kostler J. F., Slee R. G., Essed C. E., Stam H. Studies ofcumene hydroperoxide-induced lipid peroxidation in the isolated perfused rat heart // J. Mol. Cell. Cardiol. —1985. — Vol. 17. — P. 701-708.

925. Kosugi K., Morel D. W., DiCorleto P. E., Chisolm G. M. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle // J. Cell. Physiol. — 1987. — Vol. 130. — P. 311-320.

926. Kotani K., Ogawa W., Matsumoto M. et al. Requirement of atypical protein kinase C lambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes // Mol. Cell. Biol. — 1998. — Vol. 18. — P. 6971-6982.

927. Kovij A., Schijns M., Frederiks W. M. et al. Distribution of xanthine oxidoreductase activity in human tissues — A histochemical and biochemical study // Virchows Arch. B Cell Pathol. — 1992. — Vol. 63. — P. 17-23.

928. Kowanko I. C., Bates E. J., Ferrante A. Mechanisms of human neutrophil mediated cartilage damage in vitro: The role of lysosomal enzymes, hydrogen peroxide and hypochlorous acid // Immunol. Cell Biol. — 1989. — Vol. 67. — P. 321-329.

929. Koya D., Lee I. K., Ishii H. et al. Prevention of glomerular dysfunction in diabetic rats by treatment with d-a-tocopherol // J. Am. Soc. Nephrol. — 1997. — Vol. 8. — P. 426-435.

930. Koyama K., Takatsuki K., Inoue M. Determination of superoxide and ascorbyl radicals in the circulation of animals under oxidative stress // Arch. Biochem. Biophys. — 1994. — Vol. 309. — P. 323-328.

931. Kozawa O., Kawamura H., Hatakeyama D. et al. Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts involvement of p38 mitogen-activated protein kinase // Cell. Signal. — 2000. — Vol. 12. — P. 375-380.

932. Krauss R. M. Low-density lipoprotein subclasses and risk of coronary artery disease // Curr. Opin. Lipidol. — 1991. — Vol. 2. — P. 248-252.

933. Krauss S., Zhang C. Y., Scorrano L. et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction // J. Clin. Invest. — 2003. — Vol. 112. — P. 1831-1842.

934. Kretowski A., Mysliwiec J., Szelachowska M. et al. Nicotinamide inhibits enhanced in vitro production of interleukin-12 and tumour necrosis factor-α in peripheral whole blood of people at high risk of developing type 1 diabetes and people with newly diagnosed type 1 diabetes // Diabetes Res. Clin. Pract. — 2000. — Vol. 47. — P. 81-86.

935. Krieger M. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor // TIBS. — 1992. — Vol. 17. — P. 141-146.

936. Krishnan K. J., Greaves L. C., Reeve A. K., Turnbull D. M. Mitochondrial DNA mutations and aging // Ann. N.Y. Acad. Sci. — 2007. — Vol. 1100. — P. 227-240.

937. Kritharides L., Jessup W., Dean R. T. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks’ balanced salt solution // Arch. Biochem. Biophys. — 1995. — Vol. 323. — P. 127-136.

938. Kroncke K.-D., Kolb-Bachofen V., Berschick V. et al. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation // Biochem. Biophys. Res. Com- mun. — 1991. — Vol. 175. — P. 752-758.

939. Kucharska J., Braunova Z., Ulicna O. et al. Deficit of coenzyme Q in heart and liver mitochondria of rats with streptozotocin-induced diabetes // Physiol. Res. — 2000. — Vol. 49. — P. 411-418.

940. Kugiyama K., Sugiyama S., Ogata N. et al. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine // Atherosclerosis. — 1999. — Vol. 143. — P. 201-204.

941. Kuhn H., Belkner J., Suzuki H., Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities // J. Lipid Res. — 1994. — Vol. 35. — P. 1749-1759.

942. Kukreja R. C., Kontos H. A., Hess M. L., Ellis E. F. PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH // Circ. Res. — 1986. — Vol. 59. — P. 612—619.

943. Kuller L. H. A time to stop prescribing antioxidant vitamins to prevent and treat heart disease? // Arterioscler. Tromb. Vasc. Biol. — 2001. — Vol. 21. — P. 1253.

944. Kumar D., Palace V., Danelisen I. et al. Probucol induced antioxidants confers protection against ischemia-reperfusion injury // J. Mol. Cell. Cardiol. — 2001. — Vol. 33. — P. A62.

945. Kumar K. W., Das U. M. Are free radicals involved in the pathobiology of human essential hypertension? // Free Radic. Res. Commun. — 1993. — Vol. 19. — P. 59—66.

946. Kumari K., Augusti K. T. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats // Indian J. Exp. Biol. — 2002. — Vol. 40. — P. 1005-1009.

947. Kunisaki M., Bursell S. E., Umeda F. et al. Prevention of diabetes-induced abnormal retinal blood flow by treatment with d-alpha-tocopherol // Biofactors. — 1998. — Vol. 7. — P. 55-67.

948. Kupper R. W., DeWald B., Jakobs K. H. et al. G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes // Biochem. J. — 1992. — Vol. 282. — P. 429.

949. Kuppusamy P., Zweier J. L. Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation // J. Biol. Chem. — 1989. — Vol. 264. — P. 9880-9884.

950. Kurose I., Granger D. N. Evidence implicating xanthine oxidase and neutrophils in reperfusion- induced microvascular dysfunction // Ann. N.Y. Acad. Sci. — 1994. — Vol. 723. — P. 158-179.

951. Kurtul N., Bakan E., Aksoy H., Baykal O. Leukocyte lipid peroxidation, superoxide dismutase and catalase activities of type 2 diabetic patients with retinopathy // Acta Medica. — 2005. — Vol. 48. — P. 35-38.

952. Kushi L. H., Folsom A. R., Prineas R. J. et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women // New Engl. J. Med. — 1996. — Vol. 334. — P. 1156-1162.

953. Kutter D., Devaquet P., Vanderstocken G. et al. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? // Acta Haematol. — 2000. — Vol. 104. — P. 10-15.

954. Kuzmanova S. I. The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders // Folia Med. — 2005. — Vol. 47. — P. 21-25.

955. Kuzuya M., Kuzuya F. Probucol as antioxidant and antiatherogenic drug // Free Radic. Biol. Med. — 1993. — Vol. 14. — P. 67-77.

956. Kuzuya M., Naito M., Funaki C. et al. Lipid peroxide and copper are required for the toxicity of oxidized low-density lipoprotein to cultured endothelial cells // Biochim. Biophys. Acta. — 1991. — Vol. 1096. — P. 155-166.

957. Kuzuya M., Naito M., Funaki C. et al. Probucol prevents oxidative injury to endothelial cells // J. Lipid. Res. — 1991. — Vol. 32. — P. 197-204.

958. Kuzuya M., Naito M., Funaki C. et al. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells // Biochem. Biophys. Res. Commun. — 1989. — Vol. 163. — P. 1466-1472.

959. Kuzuya T., Fuji H., Hoshida S. et al. Neutrophil-induced myocardial cell damage and active oxygen metabolites // Jap. Circ. J. — 1991. — Vol. 55. — P. 1127-1131.

960. Kwon G., Corbett J. A., Rodi C. P. et al. Interleukin-1p-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kB in the signaling mechanism // Endocrinology. — 1995. — Vol. 136. — P. 4790-4795.

961. Kwon O. J. The role of nitric oxide in the immune response of tuberculosis // J. K. M. S. — 1997. — Vol. 12. — P. 481-487.

962. Labrouche S., Freyburger G., Gin H. et al. Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes: Clinical and biological correlations // Metabolism. — 1996. — Vol. 45. — P. 57-71.

963. Lai M. A., Korner A., Matsuo Y. et al. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats // Diabetes. — 2000. — Vol. 49. — P. 1381-1389.

964. Lal S., Szwergold B. S., Taylor A. et al. Metabolism of fructose-3-phosphate in the diabetic rat lens // Arch. Biochem. Biophys. — 1995. — Vol. 318. — P. 191-199.

965. Lamb D. J., Leake D. S. Iron released from transferrin at acidic pH can catalyze the oxidation oflow density lipoprotein // FEBS Lett. — 1994. — Vol. 352. — P. 15-18.

966. Lamb D. J., Wilkins G. M., Leake D. S. The oxidative modification of low density lipoprotein by human lymphocytes // Atherosclerosis. — 1992. — Vol. 92. — P. 187-192.

967. Lamb N. J., Gutteridge J. M., Baker C. et al. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration, and chlorination // Crit. Care Med. — 1999. — Vol. 27. — P. 1738-1744.

968. Lameloise N., Muzzin P., Prentki M., Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion? // Diabetes. — 2001. — Vol. 50. — P. 803-809.

969. Lammas D. A., De Heer E., Edgar J. D. et al. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-γ production pathway // Int. J. Exp. Pathol. — 2002. — Vol. 83. — P. 1-20.

970. Lampeter E. F., Klinghammer A., Scherbaum W. A. et al. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group // Diabetes. — 1998. — Vol. 47. — P. 980-984.

971. Langsjoen P. H., Langsjoen A. M. Overview of the use CoQ₁₀ in cardiovascular disease // BioFactors. — 1999. — Vol. 9. — P. 273-284.

972. Lankin V., Tikhaze A. Free radical lipoperoxidation during atherosclerosis and antioxidative therapy of this disease // Free Radicals, Nitric Oxide, and Inflammation: Molecular, Biochemical, and Clinical Aspects. — Amsterdam etc.: IOS Press, 2003. — P. 218-231.

973. Lankin V. Z., Tikhaze A. K., Kukharchuk V. V. et al. Antioxidants decreases the intensification of low density lipoprotein free radical peroxidation during therapy with statins // Mol. Cell. Bio- chem. — 2003. — Vol. 249. — P. 129-140.

974. Lanser M. E., Mao P., Brown G. E. et al. Neutrophil chemiluminescence and opsonic fibronectin levels following blunt trauma // J. Surg. Res. — 1986. — Vol. 41. — P. 264-273.

975. Larsen C. M., Wadt K. A., Juhl L. F. et al. Interleukin-lp-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases // J. Biol. Chem. — 1998. — Vol. 273. — P. 15294-15300.

976. Latha M., Pari L., Sitasawad S., Bhonde R. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo // J. Biochem. Mol. Toxicol. — 2004. — Vol. 18. — P. 261-272.

977. Lau Y. L., Chan G. C. F., Ha S. Y. et al. The role of phagocytic burst in host defense against Mycobacterium tuberculosis // Clin. Infect. Dis. — 1998. — Vol. 26. — P. 226-227.

978. Laursen J. B., Rajagopalan S., Galis Z. et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension // Circulation. — 1997. — Vol. 95. — P. 588-593.

979. Lauridsen C., Engel H., Craig A. M., Traber M. G. Relative bioactivity of dietary RRR- and all-rac- alpha-tocopheryl acetates in swine assessed with deuterium-labeled vitamin E // J. Anim. Sci. — 2002. — Vol. 80. — P. 702-707.

980. Lauridsen C., Hedemann M. S., Jensen S. K. Hydrolysis of tocopheryl and retinyl esters by porcine carboxyl ester hydrolase is affected by their carboxylate moiety and acids // J. Nutr. Biochem. — 2001. — Vol. 12. — P. 219-224.

981. Lavan B. E., Lane W. S., Lienhard G. E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family // J. Biol. Chem. — 1997. — Vol. 272. — P. 11439-11443.

982. Le Good J. A., Zeigler W. H., Parekh D. B. et al. Protein kinase C isotypes controlled by phos- phoinositide-3-kinase through the protein kinase PDK1 // Science. — 1998. — Vol. 281. — P. 20422045.

983. Leake D. S. Effects of mildly oxidized low-density lipoprotein on endothelial cell function // Curr. Opin. Lipidol. — 1991. — Vol. 2. — P. 301-305.

984. Leake D. S. Oxidized low density lipoproteins and atherogenesis // Br. Heart J. — 1993. — Vol. 69. — P. 476-478.

985. Leake D. S., Rankin S. M. The oxidative modification oflow density lipoproteins by macrophages // Biochem. J. — 1990. — Vol. 270. — P. 741-748.

986. Lee A. Y., Chung S. S. Contributions of polyol pathway to oxidative stress in diabetic cataract // FASEB J. — 1999. — Vol. 13. — P. 23-30.

987. Lee C. K., Pugh T. D., Klopp R. G. et al. The impact of α-lipoic acid, coenzyme Q₁₀ and caloric restriction on life span and gene expression patterns in mice // Free Radic. Biol. Med. — 2004. — Vol. 36. — P. 1043-1057.

988. Lee I. K., Koya D., Ishii H. et al. d-a-Tocopherol prevents the hyperglycaemia induced activation of diacylglycerol-protein kinase C pathway in vascular smooth muscle cell by an increase in DAG kinase activity // Diabetes Res. Clin. Pract. — 1999. — Vol. 45. — P. 183-190.

989. Lee J. S. Effects of Fomes fomentarius supplementation on antioxidant enzyme activities, blood glucose, and lipid profile in streptozotocin-induced diabetic rats // Nutr. Res. — 2005. — Vol. 25. — P. 187-195.

990. Lee J. S., Kahlon S. S., Culbreth R., Cooper A. D. Modulation of monocyte chemokine production and nuclear factor kappa B activity by oxidants // J. Interferon Cytokine Res. — 1999. — Vol. 19. — P. 761-767.

991. Lee S. J., Choi M. G. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients // Metabolism. — 2006. — Vol. 55. — P. 1681-1688.

992. Lee T. H. Interactions between alveolar macrophages, monocytes, and granulocytes. Implications for airway inflammation // Am. Rev. Respir. Dis. — 1987. — Vol. 135. — P. S14-S17.

993. Lee T. H., Kim S. U., Yu S. L. et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice // Blood. — 2003. — Vol. 101. — P. 5033-5038.

994. Lees G. L. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia // J. Neurol. Sci. — 1993. — Vol. 114. — P. 119-122.

995. Leeuwenburgh C., Hardy M. M., Hazen S. L. et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima // J. Biol. Chem. — 1997. — Vol. 272. — P1433-1436.

996. Lefer A. M., Ma X. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium // Arterioscler. Thromb. — 1993. — Vol. 13. — P. 771-776.

997. Lefer A. M., Siegfried M. R., Ma X. L. Protection of ischemia reperfusion injury by syndonimine NO donors via inhibition of neutrophil endothelium interaction // J. Cardiovasc. Pharmacol. — 1993. — Vol. 22. — P. S27-S33.

998. Leff J. A., Oppegard M. A., Terada L. S. et al. Human serum catalase decreases endothelial cell injury from hydrogen peroxide // J. Appl. Physiol. — 1991. — Vol. 71. — P. 1903-1906.

999. LeffJ. A., Parsons P. E., Day C. E. et al. Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis // Lancet. — 1993. — Vol. 341. — P. 777-780.

1000. Lehman J. D., Dyke C., Abdelfattah A. et al. Polyethylene glycol conjugated superoxide dismutase attenuates reperfusion injury when administered 24 hours before ischemia // J. Thoracic and Car- diovasc. Surg. — 1992. — Vol. 104. — P. 1597-1601.

1001. Lehr H.-A., Becker M., Marklund S. L. et al. Superoxide-dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo // Atheroscler. Thromb. — 1992. — Vol. 12. — P. 824-829.

1002. Lehr H.-A., Becker M., Seemuller J. et al. Microvascular events during the development of atherosclerosis: Mediator cross-talk in oxidized LDL-induced leukocyte/endothelium interaction // Microcirculation in Organ Transplantation. — Basel: Karger, 1995. — P. 79-89.

1003. Lehr H.-A., Kress E., Menger M. D. et al. Cigarette smoke elicits leukocyte adhesion to endothelium in hamsters — inhibition by CuZn-SOD // Free Radic. Biol. Med. — 1993. — Vol. 14. — P. 573-581.

1004. Lehr H.-A., Menger M. D., Messmer K. Impact of neutrophil adhesion on myocardial ischemia/ reperfusion injury: Conceivable mechanisms and proven facts // J. Lab. Clin. Med. — 1993. — Vol. 121. — P. 539-545.

1005. Leitinger N., Oguogho A., Rodrigues M., Sinzinger H. The effect of NO/EDRF and monocytes/ macrophages on LDL-oxidation // J. Physiol. Pharmacol. — 1995. — Vol. 46. — P. 385-408.

1006. Lenzen S., Drinkgern J., Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues // Free Radic. Biol. Med. — 1996. — Vol. 20. — P. 463-466.

1007. Leoncini G., Signorello M. G., Piana A. et al. Hydrogen peroxide formation in platelets of patients with non-insulin-dependent diabetes mellitus // Platelets. — 1998. — Vol. 9. — P. 213-217.

1008. Lepore D. A. Nitric oxide synthase-independent generation of nitric oxide in muscle ischemia-reperfusion injury // Nitric Oxide. — 2000. — Vol. 4. — P. 541-545.

1009. Lepore D. A., Shinkel T. A., Fisicaro N. et al. Enhanced expression of glutathione peroxidase protects islet β cells from hypoxia-reoxygenation // Xenotransplantation. — 2004. — Vol. 11. — P. 53-59.

1010. Levi R., Kotob M., Nagauker O. et al. Stimulation of oxidative burst in human monocytes by lipo- teichoic acid // Infect. Immun. — 1990. — Vol. 58. — P. 566-568.

1011. Levin E. D., Christopher N. C., Crapo J. D. Memory decline of aging reduced by extracellular superoxide dismutase overexpression // Behav. Genet. — 2005. — Vol. 35. — P. 447-453.

1012. Levine R. L. Carbonyl modified proteins in cellular regulation, aging, and disease // Free Radic. Biol. Med. — 2002. — Vol. 32. — P. 790-796.

1013. Levonen A. L., Inkala M., Heikura T. et al. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo // Arterioscler. Thromb. Vasc. Biol. — 2007. — Vol. 27. — P. 741-747.

1014. Levy Y., Kaplan M., Ben-Amotz A., Aviram M. Effect of dietary supplementation of β-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein // Israel J. Med. Sci. - 1996. - Vol. 32. - P. 473-478.

1015. Levy Y., Zaltsberg H., Ben-Amotz A. et al. Dietary supplementation of a natural isomer mixture of β-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus // Ann. Nutr. Metab. - 2000. - Vol. 44. - P. 54-60.

1016. Li P.-F., Maasch C., Haller H. et al. Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells // Circulation. - 1999. - Vol. 100. - P. 967-973.

1017. Li Q., Cathcart M. K. Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes // J. Biol. Chem. - 1994. - Vol. 269. - P. 17508-17515.

1018. Li Q., Withoff S., Verma I. M. Inflammation-associated cancer: NF-κΒ is the lynchpin // Trends Immunol. - 2005. - Vol. 26. - P. 318-325.

1019. Li W., Mital S., Ojaimi C. et al. Premature death and age-related cardiac dysfunction in male eNOS- knockout mice // J. Mol. Cell. Cardiol. - 2004. - Vol. 37. - P. 671-680.

1020. Li X., Chen H., Epstein P. N. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic β-cells // Diabetes. - 2006. - Vol. 55. - P. 1592-1604.

1021. Li X. S., Uriuda Y., Wang Q. D. et al. Role of L-arginine in preventing myocardial and endothelial injury following ischaemia/reperfusion in the rat isolated heart // Acta Physiol. Scand. - 1996. - Vol. 156. - P. 37-44.

1022. Li Y., Huang T. T., Carlson E. J. et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase // Nat. Genet. - 1995. - Vol. 11. - P. 376-381.

1023. Li Y., Schellhorn H. E. Can ageing-related degenerative diseases be ameliorated through administration of vitamin C at pharmacological levels? // Med. Hypotheses. - 2007. - Vol. 68. - P. 1315-1317.

1024. Li Z., Kelley C., Collins F. et al. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs // J. Infect. Dis. - 1998. - Vol. 177. - P. 1030-1035.

1025. Libby P., Hansson G. K. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions // Lab. Invest. - 1991. - Vol. 64. - P. 5-15.

1026. Lienhardt C., Azzurri A., Amedei A. et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo // Eur. J. Immunol. - 2002. - Vol. 32. - P. 1605-1613.

1027. Liew F. Y. Regulation of nitric oxide synthesis in infectious and autoimmune diseases // Immunol. Lett. - 1994. - Vol. 43. - P. 95-98.

1028. Liguori A., Abete P., Hayden J. M. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1 // Eur. Heart J. - 2001. - Vol. 22. - P. 2075-2084.

1029. Lin C. C., Huang W. C., Lin C. Y. Chemiluminescence and antibody-dependent, cell-mediated cytotoxicity between human alveolar macrophages in smokers, nonsmokers and lung cancer patients // Chest. - 1989. - Vol. 95. - P. 553-557.

1030. Lin C. C., Lin C. Y. Enhanced chemiluminescence with decreased antibody-dependent cellular cytotoxicity of human alveolar neutrophil in patients with adult respiratory distress syndrome // Respiration. - 1992. - Vol. 59. - P. 265-271.

1031. Lin K. T., Xue J. Y., Nomen M. et al. Peroxynitrite-induced apoptosis in HL-60 cells // J. Biol. Chem. - 1995. - Vol. 270. - P. 16487-16490.

1032. Lin L., Hwang P. L. Antiproliferative effects of oxygenated sterols: positive correlation with binding affinities for the antiestrogen-binding sites // Biochim. Biophys. Acta. - 1991. - Vol. 1082. - P. 177-184.

1033. Linford N. J., Schriner S. E., Rabinovitch P. S. Oxidative damage and aging: spotlight on mitochondria // Cancer Res. - 2006. - Vol. 66. - P. 2497-2499.

1034. Linke S., Heinle H. Metabolic indicators of macrophage activation // Exp. Cell. Biol. - 1989. - Vol. 57. - P. 105.

1035. Linnane A. W., Kios M., Vitetta L. Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide // Biogerontology. - 2007. - Vol. 8. - P. 445-467.

1036. Lipsky R. H., Eckert D. M., Tang Y., Ockenhouse C. F. The carboxyl-terminal cytoplasmic domain of CD36 is required for oxidized low-density lipoprotein modulation of NF-kB activity by tumor necrosis factor-α // Recept. Signal Transduct. - 1997. - Vol. 7. - P. 1-11.

1037. Lipton B. A., Parthasarathy S., Ord V. A. et al. Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1a production by rabbit arterial macrophage-derived foam cells // J. Lipid Res. - 1995. - Vol. 36. - P. 2232-2242.

1038. Littarru G. P., Tomasetti M., Alleva R. Relationship between coenzyme Q₁₀ content and peroxid- ability in low density lipoproteins // Pathophysiology of Lipid Peroxides and Related Free Radicals. — Tokyo etc.: Jpn Sci. Press, 1998. — P. 77-89.

1039. Liu R. H., Baldwin B., Tennant B. C., Hotchkiss J. H. Elevated formation of nitrate and N-ni- trosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection // Cancer Res. — 1991. — Vol. 51. — P. 3925-3929.

1040. Liu R. H., Hotchkiss J. H. Potential genotoxicity of chronically elevated nitric oxide: A review // Mutat. Res. — 1995. — Vol. 339. — P. 73-89.

1041. Liu S., Ajani U., Chae C. et al. Long-term β-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial // JAMA. — 1999. — Vol. 282. — P. 1073-1075.

1042. Liu S. X., Zhou M., Chen Y. et al. Injury to mitochondria of mouse peritoneal macrophages caused by oxidized low-density lipoprotein, and protection afforded by polysaccharide krestin // Med. Sci. Res. — 1996. — Vol. 24. — P. 715-717.

1043. Liu X., Tosaki A., Engelman R. M., Das D. K. Reduction of postischaemic ventricular dysfunction and arrhytmias by trapping hydroxyl radicals with salicylic acid // Int. J. Tissue React. — 1993. — Vol. 15. — P. 25-30.

1044. Liu X., Wang J., Takeda N. et al. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes // Am. J. Physiol. — 1999. — Vol. 277. — P. E798-E804.

1045. Livrea M. A., Tesoriere L., Bongiorno A. et al. Contrbution of vitamin A to the oxidation resistence of human low density lipoproteins // Free Radic. Biol. Med. — 1995. — Vol. 18. — P. 401-409.

1046. Llesuy S., Milei J., Picone V. et al. Effect of vitamins A and E on ischemia-reperfusion damage in rabbit heart // Mol. Cell. Biochem. — 1995. — Vol. 145. — P. 45-51.

1047. Loenders B., Van Mechelen E., Nicolai S. et al. Localization of extracellular superoxide dismutase in rat lung: neutrophils and macrophages as carriers of the enzyme // Free Radic. Biol. Med. —

1998. — Vol. 24. — P. 1097-1106.

1048. Lohr J. B., Browning J. A. Free radical involvement in neuropsychiatric illnesses // Psychopharma- col. Bull. — 1995. — Vol. 31. — P. 159-165.

1049. Long R., Light B., Talbot J. A. Mycobacteriocidal action of exogenous nitric oxide // Antimicrob. Agents Chemother. — 1999. — Vol. 43. — P. 403-405.

1050. Lopes-Virella M. F., Mironova M., Virella G. LDL-containing immune complexes and atherosclerosis in diabetes // Diabetes Rev. — 1997. — Vol. 5. — P. 410-424.

1051. Losonczy K. G., Harris T. B., Havlik R. J. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly // Am. J. Clin. Nutr. — 1996. — Vol. 64. — P. 190-196.

1052. Loven D., Schedl H., Wilson H. et al. Effects of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocine-induced diabetes // Diabetes. — 1986. — Vol. 35. — P. 503-507.

1053. Lowe H., Baeger I., Blastig I. E., Haseloff R. F. Oxygen radicals attenuate the contractility ofskinned muscle fibers from the pig myocardium // Pharmazie. — 1994. — Vol. 49. — P. 845-849.

1054. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development // Mol. Cancer Res. — 2006. — Vol. 4. — P. 221-233.

1055. Lucehesi B. R., Tamura Y., Chi L. et al. Sustained protection of ischemic myocardium by polyethylene glycol conjugated superoxide dismutase // J. Mol. Cell. Cardiol. — 1988. — Vol. 20, Suppl. 3. — P. 13.

1056. Lucotti P., Setola E., Monti L. D. et al. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients // Am. J. Physiol. Endocrinol. Metab. — 2006. — Vol. 291. — P. E906-E912.

1057. Ludvik B., Nolan J. J., Baloga J. et al. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM // Diabetes. — 1995. — Vol. 44. — P. 1121-1125.

1058. Lukic M. L., Stosic-Grujicic S., Ostojic N. et al. Inhibition of nitric oxide generation effects the induction of diabetes by streptozotocin in mice // Biochem. Biophys. Res. Commun. — 1991. — Vol. 178. — P. 913-920.

1059. Luo Q., Cai Y., Yan J. et al. Hypoglycemic and hypolipidemic effects and antioxidant activity offruit extracts from Lycium barbarum // Life Sci. — 2004. — Vol. 76. — P. 137-149.

1060. Lurie A., Theven D., Brun-Pascaud M. et al. Acute hyperoxic lung edema is not reduced by granulocyte depletion in rats // Respiration. — 1988. — Vol. 53. — P. 232—238.

1061. Lynch S. M., Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein // J. Lipid Res. — 1993. — Vol. 34. — P. 1745—1753.

1062. Lyons T. J., Jenkins A. J. Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis // Diabetes Rev. — 1997. — Vol. 5. — P. 365—391.

1063. Ma J., Chen T., Mandelin J. et al. Regulation of macrophage activation // Cell. Mol. Life Sci. — 2003. — Vol. 60. — P. 2334-2346.

1064. Ma Q., Battelli L., Hubbs A. F. Multiorgan autoimmune inflammation, enhanced lymphoprolifera- tion, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2 // Am. J. Pathol. — 2006. — Vol. 168. — P. 1960-1974.

1065. Ma X. L., Weyrich A. S, Lefer D. J., Lefer A. M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium // Circ. Res. — 1993. — Vol. 72. — P. 403-412.

1066. Macfarlane W. M., Smith S. B., James R. F. et al. The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic β-cells // J. Biol. Chem. — 1997. — Vol. 272. — P. 20936-20944.

1067. Mackaness G. B. The immunological basis of acquired cellular resistance // J. Exp. Med. — 1964. — Vol. 120. — P. 105-120.

1068. MacMicking J. D., North R. J., LaCourse К. et al. Identification of nitric oxide synthase as a protective locus against tuberculosis // Proc. Natl. Acad. Sci. USA. — 1997. — Vol. 94. — P. 5243-5248.

1069. Madamanchi N. R., Runge M. S. Mitochondrial dysfunction in atherosclerosis // Circ. Res. — 2007. — Vol. 100. — P. 460-473.

1070. Madamanchi N. R., Tchivilev I., Runge M. Genetic markers of oxidative stress and coronary atherosclerosis // Curr. Atheroscler. Rep. — 2006. — Vol. 8. — P. 177-183.

1071. Maddux B. A., See W., Lawrence J. C. et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid // Diabetes. — 2001. — Vol. 50. — P. 404-410.

1072. Maeba R., Maruyama A., Tarutani O. et al. Oxidized low-density lipoprotein induces the production of superoxide by neutrophils // FEBS Lett. — 1995. — Vol. 377. — P. 309-312.

1073. Maeba R., Shimasaki H., Ueta N. Conformational changes in oxidized LDL recognized by mouse peritoneal macrophages // Biochim. Biophys. Acta. — 1994. — Vol. 1215. — P. 79-86.

1074. Maechler P., Jornot L., Wollheim C. B. Hydrogen peroxide alters mitochondrial activation and insulin secretion in pancreatic beta cells // J. Biol. Chem. — 1999. — Vol. 274. — P. 27905-27913.

1075. Maedler K., Sergeev P., Ris F. et al. Glucose-induced beta cell production of IL-^ contributes to glucotoxicity in human pancreatic islets // J. Clin. Invest. — 2002. — Vol. 110. — P. 851-860.

1076. Magaro M., Zoli A., Altmonte L. et al. Effect of fish oil on neutrophil chemiluminescence induced by different stimuli in patients with rheumatoid arthritis // Ann. Rheum. Dis. — 1992. — Vol. 51. — P. 877-880.

1077. Maggirwar S. B., Dhanraj D. N., Somani S. M., Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system // Biochem. Biophys. Res. Commun. — 1994. — Vol. 201. — P. 508-515.

1078. Maier C. M., Chan P. H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders // Neuroscientist. — 2002. — Vol. 8. — P. 323-334.

1079. Maiorano V., Chianese R., Fumarulo R. et al. Thymomodulin increases the depressed production of superoxide anion by alveolar macrophages in patients with chronic bronchitis // Int. J. Tiss. React. — 1989. — Vol. 11. — P. 21-25.

1080. Major C. D., Gao Z. Y., WolfB. A. Activation ofthe sphingomyelinase/ceramide signal transduction pathway in insulin-secreting β-cells: role in cytokine-induced β-cell death // Diabetes. — 1999. — Vol. 48. — P. 1372-1380.

1081. Malaisse W. J., Malaisse-Lagae F., Sener A., Pipeleers D. G. Determinants of the selective toxicity of alloxan to the pancreatic B cell // Proc. Natl. Acad. Sci. USA. — 1982. — Vol. 79. — P. 927-930.

1082. Malhotra A., Reich D., Nakouzi A. et al. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin-I in the heart, which are prevented by angiotensin II receptor blockade // Circ. Res. — 1997. — Vol. 81. — P. 1027-1033.

1083. Malik Z. A., Iyer S. S., Kusner D. J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages // J. Immunol. — 2001. — Vol. 166. — P. 3392—3401.

1084. Malo-Ranta U., Yla-Herttuala S., Metsa-Ketela T. et al. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation oflow density lipoprotein // FEBS Lett. — 1994. — Vol. 337. — P. 179-183.

1085. Man S. F. P., Hulbert W. C., Man G. et al. Effects of SO₂ exposure on canine pulmonary epithelial functions // Exp. Lung Res. — 1989. — Vol. 15. — P. 181-198.

1086. Man S. F. P., Williams D. J., Amy R. A. et al. Sequential changes in canine pulmonary epithelial and endothelial cell functions after nitrogen dioxide // Am. Rev. Respir. Dis. — 1990. — Vol. 142. — P. 199-205.

1087. Manadik S. P., Makar T. K., Murthy J. N. et al. Temporal changes in superoxide dismutase, glutathione peroxidase, and catalase levels in primary and peri-ischemic tissue // Mol. Chem. Neuro- pathol. — 1993. — Vol. 18. — P. 1-14.

1088. Manca C., Paul S., Barry C. E. et al. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro // Infect. Immun. — 1999. — Vol. 67. — P. 74-79.

1089. Mandal S., Sarode R., Dash S., Dash R. J. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus // Am. J. Clin. Pathol. — 1993. — Vol. 100. — P. 103-107.

1090. Mandrup-Poulsen T., Bendtzen K., Nielsen H. et al. Cytokines cause functional and structural damage to isolated islets of Langerhans // Allergy. — 1985. — Vol. 40. — P. 424-429.

1091. Mangin E. L., Kugiyama K., Nguy J. H. et al. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta // Circ. Res. — 1993. — Vol. 72. — P. 161-166.

1092. Manonmani G., Bhavapriya V., Kalpana S. et al. Antioxidant activity of Cassia fistula (Linn. ) flowers in alloxan induced diabetic rats //J. Ethnopharmacol. — 2005. — Vol. 97. — P. 39-42.

1093. Mantovani A., Sozzani S., Locati M. et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes // Trends Immunol. — 2002. — Vol. 23. — P. 549-555.

1094. Manzella D., Barbieri M., Ragno E., Paolisso G. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes // Am. J. Clin. Nutr. — 2001. — Vol. 73. — P. 1052-1057.

1095. Mao S. J., Yates M. T., Parker R. A. et al. Attenuation of atherosclerosis in a modified strain of hy- percholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol // Arterioscler. Thromb. — 1991. — Vol. 11. — P. 1266-1275.

1096. Marchetti P., Del Guerra S., Marselli L. et al. Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin // J. Clin. Endocrinol. Metab. — 2004. — Vol. 89. — P. 5535-5541.

1097. Maritim A. C., Moore B. H., Sanders R. A.,Watkins J. B. III. Effects of melatonin on oxidative stress in streptozotocin-induced diabetic rats // Int. J. Toxicol. — 1999. — Vol. 18. — P. 161-166.

1098. Maritim A. C., Sanders R. A., Watkins J. B. Diabetes, oxidative stress, and antioxidants: A review // J. Biochem. Mol. Toxicol. — 2003. — Vol. 17. — P. 24-38.

1099. Marklund S. L., Bjelle A., Elmqvist L. G. Superoxide dismutase isoenzymes ofthe synovial fluid in rheumatoid arthritis and in reactive arthritides // Ann. Rheum. Dis. — 1986. — Vol. 45. — P. 847-851.

1100. Martin G. M. Genetic engineering of mice to test the oxidative damage theory of aging // Ann. N.Y. Acad. Sci. — 2005. — Vol. 1055. — P. 26-34.

1101. Martin T. R., Pistorese B. P., Huudson L. D., Maunder R. J. The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome // Am. Rev. Respir. Dis. — 1991. — Vol. 144. — P. 254-262.

1102. Martin W. J., Powis G. W., Kachel K. L. Nitrofurantoin-stimulated oxidant production in pulmonary endothelial cells // J. Lab. Clin. Med. — 1985. — Vol. 105. — P. 23-29.

1103. Martinez F. O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization // Front. Biosci. — 2008. — Vol. 13. — P. 453-461.

1104. Martin-Gallan P., Carrascosa A., Gussinye M., Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications // Free Radic. Biol. Med. — 2003. — Vol. 34. — P. 1563-1574.

1105. Martin-Gallan P., Carrascosa A., Gussinye M., Dominguez C. Estimation oflipoperoxidative damage and antioxidant status in diabetic children: relationship with individual antioxidants // Free Radic. Res. - 2005. - Vol. 39. - P. 933-942.

1106. Martinussen H. J., Walderstrom A., Ronquist G. Functional and biochemical effects ofa K+-ionophore on the isolated perfused rabbit heart // Acta Physiol. Scand. — 1993. — Vol. 147. — P. 221-225.

1107. Martorana P. A., Kettenbach B., Breipohl G. et al. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist // Eur. J. Pharmacol. — 1990. — Vol. 182. — P. 395-396.

1108. Marx J. J. M., van Asbeck B. S. Use of iron chelators in preventing hydroxyl radical damage: Adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage // Acta Haematol. — 1996. — Vol. 95. — P. 49-62.

1109. Master S., Zahrt T. C., Song J., Deretic V. Mapping of Mycobacterium tuberculosis katGpromoters and their differential expression in infected macrophages // J. Bacteriol. — 2001. — Vol. 183. — P. 4033-4039.

1110. Master S. S., Springer B., Sander P. et al. Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages // Microbiology. — 2002. — Vol. 148. — P. 3139-3144.

1111. Masters B. A., Kelly E. J., Quaife C. J. et al. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium // Proc. Natl. Acad. Sci. USA. — 1994. — Vol. 91. — P. 584-588.

1112. Matsui M., Oshima M., Oshima H. et al. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene // Dev. Biol. — 1996. — Vol. 178. — P. 179-185.

1113. Masutani H., Naito M., Takahashi K. et al. Dysregulation of adult T-cell leukemia-derived factor (ADF)/thioredoxin in HIV infection: loss of ADF high-producer cells in lymphoid tissues of AIDS patients // AIDS Res. Human Retroviruses — 1992. — Vol. 8. — P. 1707-1715.

1114. Matsunaga H., Tanaka Y., Tanaka M. et al. Antiatherogenic mitochondrial genotype in patients with type 2 diabetes // Diabetes Care. — 2001. — Vol. 24. — P. 500-503.

1115. Matsunaga-Irie S., Maruyama T., Yamamoto Y. et al. Relation between development of nephropathy and the p22^phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients // Diabetes Care. — 2004. — Vol. 27. — P. 303-307.

1116. Matz R. L., Schott C., Stoclet J. C., Andriantsitohaina R. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products // Physiol. Res. — 2000. — Vol. 49. — P. 11-18.

1117. Maulik N., Yoshida T., Das D. K. Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase // Mol. Cell. Biochem. — 1999. — Vol. 1-2. — P. 13-21.

1118. Maziere C., Auclair M., Maziere J.-C. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells // FEBS Lett. — 1994. — Vol. 338. — P. 43-46.

1119. Mazzanti L., Rabini R. A., Faloila E. et al. Altered cellular Ca²+ and Na+ transport in diabetes mel- litus // Diabetes. — 1990. — Vol. 39. — P. 850-854.

1120. Mazzetti I., Grigolo B., Borzi R. M. et al. Serum copper zinc superoxide dismutase levels in patients with rheumatoid arthritis // Intern. J. Clin. Lab. Res. — 1996. — Vol. 26. — P. 245-249.

1121. McCall T., Vallance P. Nitric oxide takes centre stage with newly defined roles // Trends Pharmacol. Sci. — 1992. — Vol. 13. — P. 1-6.

1122. McCartney-Francis N., Allen J. B., Mizel D. E. et al. Suppression ofarthritis by an inhibitor of nitric oxide synthase // J. Exp. Med. — 1993. — Vol. 178. — P. 749-754.

1123. McCarty M. F. An antithrombotic role for nutritional antioxidants: implications for tumor metastasis and other pathologies // Med. Hypotheses. — 1986. — Vol. 19. — P. 345-357.

1124. McClung J. P., Roneker C. A., Mu W. et al. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase // Proc. Natl. Acad. Sci. USA. — 2004. — Vol. 101. — P. 8852-8857.

1125. McCord J. M., Omar B. A. Sources of free radicals // Toxicol. Industr. Health. — 1993. — Vol. 9. — P. 23-37.

1126. McCusker K. Mechanisms of respiratory tissue injury from cigarette smoking // Am. J. Med. — 1992. — Vol. 93. — P. S18-S21.

1127. McDaniel M. L., Kwon G., Hill J. R. et al. Cytokines and nitric oxide in islet inflammation and diabetes // Proc. Soc. Exp. Biol. Med. — 1996. — Vol. 211. — P. 24-32.

1128. McElroy M. C., Postle A. D., Kelly F. J. Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development // Biochim. Biophys. Acta. — 1992. — Vol. 1117. — P. 153-158.

1129. McGarry J. D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes // Diabetes. — 2002. — Vol. 51. — P. 7-18.

1130. McGarry J. D., Dobbins R. L. Fatty acids, lipotoxicity and insulin secretion // Diabetologia. —

1999. — Vol. 42. — P. 128-138.

1131. McKinnon K. P., Madden M. C., Noah T. L., Devlin R. B. In vitro ozone exposure increases release of arachidonic acid products from a human bronchial epithelial cell line // Toxicol. Appl. Pharmacol. — 1993. — Vol. 118. — P. 215-223.

1132. McLaren M., Elhadd T. A., Greene S. A., Belch J. J. Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients // Clin. Appl. Thromb. Hemost. — 1999. — Vol. 5. — P. 21-24.

1133. McNally A. K., Chisolm G. M., Morel D. W., Cathcart M. K. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway // J. Immunol. — 1990. — Vol. 145. — P. 254-259.

1134. Mehrabian M., Allayee H., Wong J. et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice // Circ. Res. — 2002. — Vol. 91. — P. 120-126.

1135. Mekinova D., Chorvathova V., Volkova K. et al. Effect of intake of exogenous vitamins C, E and β-carotene on the antioxidative status in kidneys of rats with streptozotocin-induced diabetes // Nahrung. — 1995. — Vol. 39. — P. 257-261.

1136. Melov S., Coskun P., Patel M. et al. Mitochondrial disease in superoxide dismutase 2 mutant mice // Proc. Natl. Acad. Sci. USA. — 1999. — Vol. 96. — P. 846-851.

1137. Melov S., Doctrow S. R., Schneider J. A. et al. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-cata- lase mimetics // J. Neurosci. — 2001. — Vol. 21. — P. 8348-8353.

1138. Menini S., Amadio L., Oddi G. et al. Deletion of p66^Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress // Diabetes. — 2006. — Vol. 55. — P. 1642-1650.

1139. Merhi-Soussi F., Kwak B. R., Magne D. et al. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice // Cardiovasc. Res. — 2005. — Vol. 66. — P. 583-593.

1140. Merry P., Winyard P. G., Morris C. J. et al. Oxygen free radicals, inflammation, and synovitis: the current status // Ann. Rheum. Dis. — 1989. — Vol. 48. — P. 864-870.

1141. Meyer F., Bairati I., Dagenais G. R. Lower ischemic heart disease incidence and mortality among vitamin supplement users // Can. J. Cardiol. — 1996. — Vol. 12. — P. 930-934.

1142. Meyne J., Ratliff R. L., Moyzis R. K. Conservation of the human telomere sequence (TTAGGG)n among vertebrates // Proc. Natl. Acad. Sci. USA. — 1989. — Vol. 86. — P. 7049-7053.

1143. Mickle D. A. G. Efficacy of water-soluble analogs of vitamin E in the prevention of myocardial ischemia-reperfusion injury // Toxicol. Industrial Health. — 1993. — Vol. 9. — P. 309-322.

1144. Miesel R., Sanocka D., Kurpisz M., Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors // Inflammation. — 1995. — Vol. 19. — P. 347-362.

1145. Miesel R., Zuber M. Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases // Inflammation. — 1993. — Vol. 17. — P. 551-561.

1146. Migliaccio E., Giorgio M., Mele S. et al. The p66^Shc adaptor protein controls oxidative stress response and life span in mammals // Nature. — 1999. — Vol. 402. — P. 309-313.

1147. Migliaccio E., Giorgio M., Pelicci P. G. Apoptosis and aging: role of p66Shc redox protein // Anti- oxid. Redox Signal. — 2006. — Vol. 8. — P. 600-608.

1148. Millar T. M., Stevens C. R., Benjamin N. et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions // FEBS Lett. — 1998. — Vol. 427. — P. 225-228.

1149. Miller D. M., Grover T. A., Nayini N., Aust S. D. Xanthine oxidase- and iron-dependent lipid peroxidation // Arch. Biochem. Biophys. — 1993. — Vol. 301. — P. 1-7.

1150. Miller R. A., Britigan B. E. Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation // J. Clin. Invest. — 1995. — Vol. 6. — P. 2491-2500.

1151. Milligan S. A., Hoeffel J. M., Golstein I. M., Flick M. R. Effect of catalase on endotoxin-induced acute lung injury in unanaesthetized sheep // Am. Rev. Respir. Dis. — 1988. — Vol. 137. — P. 420-428.

1152. Mills C. D., Kincaid K., Alt J. M. et al. M-1/M-2 macrophages and the Th1/Th2 paradigm // J.Immunol. - 2000. - Vol. 164. - P. 6166-6173.

1153. Minor R. L., Myers P. R., Guerra R. et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta // J. Clin. Invest. — 1990. — Vol. 86. — P. 2109-2116.

1154. Minotti G., DiGennaro M., D’Ugo D., Granone P. Possible sources of iron for lipid peroxidation // Free Radic. Res. Commun. — 1991. — Vol. 12-13. — P. 99-106.

1155. Mitsui A., Hamuro J., Nakamura H. et al. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span // Antioxid. Redox. Signal. — 2002. — Vol. 4. — P. 693-696.

1156. Mizutani M., Kern T. S., Lorenzi M. Accelerated death of retinal microvascular pericytes in human and experimental diabetic retinopathy // J. Clin. Invest. — 1996. — Vol. 97. — P. 2883-2890.

1157. Mocchegiani E., Muzzioli M. Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing // Biogerontology. — 2000. — Vol. 1. — P. 133-143.

1158. Modak M. A., Datar S. P., Bhonde R. R., Ghaskadbi S. S. Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status // J. Comp. Physiol. [B]. — 2007. — Vol. 177. — P. 247-257.

1159. Modolell M., Corraliza I. M., Link F. et al. Reciprocal regulation of the nitric oxide synthase/argi- nase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines // Eur. J. Immunol. — 1995. — Vol. 25. — P. 1101-1104.

1160. Mohan Kumar M., Joshi M. C., Prabha T. et al. Effect of plantain banana on gastric ulceration in NIDDM rats: role of gastric mucosal glycoproteins, cell proliferation, antioxidants and free radicals // Indian J. Exp. Biol. — 2006. — Vol. 44. — P. 292-299.

1161. Moilanen E., Vapaatalo H. Nitric oxide in inflammation and immune response // Ann. Med. — 1995. — Vol. 27. — P. 359-367.

1162. Moller D. E. Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes // Trends Endocrinol. Metab. — 2000. — Vol. 11. — P. 212-217.

1163. Molloy A., Laochumroonvorapong P., Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin // J. Exp. Med. — 1994. — Vol. 180. — P. 1499-1509.

1164. Mollsten A., Marklund S. L., Wessman M. et al. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy // Diabetes. — 2007. — Vol. 56. — P. 265-269.

1165. Molnar G. A., Wagner Z., Marky L. et al. Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production // Kidney Int. — 2005. — Vol. 68. — P. 2281-2287.

1166. Moncada S. The L-arginine:nitric oxide pathways // Acta Physiol. Scand. — 1992. — Vol. 145. — P. 201-227.

1167. Moorhouse P. C., Grootveld M., Halliwell B. et al. Allopurinol and oxypurinol are hydroxyl radical scavengers // FEBS Lett. — 1987. — Vol. 213. — P. 23-28.

1168. Moreira P. I., Santos M. S., Seica R., Oliveira C. R. Brain mitochondrial dysfunction as a link between Alzheimer’s disease and diabetes // J. Neurol. Sci. — 2007. — Vol. 257. - P. 206-214.

1169. Morel D. W., DiCorleto P. E., Chisolm G. M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation // Arteriosclerosis. — 1984. — Vol. 4. — P. 357-364.

1170. Mori I., Yoshimura S., Watanabe K. Immunohistochemical localization of glutathione peroxidase, a lipid peroxides scavenger, in atherosclerotic lesions of human arteries // Pathol. Int. — 1995. — Vol. 45. — P. 343-351.

1171. Morris D. L., Kritchevsky S. B., Davis C. E. Serum carotenoids and coronary heart disease: The lipid research clinics coronary primary prevention trial and follow-up study // J. A. M. A. — 1994. — Vol. 272. — P. 1439-1441.

1172. Mosca L., Rubenfire M., Mandel C. et al. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease // J. Am. Coll. Cardiol. — 1997. — Vol. 30. — P. 393-399.

1173. Moskovitz J., Bar-Noy S., Williams W. M. et al. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals // Proc. Natl. Acad. Sci. USA. — 2001. — Vol. 98. — P. 12920-12925.

1174. Moskovitz J., Yim M. B., Chock P. B. Free radicals and disease // Arch. Biochem. Biophys. — 2002. — Vol. 397. — P. 354-359.

1175. Mosser D. M. The many faces of macrophage activation // J. Leukoc. Biol. — 2003. — Vol. 73. — P. 209-212.

1176. Muller F. L., Lustgarten M. S., Jang Y. et al. Trends in oxidative aging theories // Free Radic. Biol. Med. - 2007. - Vol. 43. - P. 477-503.

1177. Muller F. L., Song W., Liu Y et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy // Free Radic. Biol. Med. — 2006. — Vol. 40. — P. 1993-2004.

1178. Muller G., Ertl J., Gerl M., Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes // J. Biol. Chem. — 1997. — Vol. 272. — P. 10585-10593.

1179. Munder M., Eichmann K., Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype // J. Immunol. — 1998. — Vol. 160. — P. 5347-5354.

1180. Munro J. M., Cotran R. S. The pathogenesis of atherosclerosis: Atherosclerosis and inflammation // Lab. Invest. — 1988. — Vol. 58. — P. 249-261.

1181. Murata Y., Shimamura T., Hamuro J. The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production // Int. Immunol. — 2002. — Vol. 14. — P. 201-212.

1182. Murohara T., Kugiyama K., Sugiyama S. et al. Activated human polymorphonuclear leukocytes elicit endothelium-dependent contraction in isolated pig coronary arteries // J. Cardiovasc. Pharmacol. — 1993. — Vol. 21. — P. 760-766.

1183. Murphy H. S., Warner R. L., Bakopoulos N. et al. Endothelial cell determinants of susceptibility to neutrophil-mediated killing // Shock. — 1999. — Vol. 12. — P. 111-117.

1184. Murphy J. E., Tedbury P. R., Homer-Vanniasinkam S. et al. Biochemistry and cell biology of mammalian scavenger receptors // Atherosclerosis. — 2005. — Vol. 182. — P. 1-15.

1185. Murugesh K., Yeligar V., Dash D. K. et al. Antidiabetic, antioxidant and antihyperlipidemic status of Heliotropium zeylanicum extract on streptozotocin-induced diabetes in rats // Biol. Pharm. Bull. — 2006. — Vol. 29. — P. 2202-2205.

1186. Mutmansky J . M. The war on black lung // Earth Miner. Sci. — 1990. — Vol. 59. — P. 6-10.

1187. Myers P. R., Wright T. F., Tanner M. A., Ostlund R. E. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium // J. Lab. Clin. Med. — 1994. — Vol. 124. — P. 672-683.

1188. Mylona-Karayanni C., Gourgiotis D., Bossios A., Kamper E. F. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link // Pediatr. Diabetes. — 2006. — Vol. 7. — P. 51-59.

1189. Mysore T. B., Shinkel T. A., Collins J. et al. Overexpression of glutathione peroxidase with two isoforms of superoxide dismutase protects mouse islets from oxidative injury and improves islet graft function // Diabetes. — 2005. — Vol. 54. — P. 2109-2116.

1190. Nadler J. L., Natarajan R. Oxidative stress, inflammation, and diabetic complications // Diabetes Mellitus: A Fundamental and Clinical Text. — Philadelphia: Lippincott Williams & Wilkins,

2000. — P. 1008-1016.

1191. Nagano Y., Nakamura T., Matsuzawa Y. et al. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit-long-term antiatherogenic effect and effects on established plaques // Atherosclerosis. — 1992. — Vol. 92. — P. 131-140.

1192. Nagy N., Malik G., Fisher A. B., Das D. K. Targeted disruption of peroxiredoxn 6 gene renders the heart vulnerable to ischemia reperfusion injury // Am. J. Physiol. Heart Circ. Physiol. — 2006. — Vol. 291. — P. H2636-H2640.

1193. Naito M., Hayashi T., Iguchi A. New approaches to the prevention of atherosclerosis // Drugs. —

1995. — Vol. 50. — P. 440-453.

1194. Naito M., Kuzuya M. Iguchi A. Mechanisms of endothelial cell injury induced by oxidatively modified LDL // J. Jap. Atherosclerosis Soc. — 1994. — Vol. 22. — P. 257-262.

1195. Nakagawa K., Fujimoto K., Miyazawa T. β-Carotene as a high-potency antioxidant to prevent the formation of phospholipid hydroperoxides in red blood cells of mice // Biochim. Biophys. Acta. —

1996. — Vol. 1299. — P. 110-116.

1196. Nakanishi K., Vinten-Johansen J., Lefer D. J. et al. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size // Am. J. Physiol. — 1992. — Vol. 263. — P. H1650-1658.

1197. Napoli C., Martin-Padura I., de Nigris F. et al. Deletion of the p66^Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high- fat diet // Proc. Natl. Acad. Sci. USA. — 2003. — Vol. 100. — P. 2112-2116.

1198. Nathan C. Nitric oxide as a secretory product of mammalian cells // FASEB J. — 1992. — Vol. 6. — P. 3051-3064.

1199. Nathan C. F. Respiratory burst in adherent human neutrophils, triggering by colony-stimulating factor GSF-GM and GSF-G // Blood. — 1989. — Vol. 73. — P. 301-306.

1200. Nauseef W. M. Myeloperoxidase deficiency // Hematol. Pathol. — 1990. — Vol. 4. — P. 165-178.

1201. Navarro A. Mitochondrial enzyme activities as biochemical markers of aging // Mol. Aspects Med. — 2004. — Vol. 25. — P. 37-48.

1202. Navarro A., Gomez C., Sanchez-Pino M. J. et al. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice // Am. J. Physiol. Regul. Integr. Comp. Physiol. — 2005. — Vol. 289. — P. R1392-R1399.

1203. Neumann C. A., Krause D. S., Carman C. V. et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression // Nature. — 2003. — Vol. 424. — P. 561-565.

1204. Neve J., Fontaine J., Peretz A., Famaey J. P. Changes in zinc, copper and selenium status during adjuvant-induced arthritis in rats // Agents Actions. — 1988. — Vol. 25. — P. 146-155.

1205. Newaz M. A., Yousefipour Z., Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent // J. Cardiovasc. Pharmacol. — 2006. — Vol. 48. — P. 88-94.

1206. Newton A. C. Protein kinase C: structure, function and regulation; minireview // J. Biol. Chem. — 1995. — Vol. 270. — P. 28495-28498.

1207. Nguyen-Khoa T., Massy Z. A., Witko-Sarsat V. et al. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety: A novel pathway in atherogenesis? // Biochem. Biophys. Res. Commun. — 1999. — Vol. 263. — P. 804-809.

1208. Nicholson K. M., Anderson N. G. The protein kinase B/Akt signaling pathway in human malignancy // Cell. Signal. — 2002 . — Vol. 14. — P. 381-395.

1209. Nicholson S., Bonecini-Almeida M. G., Lapa e Silva J. R. et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis // J. Exp. Med. — 1996. — Vol. 183. — P. 2293-2302.

1210. Nie H., Wu J. L., Zhang M. et al. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo// Diabetes. — 2006. — Vol. 55. — P. 3133-3141.

1211. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals // Am. J. Klin. Nutr. — 1991. — Vol. 54. — P. S1119-S1124.

1212. Nikkila M., Pitkajarvi T., Koivula T. et al. Women have a larger and less atherogenic low density lipoprotein particle size then men // Atherosclerosis. — 1996. — Vol. 119. — P. 181-190.

1213. Nikula K. J., Wilson D. W. Response of rat tracheal epithelium to ozone and oxygen exposure in vitro // Fundam. Appl. Toxicol. —1990. — Vol. 15. — P. 121-131.

1214. Nishikawa T., Edelstein D., Du X. L. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage // Nature. — 2000. — Vol. 404. — P. 787-790.

1215. Nishikawa T., Edelstein D., Brownlee M. The missing link: a single unifying mechanism for diabetic complications // Kidney Int. — 2000. — Vol. 58. — P. 26-30.

1216. Node K., Kitakaze M., Kosaka H. et al. Plasma nitric oxide end products are increased in the ischemic canine heart // Biochem. Biophys. Res. Commun. — 1995. — Vol. 211. — P. 370-374.

1217. Noel W., Raes G., Ghassabeh G. H. et al. Alternatively activated macrophages during parasite infections // Trends Parasitol. — 2004. — Vol. 20. — P. 126-133.

1218. Nolan J. J., Freidenberg G., Henry R. et al. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity // J. Clin. Endocrinol. Metab. — 1994. — Vol. 78. — P. 471-477.

1219. Nonn L., Williams R. R., Erickson R. P., Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice // Mol. Cell. Biol. — 2003. — Vol. 23. — P. 916-922.

1220. Nossuli T. O., Hayward R., Scalia R., Lefer A. M. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats // Circulation. — 1997. — Vol. 96. — P. 2317-2324.

1221. Nouroozzadeh J., Tajaddinisarmadi J., Ling K. L. E., Wolff S. P. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma — Relevance to determination of total plasma lipid hydroperoxide concentrations // Biochem. J. — 1996. — Vol. 313. — P. 781-786.

1222. Nurcombe H. L., Bucknall R. C., Edwards S. W. Activation of the neutrophil myeloperoxidase- H₂O₂ system by synovial fluid isolated from patients with rheumatoid arthritis // Ann. Rheum. Dis. - 1991. - Vol. 50. - P. 237-242.

1223. Nussler A. K., Billiar T. R. Inflammation, immunoregulation, and inducible nitric oxide synthase // J. Leukoc. Biol. - 1993. - Vol. 54. - P. 171-178.

1224. Nwanjo H. U. Efficacy of aqueous leaf extract of Vernonia amygdalina on plasma lipoprotein and oxidative status in diabetic rat models // Niger. J. Physiol. Sci. - 2005. - Vol. 20. - P. 39-42.

1225. Nystrom T. Role of oxidative carbonylation in protein quality control and senescence // EMBO J. - 2005. - Vol. 24. - P. 1311-1317.

1226. O’Brien B. A., Harmon B. V., Cameron D. P., Allan D. J. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing β-cell apoptosis // J. Pathol. - 2000. - Vol. 191. - P. 86-92.

1227. O’Brien L., Carmichael J., Lowrie D. B., Andrew P. W. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro // Infect. Immun. - 1994. - Vol. 62. - P. 5187-5190.

1228. O’Brien S., Andrew P. W. Guinea-pig alveolar macrophage killing of Mycobacterium tuberculosis, in vitro, does not require hydrogen peroxide or hydroxyl radical // Microb. Pathog. - 1991. - Vol. 11. - P. 229-236.

1229. O’Brien S., Jackett P. S., Lowrie D. B., Andrew P. W. Guinea-pig alveolar macrophages kill Mycobacterium tuberculosis in vitro, but killing is independent of susceptibility to hydrogen peroxide or triggering of the respiratory burst // Microb. Pathog. - 1991. - Vol. 10. - P. 199-207.

1230. Ochoa J. B., Udekwu A. O., Billiar T. R. et al. Nitrogen oxide levels in patients after trauma and sepsis // Ann. Surg. - 1991. - Vol. 214. - P. 621-626.

1231. Oddo M., Renno T., Attinger A. et al. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis // J. Immunol. - 1998. - Vol. 160. - P. 5448-5454.

1232. Ohara Y., Peterson T. E., Sayegh H. S. et al. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production // Circulation. - 1995. - Vol. 92. - P. 898-903.

1233. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mel- litus: A randomized prospective 6-year study // Diabetes Res. Clin. Pract. - 1995. - Vol. 28. - P. 103-117.

1234. Ohno H., Zhu G., Mohan V. P. et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis// Cell Microbiol. - 2003. - Vol. 5. - P. 637-648.

1235. Ohoi T., Sone K., Tobari H. et al. A simple chemiluminescence method for measuring oxygen- derived free radicals generated in oxygenated rat myocardium // Jap. J. Pharmacol. - 1993. - Vol. 61. - P. 101-107.

1236. Ohta H., Nakazawa H., Jinno Y. et al. Effects of K⁺ channel openers on ischemic dysfunction and metabolic disturbance in isolated perfused rat heart // Eur. J. Pharmacol. - 1993. - Vol. 231. - P. 323-330.

1237. Oikawa S., Tada-Oikawa S., Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening // Biochemistry. - 2001. - Vol. 40. - P. 4763-4768.

1238. Oka S., Ogino K., Matsuura S. et al. Human serum immunoreactive copper,zinc-superoxide dis- mutase assayed with an enzyme monoclonal immunosorbent in patients with digestive cancer // Clin. Chim. Acta. - 1989. - Vol. 182. - P. 209-220.

1239. Okabe E., Kato Y., Kontos H. et al. Inhibition by free radical scavengers and by cyclooxygenase inhibitors of the effect of acidosis on calcium transport by masseter muscle sarcoplasmic reticulum // Biochem. Pharmacol. - 1985. - Vol. 34. - P. 961-968.

1240. Okado A., Kawasaki Y., Hasuike Y. et al. Induction of apoptotic cell death by methylglyoxal and 3- deoxyglucosone in macrophage-derived cell lines // Biochem. Biophys. Res. Commun. - 1996. - Vol. 225. - P. 219-224.

1241. O’Leary V. J., Darley-Usmar V. M., Russell L. J., Stone D. Pro-oxidant effects of lipoxygenase- derived peroxides on the copper-initiated oxidation of low-density lipoprotein // Biochem. J. - 1992. - Vol. 282. - P. 631-634.

1242. Olmos P. R., Hodgson M. I., Maiz A. et al. Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics // Diabetes Res. Clin. Pract. - 2006. - Vol. 71. - P. 320-333.

1243. Olson L. K., Redmon J. B., Towle H. C., Robertson R. P. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein // J. Clin. Invest. -1993. — Vol. 92. — P. 514-519.

1244. Omenn G. S., Goodman G. E, Thornquist M. D. et al. Effects of a combination ofbeta carotene and vitamin A on lung cancer and cardiovascular disease // New Engl. J. Med. — 1996. — Vol. 334. — P. 1150-1155.

1245. O’Neill B., Leonard B. E. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of deppression // J. Affect. Disord. — 1990. — Vol. 19. — P. 265-273.

1246. Oranje W. A., Rondas-Colbers G. J., Swennen G. N., Wolffenbuttel B. H. Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease? // Neth. J. Med. — 1998. — Vol. 53. — P. 61-68.

1247. Orhan D. D., Aslan M., Sendogdu N. et al. Evaluation of the hypoglycemic effect and antioxidant activity of three Viscum album subspecies (European mistletoe) in streptozotocin-diabetic rats // J. Ethnopharmacol. — 2005. — Vol. 98. — P. 95-102.

1248. Orie N. N., Zidek W., Tepel M. Increased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus type 2 // Exp. Clin. Endocrin. Diabetes. — 2000. — Vol. 108. — P. 175-180.

1249. Orie N. N., Zidek W., Tepel M. Reactive oxygen species in essential hypertension and non-insulin- dependent diabetes mellitus // Am. J. Hypertens. — 1999. — Vol. 12. — P. 1169-1174.

1250. Orr W. C., Sohal R. S. Extension oflife-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster// Science. — 1994. — Vol. 263. — P. 1128-1130.

1251. Oschilewski U., Kiesel U., Kolb H. Administration of silica prevents diabetes in BB rats // Diabetes. — 1985. — Vol. 34. — P. 197-199.

1252. Osicka T. M., Yu Y., Panagiotopoulos S. et al. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C // Diabetes. — 2000. — Vol. 49. — P. 87-93.

1253. Ouchi N., Kihara S., Arita Y. et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway // Circulation. — 2000. — Vol. 102. — P. 1296-1301.

1254. Oury T. D., Day B. J., Crapo J. D. Extracellular superoxide dismutase in vessels and airways of humans and baboons // Free Radic. Biol. Med. — 1996. — Vol. 20. — P. 957-963.

1255. Ozaki Y., Ohashi T., Niwa Y. Oxygen radical production by neutrophils from patients with bacterial infection and rheumatoid arthritis // Inflammation. — 1986. — Vol. 10. — P. 119-130.

1256. Ozsoy-Sacan O., Yanardag R., Orak H. et al. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats // J. Ethnopharmacol. — 2006. — Vol. 104. — P. 175-181.

1257. Packer L. Antioxidants: molecular interactions between vitamins E and C, biothiols and carotenes // NATO ASI Series. — Vol. H92. — Berlin, Heidelberg: Springer-Verlag, 1995. — P. 187-216.

1258. Padayatty S. J., Sun H., Wang Y. et al. Vitamin C pharmacokinetics: implications for oral and intravenous use // Ann. Intern. Med. — 2004. — Vol. 140. — P. 533-537.

1259. Padmaja S., Huie R. E. The reaction of nitric oxide with organic peroxyl radicals // Biochem. Bio- phys. Res. Commun. — 1993. — Vol. 195. — P. 539-544.

1260. Padmanabhan R. V., Gudapaty R., Liener I. E. et al. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase // Am. Rev. Respir. Dis. — 1985. — Vol. 132. — P. 164-167.

1261. Paganga G., Rice-Evans C., Rule R., Leake D. S. The interaction between ruptured erythrocytes and low-density lipoprotein // FEBS Lett. — 1992. — Vol. 303. — P. 154-158.

1262. Pages G., Berra E., Milanini J. et al. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability // J. Biol. Chem. — 2000. — Vol. 275. — P. 26484-26491.

1263. Palanduz S., Ademoglu E., Gokkusu C., Tamer S. Plasma antioxidants and type 2 diabetes mellitus // Res. Commun. Mol. Pathol. Pharmacol. — 2001. — Vol. 109. — P. 309-318.

1264. Palinski W., Rosenfeld M. E., Yla-Herttuala S. et al. Low density lipoprotein undergoes oxidative modification in vivo // Proc. Natl. Acad. Sci. USA. — 1989. — Vol. 86. — P. 1372—1376.

1265. Palladini G., Finardi G., Bellomo G. Disruption of actin microflament organization by cholesterol oxides in 73/73 endothelial cells // Exp. Cell Res. — 1996. — Vol. 223. — P. 72—82.

1266. Palmer R. M. J., Hickery M. S., Charles I. C. et al. Induction of nitric oxide synthase in human chondrocytes // Biochem. Biophys. Res. Commun. — 1993. — Vol. 193. — P. 398—405.

1267. Panasenko O. M., Arnhold J. Linoleic acid hydroperoxide favours hypochlorite- and myeloperoxidase-induced lipid peroxidation // Free Radic. Res. — 1999. — Vol. 30. — P. 479—487.

1268. Panasenko O. M., Briviba K., Klotz L. O., Sies H. Oxidative modification and nitration of human low-density lipoproteins by the reaction of hypochlorous acid with nitrite // Arch. Biochem. Biophys. — 1997. — Vol. 343. — P. 254-259.

1269. Panasenko O. M., Evgina S. A., Nikitin S. V., Sergienko V. I. Effect of hypochlorite on the surface electric properties of human blood lipoproteins // Biofzika. — 1995. — Vol. 40. — P. 545-550.

1270. Pandey K. K., Shekelle R., Selwyn B. J. et al. Dietary vitamin C and beta-carotene and risk of death in middle-aged men // J. Am. Epidemiol. — 1995. — Vol. 142. — P. 1269-1278.

1271. Panus P. C., Shearer J., Freeman B. A. Pulmonary metabolism of reactive oxygen species // Exp. Lung Res. — 1988. — Vol. 14, Suppl. — P. 959-976.

1272. Paolisso G., D’Amore A., Giugliano D. et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients // Am. J. Clin. Nutr. — 1993. — Vol. 57. — P. 650-656.

1273. Paolisso G., Di Maro G., Pizza G. et al. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics // Am. J. Physiol. — 1992. — Vol. 263. — P. E435-E440.

1274. Paolisso G., Gambardella A., Tagliamonte M. R. et al. Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? // J. Clin. Endocrinol. Metab. — 1996. — Vol. 81. — P. 4244-4248.

1275. Paolisso G., Giugliano D. Oxidative stress and insulin action: is there a relationship? // Diabetolo- gia. — 1996. — Vol. 39. — P. 357-363.

1276. Paolisso G., Tagliamonte M. R., Barbieri M. et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients // J. Clin. Endocrinol. Metab. — 2000. — Vol. 85. — P. 109-115.

1277. Paraidathathu T., De Groot H., Kehrer J. P. Production of reactive oxygen by mitochondria from normoxic and hypoxic rat heart tissue // Free Radic. Biol. Med. — 1992. — Vol. 13. — P. 289-297.

1278. Pari L., Latha M. Antidiabetic effect of Scoparia dulcis, effect on lipid peroxidation in streptozotocin diabetes // Gen. Physiol. Biophys. — 2005. — Vol. 24. — P. 13-26.

1279. Pari L., Latha M. Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipidperoxidation in STZ diabetic male Wistar rats // BMC Complement. Altern. Med. — 2004. — Vol. 4. — Paper 16.

1280. Parihar M. S., Chaudhary M., Shetty R., Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania som- nifera and Aloe vera // J. Clin. Neurosci. — 2004. — Vol. 11. — P. 397-402.

1281. Park C. W., Kim J. H., Lee J. W. et al. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-KB-dependent // Diabetologia. — 2000. — Vol. 43. — P. 1544-1553.

1282. Park J.-Y., Takahara N., Gabriele A. et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation // Diabetes. — 2000. — Vol. 49. — P. 1239-1248.

1283. Park S. A., Choi M. S., Jung U. J. et al. Eucommia ulmoides Oliver leaf extract increases endogenous antioxidant activity in type 2 diabetic mice // J. Med. Food. — 2006. — Vol. 9. — P. 474-479.

1284. Park Y. S., Koh Y. H., Takahashi M. et al. Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185 // Free Radic. Res. — 2003. — Vol. 37. — P. 205-211.

1285. Parke D. V., Symons A. M., Parke A. L. Oxyradicals, inflammation and drugs acting on oxyradi- cal production // New Developments in Antirheumatic Therapy: Inflammation and Drug Therapy Series. — Vol. 3. — Dodrecht: Kluwer Acad. Publishers, 1989. — P. 187-206.

1286. Parkes H. G., Allen R. E., Furst A. et al. Speciation of non-transferrin-bound iron ions in synovial fluid from patients with rheumatoid arthritis by proton nuclear magnetic resonance spectroscopy // J. Pharm. Biomed. Anal. — 1991. — Vol. 1. — P. 29-32.

1287. Parlar H. Photochemical generated reactive oxygen species in the environment // Reactions and Processes. — Vol. 2, Pt. F. — Berlin: Springer-Verlag, 1991. — P. 229—252.

1288. Parthasarathy S. Oxidation of low-density lipoprotein by thiol compound leads to its recognition by the acetyl LDL receptor // Biochim. Biophys. Acta. — 1987. — Vol. 917. — P. 337—340.

1289. Parthasarathy S., Khoo J. C., Miller E. et al. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 3894-3898.

1290. Parthasarathy S., Printz D. J., Boyd D. et al. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor // Arteriosclerosis. — 1986. — Vol. 6. — P. 505-510.

1291. Parthasarathy S., Steinbrecher U. P., Barnett J. et al. Essential role of phospholipase A2 activity in endothelial cell-induced modification of LDL // Proc. Natl. Acad. Sci. USA. — 1985. — Vol. 82. — P. 3000-3004.

1292. Parthasarathy S., Wieland E., Steiberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein // Proc. Natl. Acad. Sci. USA. — 1989. — Vol. 86. — P. 1046-1050.

1293. Parthasarathy S., Young S. G., Witztum J. L., Pittman R. C. Probucol inhibits oxidative modification of low density lipoprotein // J. Clin. Invest. — 1986. — Vol. 77. — P. 641-644.

1294. Parthiban A., Vijayalingam S., Shanmugasundaram K. R., Mohan R. Oxidative stress and the development of diabetic complications — antioxidants and lipid peroxidation in erythrocytes and cell membrane // Cell Biol. Int. — 1995. — Vol. 19. — P. 987-993.

1295. Patterson C. E., Rhoades R. A. Protective role of sulfhydryl reagents in oxidant lung injury // Exp. Lung Res. — 1988. — Vol. 14. — P. 1005-1020.

1296. Pavlovic D., Andersen N. A., Mandrup-Poulsen T., Eizirik D. L. Activation of extracellular signal- regulated kinase (ERK) 1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells // Eur. Cytokine Netw. — 2000. — Vol. 11. — P. 267-274.

1297. Pawson T., Scott J. D. Signaling through scaffold, anchoring, and adaptor proteins // Science. — 1997. — Vol. 278. — P. 2075-2080.

1298. Paz K., Hemi R., LeRoith D. et al. A molecular basis for insulin resistance. Elevated serine/threo- nine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation // J. Biol. Chem. — 1997. — Vol. 272. — P. 29911-29918.

1299. PDAY research group: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking // JAMA. — 1990. — Vol. 264. — P. 3018-3024.

1300. Pearl R. G. Inhaled nitric oxide — the past, the present, and the future // Anesthesiology. — 1993. — Vol. 78. — P. 413-416.

1301. Peiro C. Angulo J., Rodriguez-Manas L. et al. Vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin // Br. J. Pharmacol. — 1998. — Vol. 125. — P. 637-644.

1302. Peiro C., Vallejo S., Nevado J. et al. Pharmacological interference of vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin // Eur. J. Pharmacol. — 1999. — Vol. 386. — P. 317-321.

1303. Peng H. B. Rajavashisth T. B., Libby P., Liao J. K. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells // J. Biol. Chem. — 1995. — Vol. 28. — P. 17050-17055.

1304. Pennington J. E., Rossing T. H., Boerth L. W., Lee T. H. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil activating factor // J. Clin. Invest. — 1985. — Vol. 75. — P. 1230-1237.

1305. Pepke-Zaba J. Higenbottam T. W., Dinh-Xuan A. T. et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension // Lancet. — 1991. — Vol. 338. — 1173-1174.

1306. Peponis V., Popothanasiou M., Kapranou A. et al. Protective role of oral antioxidant supplementation in ocular surface of diabetic patients // Br. J. Ophthalmol. — 2002. — Vol. 86. — P. 1369-1373.

1307. Pereira B., Costa Rosa L. F. B. P., Safi D. A. et al. Hormonal regulation of superoxide dismutase, catalase, and glutathione peroxidase activities in rat macrophages // Biochem. Pharmacol. — 1995. — Vol. 50. — P. 2093-2098.

1308. Perez C., Canal J. R., Torres M. D. Experimental diabetes treated with Ficus carica extract: effect on oxidative stress parameters // Acta Diabetol. — 2003. — Vol. 40. — P. 3-8.

1309. Perkowski S., Sun J., Singhal S. et al. Gene expression profiling of the early pulmonary response to hyperoxia in mice // Am. J. Respir. Cell Mol. Biol. — 2003. — Vol. 28. — P. 682—696.

1310. Perry J. J., Fan L., Tainer J. A. Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair // Neuroscience. — 2007. — Vol. 145. — P. 1280-1299.

1311. Perseghin G., Ghosh S., Gerow K., Shulman G. I. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study // Diabetes. —1997. — Vol. 46. — P. 1001-1009.

1312. Perskvist N., Long M., Stendahl O., Zheng L. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-x_L via an oxygen-dependent pathway // J. Immunol. — 2002. — Vol. 168. — P. 6358-6365.

1313. Pesce J., Kaviratne M., Ramalingam T. R. et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation // J. Clin. Invest. — 2006. — Vol. 116. — P. 2044-2055.

1314. Petersen S., Saretzki G., von Zglinicki T. Preferential accumulation of single-stranded regions in telomeres of human fibroblasts // Exp. Cell Res. — 1998. — Vol. 239. — P. 152-160.

1315. Peterson D. A., Kelly B., Gerraro G. M. Allopurinol can act as an electron transfer agent // Bio- chem. Res. Commun. — 1986. — Vol. 137. — P. 76-79.

1316. Petros A., Lamb G., Leone A. et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock // Cardiovasc. Res. — 1994. — Vol. 28. — P. 34-39.

1317. Peuchant E., Delmas-Beauvieux M. C., Couchouron A. et al. Short-term insulin therapy and nor- moglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients // Diabetes Care. — 1997. — Vol. 20. — P. 202-207.

1318. Pfeiffer A., Schatz H. Diabetic microvascular complications and growth factors // Exp. Clin. Endocrinol. Diabetes. — 1995. — Vol. 103. — P. 7-14.

1319. Pfeilschifter J., Eberhardt W., Hummel R. et al. Therapeutic strategies for the inhibition of inducible nitric oxide synthase — potential for a novel class of anti-inflammatory agents // Cell Biol. Intern. — 1996. — Vol. 20. — P. 51-58.

1320. Phillips A. N., Neaton J. D., Cook D. G. et al. Leukocyte count and risk of major coronary heart disease events // Am. J. Epidemiol. — 1992. — Vol. 136. — P. 59-70.

1321. Phillips J. P., Campbell S. D., Michaud D. et al. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity // Proc. Natl. Acad. Sci. USA. — 1989. — Vol. 86. — P. 2761-2765.

1322. Piddington D. L., Fang F. C., Laessig T. et al. Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst // Infect. Immun. — 2001. — Vol. 69. — P. 4980-4989.

1323. Pieper G. M., Gross G. Oxygen-derived free radicals abolish endothelium-dependent relaxation in diabetic rat aorta // Am. J. Physiol. — 1988. — Vol. 255. — P. H825-H833.

1324. Pieper G. M., Siebeneich W. J. Oral administration ofthe antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction // Cardiovasc. Pharmacol. — 1998. — Vol. 32. — P. 101-105.

1325. Pieri C., Moroni F., Marra M. et al. Melatonin is an efficient antioxidant // Arch. Gerontol. Geri- atr. — 1995. — Vol. 20. — P. 159-165.

1326. Pierpaoli W., Regelson W. Pineal control of aging: effect of melatonin and pineal grafting on aging mice // Proc. Natl. Acad. Sci. USA. — 1994. — Vol. 91. — P. 787-791.

1327. Pierrefiche G., Topall G., Courboin G. et al. Antioxidant activity of melatonin in mice // Res. Commun. Chem. Pathol. Pharmacol. — 1993. — Vol. 80. — P. 211-223.

1328. Pietersma A., De Jong N., Sluiter W., Koster J. F. Studies on the interaction of leucocytes and the myocardial vasculature. 1. Effect of hypoxia on the adherence of blood granulocytes // Mol. Cell Biochem. — 1992. — Vol. 116. — P. 197-202.

1329. Pinkney J. H., Downs L., Hopton M. et al. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E // Diabet. Med. — 1999. — Vol. 16. — P. 993-999.

1330. Pino M., Levin J., Stovall M., Hyde D. Pulmonary inflammation and epithelial injury in response to acute ozone exposure in the rat // Toxicol. Appl. Pharmacol. — 1992. — Vol. 112. — P. 64-72.

1331. Pitas R. E. Expression ofthe acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. Up-regulation by phorbol esters // J. Biol. Chem. — 1990. — Vol. 265. — P. 12722-12727.

1332. Plachta H., Bartnikowska E., Obara A. Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries // Clin. Chim. Acta. — 1992. — Vol. 211. — P. 101-112.

1333. Placido R., Mancino G., Amendola A. et al. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection // J. Pathol. — 1997. — Vol. 181. — P. 31—38.

1334. Podrez E. A., Febbraio M., Sheibani N. et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species // J. Clin. Invest. —

2000. — Vol. 105. — P. 1095-1108.

1335. Poitout V., Robertson R. P. Minireview: secondary β-cell failure in type 2 diabetes — a convergence of glucotoxicity and lipotoxicity // Endocrinology. — 2002. — Vol. 143. — P. 339-342.

1336. Polak M., Zagorski Z. Lipid peroxidation in diabetic retinopathy // Ann. Univ. Mariae Curie Sklodowska. — 2004. — Vol. 59. — P. 434-437.

1337. Polidori M. K., Stahl W., Eichler O. et al. Profiles of antioxidants in human plasma // Free Radic. Biol. Med. — 2001. — Vol. 30. — P. 456-462.

1338. Pontremoli S., Melloni E., Michetti M. et al. Cytolystic effects of neutrophils, role for a membrane- bound neutrophil proteinase // Proc. Natl. Acad. Sci. USA. — 1986. — Vol. 83. — P. 1685-1689.

1339. Porcheray F., Viaud S., Rimaniol A. C. et al. Macrophage activation switching: an asset for the resolution of inflammation // Clin. Exp. Immunol. — 2005. — Vol. 142. — P. 481-489.

1340. Porsti I., Paakkari I. Nitric oxide-based possibilities for pharmacotherapy // Ann. Med. — 1995. — Vol. 27. — P. 407-420.

1341. Porte D. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications // Diabetes Metab. Res. Rev. — 2001. — Vol. 17. — P. 181-188.

1342. Pouyssegur J., Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor // Biol. Chem. — 2006. — Vol. 387. — P. 1337-1346.

1343. Poveda F., Camacho J., Arnalich F. et al. Circulating cytokine concentrations in tuberculosis and other chronic bacterial infections // Infection. — 1999. — Vol. 27. — P. 272-274.

1344. Pozo D., Reiter R. J., Calvo J. R., Guerrero J. M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum // Life Sci. — 1994. — Vol. 55. — P. PL455-PL460.

1345. Pozzilli P., Browne P. D., Kolb H. Meta-analysis of nicotinamide treatment in patients with recent- onset IDDM. The Nicotinamide Trialists // Diabetes Care. — 1996. — Vol. 19. — P. 1357-1363.

1346. Pozzilli P., Visalli N., Cavallo M. G. et al. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes // Eur. J. Endocrinol. — 1997. — Vol. 137. — P. 234-239.

1347. Prakasam A., Sethupathy S., Pugalendi K. V. Antiperoxidative and antioxidant effects of Casearia esculenta root extract in streptozotocin-induced diabetic rats // Yale J. Biol. Med. — 2005. — Vol. 78. — P. 15-23.

1348. Prakasam A., Sethupathy S., Pugalendi K. V. Erythrocyte redox status in streptozotocin diabetic rats: effect of Casearia esculenta root extract // Pharmazie. — 2003. — Vol. 58. — P. 920-924.

1349. Prasad K., Kalra J. Experimental atherosclerosis and oxygen free radical // Angiology. — 1989. — Vol. 40. — P. 835-843.

1350. Prasad K., Lee P., Mantha S. V. et al. Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence // Mol. Cell. Biochem. — 1992. — Vol. 115. — P. 49-58.

1351. Pre J., Le Floch A. Lipid-peroxidation products and antioxidants in plasma of cigarette smokers // Clin. Chem. — 1990. — Vol. 36. — P. 1849-1850.

1352. Preet A., Siddiqui M. R., Taha A. et al. Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues // Mol. Cell. Biochem. — 2006. — Vol. 289. — P. 137-147.

1353. Prince P. S., Kamalakkannan N., Menon V. P. Restoration of antioxidants by ethanolic Tinospora cor- difolia in alloxan-induced diabetic Wistar rats // Acta Pol. Pharm. — 2004. — Vol. 61. — P. 283-287.

1354. Prince P. S., Padmanabhan M., Menon V. P. Restoration of antioxidant defence by ethanolic Tinospora cordifolia root extract in alloxan-induced diabetic liver and kidney // Phytother. Res. — 2004. — Vol. 18. — P. 785-787.

1355. Prince P. S., Srinivasan M. Enicostemma littorale Blume aqueous extract improves the antioxidant status in alloxan-induced diabetic rat tissues // Acta Pol. Pharm. — 2005. — Vol. 62. — P. 363-367.

1356. Princen H. M. G., VanPoppel G., Vogelezang C. et al. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking // Arterioscler. Thromb. — 1992. — Vol. 12. — P. 554-562.

1357. Prohaska J. R. Changes in Cu,Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats // J. Nutr. — 1991. — Vol. 121. — P. 355-363.

1358. Pryor W. A. Biological effects of cigarette smoke, wood smoke, and the smoke from plastics: The use of electron spin resonance // Free Radic. Biol. Med. — 1992. — P. 659-676.

1359. Pryor W. A. Free radicals and lipid peroxidation: What they are and how they got that way // Natural Antioxidants in Human Health and Disease. — San Diego: Acad. Press, 1994. — P. 1-24.

1360. Pryor W. A. Free radical reactions in biology: Initiation of lipid autoxidation by ozone and nitrogen dioxide // Environ. Health Perspect. — 1976. — Vol. 16. — Vol. 180-181.

1361. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low-density lipoproteins // Meth. Enzymol. — 1994. — Vol. 233. — P. 425-441.

1362. Punitha I. S., Rajendran K., Shirwaikar A. Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats // Evid. Based Complement. Alternat. Med. — 2005. — Vol. 2. — P. 375-381.

1363. Punitha R., Manoharan S. Antihyperglycemic and antilipidperoxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan induced diabetic rats // J. Ethnopharmacol. — 2006. — Vol. 105. — P. 39-46.

1364. Putman E., Van Golde L. M. G., Haagsman H. P. Toxic oxidant species and their impact on the pulmonary surfactant system // Lung. — 1997. — Vol. 175. — P. 75-103.

1365. Quiles J. L., Ochoa J. J., Huertas J. R., Mataix J. Coenzyme Q supplementation protects from age- related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet // Exp. Gerontol. — 2004. — Vol. 39. — P. 189-194.

1366. Quilliot D., Walters E., Bonte J. P. et al. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis // Am. J. Clin. Nutr. — 2005. — Vol. 81. — P. 1117-1125.

1367. Quyyumi A. A. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease // Am. J. Med. — 1998. — Vol. 105. — P. 32S—39S.

1368. Rabini R. A., Staffolani R., Fumelli P. et al. Decreased nitric oxide synthase activity in platelets IDDM and NIDDM patients // Diabetologia. — 1998. — Vol. 41. — P. 101-104.

1369. Radi R., Turrens J. F., Freeman B. A. Cytochrome c-catalyzed membrane lipid peroxidation by hydrogen peroxide // Arch. Biochem. Biophys. — 1991. — Vol. 288. — P. 118-125.

1370. Radmark O., Samuelsson B. 5-Lipoxygenase: Regulation and possible involvement in atherosclerosis // Prostaglandins Other Lipid Mediat. — 2007. — Vol. 83. — P. 162-174.

1371. Raghavan B., Kumari S. K. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats // Indian J. Physiol. Pharmacol. — 2006. — Vol. 50. — P. 133-142.

1372. Rahimi R., Nikfar S., Larijani B., Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications // Biomed. Pharmacother. — 2005. — Vol. 59. — P. 365-373.

1373. Rajasekaran S., Sivagnanam K., Subramanian S. Antioxidant effect of Aloe vera gel extract in strep- tozotocin-induced diabetes in rats // Pharm. Rep. — 2005. — Vol. 57. — P. 90-96.

1374. Ramasamy S., Parthasarathy S., Harrison D. G. Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid // J. Lipid Res. — 1998. — Vol. 39. — P. 268-276.

1375. Ramkumar K. M., Latha M., Venkateswaran S. et al. Modulatory effect of Gymnema montanum leaf extract on brain antioxidant status and lipid peroxidation in diabetic rats // J. Med. Food. — 2004. — Vol. 7. — P. 366-371.

1376. Ran Q., Liang H., Ikeno Y. et al. Reduction in glutathione peroxidase 4 increases life span through increased sensitivity to apoptosis // J. Gerontol. A. Biol. Sci. Med. Sci. — 2007. — Vol. 62. — P. 932-942.

1377. Randle P. J., Priestman D. A., Mistry S., Halsall A. Mechanisms modifying glucose oxidation in diabetes mellitus // Diabetologia. — 1994. — Vol. 37, Suppl. 2. — P. S155-S161.

1378. Rankin S. M., Parthasarathy S. Steinberg D. Evidence for a dominant role oflipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages // J. Lipid Res. — 1991. — Vol. 32. — P. 449-456.

1379. Rao С. V. Nitric oxide signaling in colon cancer chemoprevention // Mutat. Res. — 2004. — Vol. 555. — P. 107-119.

1380. Rao G., Parthasarathy S. Antioxidants, atherosclerosis and thrombosis // Prostaglandins Leukot. Essent. Fatty Acids. — 1996 . — Vol. 54. — P. 155-166.

1381. Ratnam S., Mookerjea S. The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein // Immunology. — 1998. — Vol. 94. — P. 560-568.

1382. Rauscher F. M., Sanders R. A., Watkins J. B. III. Effects of coenzyme Q₁₀ treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats // J. Biochem. Mol. Toxicol. — 2001. — Vol. 15. — P. 41-46.

1383. Ravelli A. Macrophage activation syndrome // Curr. Opin. Rheumatol. — 2002. — Vol. 14. — P. 548-552.

1384. Ravi K., Ramachandran B., Subramanian S. Effect of Eugenia jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats // Life Sci. — 2004. — Vol. 75. — P. 2717-2731.

1385. Ray R., Shah A. M. NADPH oxidase and endothelial cell function // Clin. Sci. — 2005. — Vol. 109. — P. 217-226.

1386. Raynaud C., Etienne G., Peyron P. et al. Extracellular enzyme activities potentially involved in the pathogenicity of Mycobacterium tuberculosis // Microbiology. — 1998. — Vol. 144. — P. 577-587.

1387. Reaume A. G., Elliott J. L., Hoffman E. K. et al. Motor neurons in Cu/Zn superoxide dismutase- deficient mice develop normally but exhibit enhanced cell death after axonal injury // Nat. Genet. — 1996. — Vol. 13. — P. 43-47.

1388. Reaven G. M. Insulin resistance and its consequences: type 2 diabetes mellitus and coronary heart disease // Diabetes Mellitus: A Fundamental and Clinical Text. — Philadelphia: Lippincott Williams & Wilkins, 2000. — P. 604-615.

1389. Reaven G. M., Brand R. J., Chen I. D. et al. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals // Diabetes. — 1993. — Vol. 42. — P. 1324-1332.

1390. Reaven G. M., Hollenbeck C. B., Chen I. D. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance // Diabetologia. — 1989. — Vol. 32. — P. 52-55.

1391. Reaven P., Parthasarathy S., Grasse B. J. et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans // Am. J. Clin. Nutr. — 1991. — Vol. 54. — P. 701-706.

1392. Reaven P. D., Herold D. A., Barnett J., Edelman S. Effect of vitamin E on susceptibility of low- density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glication in NIDDM // Diabetes Care. — 1995. — Vol. 18. — P. 807-816.

1393. Reaven P. D., Khouw A., Beltz W. F. Effect of dietary antioxidant combinations in humans — Protection of LDL by vitamin-E but not by β-carotene // Arterioscler. Thromb. — 1993. — Vol. 13. — P. 590-600.

1394. Redondo P. C., Jardin I., Hernandez-Cruz J. M. et al. Hydrogen peroxide and peroxynitrite enhance Ca²+ mobilization and aggregation in platelets from type 2 diabetic patients // Biochem. Bio- phys. Res. Commun. — 2005. — Vol. 333. — P. 794-802.

1395. Regnstrom J., Nilsson J., Moldeus P., Strom K., Bavenholm P., Tornvall P., Hamsten A. Inverce relation between the concentration of low density lipoprotein vitamin E and severity of coronary artery disease // Am. J. Clin. Nutr. — 1996. — Vol. 63. — P. 377-385.

1396. Reid V. C., Mitchinson M. J. Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro // Atherosclerosis. — 1993. — Vol. 98. — P. 17-24.

1397. Reiman R. M., Thompson R. W., Feng C. G. et al. Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity // Infect. Immun. — 2006. — Vol. 74. — P. 1471-1479.

1398. Reiter R. J., Tan D., Poeggeler B. et al. Melatonin, free radicals and cancer initiation // Advances in Pineal Research. — Vol. 7. — London: John Libbey & Company Ltd., 1994. — P. 211-228.

1399. Reljanovic M., Reichel G., Rett K. et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo- controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy // Free Radic. Res. —

1999. — Vol. 31. — P. 171-179.

1400. Remick D. G., Villarete L. Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates // J. Leukoc. Biol. — 1996. — Vol. 59. — P. 471-475.

1401. Rengasamy A., Johns R. A. Determination of Km for oxygen of nitric oxide synthase isoforms // J. Pharmacol. Exp. Ther. — 1996. — Vol. 276. — P. 30-33.

1402. Resmi C. R., Venukumar M. R., Latha M. S. Antioxidant activity of Albizzia lebbeck(Linn. ) Benth. in alloxan diabetic rats // Indian J. Physiol. Pharmacol. — 2006. — Vol. 50. — P. 297-302.

1403. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation // Nat. Immunol. — 2002. — Vol. 3. — P. 1129-1134.

1404. Retsky K. L. Frei B. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein // Biochim. Biophys. Acta. — 1995. — Vol. 1257. — P. 279-287.

1405. Reznick A. Z., Kagan V. E., Ramsey R. et al. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia reperfusion injury — The possible role of iron chelation // Arch. Biochem. Biophys. — 1992. — Vol. 296. — P. 394-401.

1406. Reznick A. Z., Shehadeh N., Shafir Y., Nagler R. M. Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus // Arch. Oral Biol. — 2006. — Vol. 51. — P. 640-648.

1407. Ricevuti G., Mazzone A., Pasotti D. et al. Role of granulocytes in endothelial injury in coronary heart disease in humans // Atherosclerosis. — 1991. — Vol. 91. — P. 1-14.

1408. Rich E. A., Torres M., Sada E. et al. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB // Tuberc. Lung Dis. — 1997. — Vol. 78. — P. 247-255.

1409. Richard J. P. Mechanism for the formation of methylglyoxal from triosephosphates // Biochem. Soc. Trans. — Vol. 21. — P. 549-553.

1410. Richard V. J., Murry C. E., Jennings R. B., Reimer K. A. Oxygen-derived free radicals and postischemic myocardial reperfusion: therapeutic implications // Fundam. Clin. Pharmacol. — 1990. — Vol. 4. — P. 85-103.

1411. Richard V. J., Murry C. E., Jennings R. B., Reimer K. A. Therapy to reduce free radical during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs // Circulation. — 1988. — Vol. 78. — P. 473-480.

1412. Richter C. Oxidative damage to mitochondrial DNA and its relationship to ageing // Int. J. Biochem. Cell Biol. — 1995. — Vol. 27. — P. 647-653.

1413. Riemersma R. A., Wood D. A., Macintyre C. C. et al. Risk ofangina pectoris and plasma concentration ofvitamins A, C and E and carotene // Lancet. — 1991. — Vol. 337. — P. 1-5.

1414. Rimm E. B., Stampfer M. J., Ascherio A. et al. Vitamin E consumption and the risk of coronary heart disease in men // New Engl. J. Med. — 1993. — Vol. 328. — P. 1450-1456.

1415. Riser B. L., Denichilo M., Cortes P. et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis // J. Am. Soc. Nephrol. — 2000. — Vol. 11. — P. 25-38.

1416. Ristola M. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous yersinia arthritis // APMIS. — 1990. — Vol. 98. — P. 125-130.

1417. Robertson R. P., Harmon J. S. Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell // Free Radic. Biol. Med. — 2006. — Vol. 41. — P. 177-184.

1418. Robertson R. P., Harmon J. S. Pancreatic islet β-cell and oxidative stress: The importance of glutathione peroxidase // FEBS Lett. — 2007. — Vol. 581. — P. 3743-3748.

1419. Robinson J., Watson F., Bucknall R. C., Edwards S. W. Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease: Soluble and insoluble immunoglobulin aggregate activates different pathways in primed and unprimed cells // Biochem. J. — 1992. — Vol. 286. — P. 345-351.

1420. Roden M., Price T. B., Perseghin G. et al. Mechanism of free fatty acid-induced insulin resistance in humans // J. Clin. Invest. — 1996. — Vol. 97. — P. 2859-2865.

1421. Rodes J., Cote G., Lesperance J. et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol // Circulation. — 1998. — Vol. 97. — P. 429-436.

1422. Rodier M., Colette C., Crastes de Paulet P. et al. Relationships between serum lipids, platelet membrane fatty acid composition and platelet aggregation in type 2 diabetes mellitus // Diabetes Metab. — 1993. — Vol. 19. — P. 560-565.

1423. Rojas M., Barrera L. F., Garcia L. F. Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent // Biochem. Biophys. Res. Com- mun. — 1998. — Vol. 247. — P. 436-442.

1424. Rolo A. P., Palmeira C. M. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress // Toxicol. Appl. Pharmacol. — 2006. — Vol. 212. — P. 167-178.

1425. Rose R. Atherosclerosis — an inflammatory disease // New Engl. J. Med. — 1999. — Vol. 340. — P. 115-126.

1426. Rosen P., Nawroth P. P., King G. et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society // Diabetes Metab. Res. Rev. —

2001. — Vol. 17. — P. 189-212.

1427. Rosen P., Zink S., Tschope D. Vascular damage due to oxidative stress: A pathogenetic concept for diabetic macro- and microangiopathy? // Structural and Functional Abnormalities in Subclinical Diabetic Angiopathy. — Basel: Karger, 1992. — P. 23-31.

1428. Rosenfeld M. E., Khoo J. C., Miller E. et al. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of LDL, and contain oxidation-specific lipid-protein adducts // J. Clin. Invest. — 1991. — Vol. 87. — P. 90-99.

1429. Rosenfeld M. E., Palinski W., Yla-Herttuala S., Carew T. E. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis // Toxicol. Pathol. — 1990. — Vol. 18. — P. 560-571.

1430. Rosenkranz-Weiss P., Sessa W. C., Milstien S. et al. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells // J. Clin. Invest. — 1994. — Vol. 93. — P. 2236-2243.

1431. Rossaint R., Falke K. J., Lopez F. et al. Inhaled nitric oxide for the adult respiratory distress syndrome // New Engl. J. Med. — 1993. — Vol. 328. — P. 399-405.

1432. Roufail E., Soulis T. Depletion of nitric oxide synthase containing in the diabetic retinas — reversal by aminoguanidine // Diabetologia. — 1998. — Vol. 41. — P. 1419-1425.

1433. Ruan H., Tang X. D., Chen M.-L. et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase // Proc. Natl. Acad. Sci. USA. — 2002. — Vol. 99. — P. 2748-2753.

1434. Rubbo H., Parthasarathy S., Barnes S. et al. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives // Arch. Biochem. Biophys. — 1995. — Vol. 324. — P. 15-25.

1435. Rubinstein J. D., Lesnefsky E. J., Byler R. M. et al. Trolox C, a lipid-soluble membrane protective agent, attenuates myocardial injury from ischemia and reperfusion // Free Radic. Biol. Med. — 1992. — Vol. 13. — P. 627-634.

1436. Ruderman N. B., Saha A. K., Vavvas D., Witters L. A. Malonyl-CoA, fuel sensing, and insulin resistance // Am. J. Physiol. Endocrinol. Metab. — 1999. — Vol. 39. — P. E1-E18.

1437. Ruf J. C., Ciavatti M., Gustafsson T., Renaud S. Effects of PP-56 and vitamin E on platelet hyper- aggregability, fatty acid abnormalities, and clinical manifestations in streptozozin-induced diabetic rats // Diabetes. — 1991. — Vol. 40. — P. 233-239.

1438. Rustow B., Haupt R., Stevens P. A., Kunze D. Type II pneumocytes secrete vitamin E together with surfactant lipids // Am. J. Physiol. — 1993. — Vol. 265. — P. L133-L139.

1439. Ryu J. K., Lee T., Kim D. J. et al. Free radical scavenging activity of Korean red ginseng for erectile dysfunction in non insulin dependent diabetes mellitus rats // Urology. — 2005. — Vol. 65. — P. 611-615.

1440. Sabu M. C., Kuttan R. Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties // Indian J. Physiol. Pharmacol. — 2004. — Vol. 48. — P. 81-88.

1441. Sage S. O., Merritt J. E., Hallam T. J., Rink T. J. Receptor-mediated calcium entry in fura-2-loaded human platelets with ADP and thrombin // Biochem. J. — 1989. — Vol. 258. — P. 923-926.

1442. Sahu S. C. Role of oxygen free radicals in the molecular mechanisms of carcinogenesis: a review // Environ. Carcin. Ecotoxicol. Rev. — 1991. — Vol. C9. — P. 83-112.

1443. Sakamoto H., Firkin F. C., Chesterman C. N. Stimulation of leukocyte phagocytic activity by the platelet release reaction // Pathology. — 1984. — Vol. 16. — P. 126-130.

1444. Sakuraba H., Mizukami H., Yagihashi N. et al. Reduced β-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients // Diabetologia. —

2002. — Vol. 45. — P. 85-96.

1445. Salonen J. T., Alfthan G., Huttunen J. K. et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study // Lancet. — 1982. — Vol. 24. — P. 175-179.

1446. Salonen J. T., Salonen R., Seppanen K. et al. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis // Br. Med. J. — 1991. — Vol. 302. — P. 756-760.

1447. Salonen J. T., Yla-Herttuala S., Yamamoto R. et al. Autoantibody against oxidized LDL and progression of carotid atherosclerosis // Lancet. — 1992. — Vol. 339. — P. 883—887.

1448. Saltiel A. R., Kahn C. R. Insulin signaling and the regulation of glucose and lipid metabolism // Nature. — 2001. — Vol. 414. — P. 799-806.

1449. Salvemini D., De Nucci G., Vane J. R. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma // Thromb. Haemost. — 1991. — Vol. 65. — P. 421-424.

1450. Salvemini D., Wang Z. Q., Wyatt P. S. et al. Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation // Br. J. Pharmacol. — 1996. — Vol. 118. — P. 829-838.

1451. San Martin A., Foncea R., Laurindo F. R. et al. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products // Free Radic. Biol. Med. — 2007. — Vol. 42. — P. 1671-1679.

1452. Sanders S., Eisental R. S., Harrison R. NADH oxidase activity of human xanthine oxidoreduc- tase — generation of superoxide anion // Eur. J. Biochem. — 1997. — Vol. 245. — P. 541-548.

1453. Sandstrom P. A., Roberts B., Folks T. M., Buttke T. M. HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis // AIDS Res. Human Retroviruses. — 1993. — Vol. 9. — P. 1107-1113.

1454. Sang K.-H. L. Q., Lantoine F., Devynck M.-A. Influence of authentic nitric oxide on basalcytosolic (Ca^tt)_i and Ca++ release from internal stores in human platelets // Br. J. Pharmacol. — 1996. — Vol. 119. — P. 1361-1366.

1455. Santanam N., Parthasarathy S. Cellular cysteine generation does not contribute to the initiation of LDL oxidation // J. Lipid Res. — 1995. — Vol. 36. — P. 2203-2211.

1456. Sanz A., Pamplona R., Baqa G. Is the mitochondrial free radical theory of aging intact? // Antioxid. Redox. Signal. — 2006. — Vol. 8. — P. 582-599.

1457. Sardas S., Yilmaz M., Oztok L. I. et al. Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation // Mutat. Res. — 2001. — Vol. 490. — P. 123-129.

1458. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis // Biochem. Biophys. Res. Commun. — 1993. — Vol. 191. — P. 503-508.

1459. Saris N. E. L., Eriksson K. O. Mitochondrial dysfunction in ishaemia-reperfusion // Acta Anaesthe- siol. Scand. — 1995. — Vol. 39, Suppl. 107. — P. 171-176.

1460. Sarkar R., Meinberg E. G., Stanley J. C. et al. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells // Circ. Res. — 1996. — Vol. 78. — P. 225-230.

1461. Sarricolea M. L., Villa-Elizaga I., Lopez J. Respiratory distress syndrome in copper deficiency: An experimental model developed in rats // Biol. Neonate. — 1993. — Vol. 63. — P. 14-25.

1462. Sasahara M., Raines E. W., Chait A. et al. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. Is the extent of atherosclerosis related to resistance of LDL to oxidation? // J. Clin. Invest. — 1994. — Vol. 94. — P. 155-164.

1463. Satheesh M. A., Pari L. Antioxidant effect of Boerhavia diffusa L. in tissues of alloxan induced diabetic rats // Indian J. Exp. Biol. — 2004. — Vol. 42. — P. 989-992.

1464. Sathishsekar D., Subramanian S. Antioxidant properties of Momordica charantia (bitter gourd) seeds on streptozotocin induced diabetic rats // Asia Pac. J. Clin. Nutr. — 2005. — Vol. 14. — P. 153-158.

1465. Sathishsekar D., Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats // Biol. Pharm. Bull. — 2005. — Vol. 28. — P. 978-983.

1466. Sato K., Niki E., Shimasaki H. Free radical mediated chain oxidation oflow density lipoprotein and its synergistic inhibition by vitamin E and vitamin C // Arch. Biochem. Biophys. — 1990. — Vol. 279. — P. 402-405.

1467. Saura M., Martinez-Dalmau R., Minty A. et al. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells // Biochem. J. — 1996. — Vol. 313. — P. 641-646.

1468. Scaccini C., Chiesa G., Jialal I. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine // J. Lipid Res. — 1994. — Vol. 35. — P. 1085-1092.

1469. Schaeffer G., Wascher T. S., Kostner G. M., Graer W. F. Alterations in platelet Ca²+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production // Diabetologia. — 1999. — Vol. 42. — P. 167-176.

1470. Schluter K. D., Weber M., Schraven E., Piper H. M. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action // Am. J. Physiol. — 1994. — Vol. 36. — P. H1461-H1466.

1471. Schmidt A. M., Hori O., Cao R. et al. RAGE: a novel cellular receptor for advanced glycation end- products // Diabetes. — 1996. — Vol. 45, Suppl. 3. — P. S77-S80.

1472. Schmidt A. M., Stern D. M. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes // Trends Endocrinol. Metab. — 2000. — Vol. 11. — P. 368-375.

1473. Schmidt A. M., Yan S. D., Wautier J. L., Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis // Circ. Res. — 1999. — Vol. 84. — P. 489-497.

1474. Schmidt H., Warner T. D., Ishii K. et al. Insulin secretion from pancreatic β cells caused by L-argi- nine-derived nitrogen oxides // Science. — 1992. — Vol. 255. — P. 721-723.

1475. Schmidt H. H. H. W., Seifert R., Bohme E. Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor, and leu- kotriene B4 // FEBS Lett. — 1989. — Vol. 244. — P. 357-362.

1476. Schmitt A., Negresalvayre A., Troly M. et al. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogen- esis // Biohcim. Biophys. Acta. — 1995. — Vol. 1256. — P. 284-292.

1477. Schneider M., Verges B., Klein A. et al. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity // Diabetes. — 2004. — Vol. 53. — P. 2633-2639.

1478. Schott R. J., Nao B. S., McClanah T. B. et al. F(ab')2 fragments of anti-Mo1 (904) monoclonal antibodies do not prevent myocardial stunning // Circ. Res. — 1989. — Vol. 65. — P. 1112-1124.

1479. Schrauwen P., Hesselink M. K., Blaak E. E. et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes // Diabetes. — 2001. — Vol. 50. — P. 2870-2873.

1480. Schriner S. E., Linford N. J., Martin G. M. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria // Science. — 2005. — Vol. 308. — P. 1909-1911.

1481. Schulz R., Wambolt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from iscaemia-reperfusion injury // Cardiovasc. Res. — 1995. — Vol. 30. — P. 432-439.

1482. Seah G. T., Scott G. M., Rook G. A. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis // J. Infect. Dis. — 2000. — Vol. 181. — P. 385-389.

1483. Seccia M., Perugim С., Albano E., Bellomo G. Inhibition of Cu²⁺-induced LDL oxidation by nitric oxide: A study using donors with different half-time of NO release // Biochem. Biophys. Res. Com- mun. — 1996. — Vol. 220. — P. 306-309.

1484. Seghrouchni I., Drai J., Bannier E. et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency // Clin. Chim. Acta. — 2002. — Vol. 321. — P. 89-96.

1485. Selman C., McLaren J. S., Meyer C. et al. Life-long vitamin C supplementation in combination with cold exposure does not affect oxidative damage or lifespan in mice, but decreases expression of antioxidant protection genes // Mech. Ageing Dev. - 2006. - Vol. 127. - P. 897-904.

1486. Semb A. G., Ytrenus K., Vaage J. et al. Functional impairment in isolated rat hearts induced by activated leukocytes: Protective effect of oxygen free radical scavengers // J. Mol. Cell. Cardiol. —

1989. — Vol. 21. — P. 877-887.

1487. Sentman M. L., Granstrom M., Jakobson H. et al. Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase // J. Biol. Chem. — 2006. — Vol. 281. — P. 6904-6909.

1488. Seppi C., Castellana M. A., Minetti G. et al. Evidence for membrane protein oxidation during in vivo aging of human erythrocytes // Mech. Ageing Dev. — 1991. — Vol. 57. — P. 247-258.

1489. Seres T., Knickelbein R. G., Warshaw J. B., Johnston R. B. The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione // J. Immunol. —

2000. — Vol. 165. — P. 3333-3340.

1490. Sethi R., Takeda N., Nagano M., Dhalla N. S. Beneficial effects of vitamin E treatment in acute myocardial infarction // J. Cardiovasc. Pharmacol. Ther. — 2000. — Vol. 5. — P. 51-58.

1491. Sethi S., Eastman A. Y., Eaton J. W. Inhibition of phagocyte-endothelium interactions by oxidized fatty acids: A natural anti-inflammatory mechanism // J. Lab. Clin. Med. — 1996. — Vol. 128. — P. 27-38.

1492. Shaish A., Daugherty A., O’Sullivan F. et al. Carotene inhibits atherosclerosis in hypercholesterol- emic rabbits // J. Clin. Invest. - 1995. - Vol. 96. - P. 2075-2082.

1493. Shandelya S. M. L., Kuppusamy P., Weisfeldt M. L., Zweier J. L. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury — Evidence for plasma-mediated leukocyte activation // Circulation. — 1993. — Vol. 87. — P. 536-546.

1494. Sharma A., Kharb S., Chugh S. N. et al. Evaluation of oxidative stress before and after control of gly- cemia and after vitamin E supplementation in diabetic patients // Metabolism. — 2000. — Vol. 49. — P. 160-162.

1495. Sharma K., DanoffT., DePierro A., Ziyadeh F. N. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C // Biochem. Biophys. Res. Commun. — 1995. — Vol. 207. — P. 80-88.

1496. Sharma K., Ziyadeh F. N. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy // Semin. Nephrol. — 1997. — Vol. 17. — P. 80-92.

1497. Sharov V. S., Galeva N. A., Kanski J. et al. Age-associated tyrosine nitration of rat skeletal muscle glycogen phosphorylase b: characterization by HPLC-nanoelectrospray-Tandem mass spectrometry // Exp. Gerontol. — 2006. — Vol. 41.- P. 407-416.

1498. Shattock M. J., Matsuura H. Measurement of Na⁺-K⁺ pump current in isolated rabbit ventricular myocytes using the whole-cell voltage-clamp technique: Inhibition of the pump by oxidant stress // Circ. Res. — 1993. — Vol. 72. — P. 91-101.

1499. Sheehan R. H., Epstein S. E. Determinants of arrhythmia death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia // Circulation. — 1983. — Vol. 65. — P. 259-264.

1500. Sherman D. R., Mdluli K., Hickey M. J. et al. Compensatory ahpC gene expression in isoniazid- resistant Mycobacterium tuberculosis// Science. — 1996. — Vol. 272. — P. 1641-1643.

1501. Shibuki K., Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum // Nature. — 1991. — Vol. 349. — P. 326-328.

1502. Shih C. C., Wu Y. W., Lin W. C. Antihyperglycaemic and anti-oxidant properties of Anoectochilus formosanus in diabetic rats // Clin. Exp. Pharmacol. Physiol. — 2002. — Vol. 29. — 684-688.

1503. Shiloh M. U., MacMicking J. D., Nicholson S. et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase // Immunity. — 1999. — Vol. 10. — P. 29-38.

1504. Shiloh M. U., Nathan C. F. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria // Curr. Opin. Microbiol. — 2000. — Vol. 3. — P. 35-42.

1505. Shimabukuro M., Higa M., Zhou Y.-T. et al. Lipoapoptosis in β-cells of obese prediabetic fa/fa rats: role of serine palmitoyl transferase overexpression // J. Biol. Chem. — 1998. — Vol. 273. — P. 32487-32490.

1506. Shimabukuro M., Ohneda M., Lee Y., Unger R. H. Role of nitric oxide in obesity-induced β-cell disease // J. Clin. Invest. — 1997. — Vol. 100. — P. 290-295.

1507. Shimabukuro M., Zhou Y.-T., Levi M. Unger R. H. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes // Proc. Natl. Acad. Sci. USA. — 1998. — Vol. 95. — P. 2498-2502.

1508. Shimano H., Yamada N., Ishibashi S. et al. Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography // J. Lipid Res. — 1991. — Vol. 32. — P. 763-773.

1509. Shingu M., Yoshioka K., Nobunaga M. Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide // Inflammation. — 1985. — Vol. 9. — P. 309-320.

1510. Shiomi T., Tsutsui H., Matsusaka H. et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice // Circulation. — 2004. — Vol. 109. — P. 544-549.

1511. Shlafer M., Myers C. L., Adkins S. Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dismutase following global ischemia // J. Mol. Cell. Cardiol. — 1987. — Vol. 19. — P. 1195-1206.

1512. Shulman G. I. Cellular mechanisms of insulin resistance // J. Clin. Invest. — 2000. — Vol. 106. — P. 171-176.

1513. Sibille Y., Reynolds H. Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury // Am. Rev. Respir. Dis. — 1990. — Vol. 141. — P. 471-501.

1514. Siddiqui M. R., Taha A., Moorthy K. et al. Amelioration of altered antioxidant status and membrane linked functions by vanadium and Trigonella in alloxan diabetic rat brains // J. Biosci. — 2005. — Vol. 30. — P. 483-490.

1515. Siedlik P. H., Marnett L. J. Oxidizing radical generation by prostaglandin H synthase // Meth. En- zymol. — Vol. 105. — N.Y.: Acad. Press, 1984. — P. 412-416.

1516. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic // Free Radic. Biol. Med. — 1993. — Vol. 14. — P. 313-323.

1517. Siess W. Molecular mechanisms ofplatelets activation // Physiol. Rev. — 1989. — Vol. 69. — P. 48-178.

1518. Siman C. M., Eriksson U. J. Vitamin C supplementation ofthe maternal diet reduces the rate of malformation in the offspring of diabetic rats // Diabetologia. — 1997. — Vol. 40. — P. 1416-1424.

1519. Simeonova P. P., Luster M. I. Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-α response from alveolar macrophages // Am. J. Respir. Cell Mol. Biol. — 1995. — Vol. 12. — P. 676-683.

1520. Siminiak T., Egdell R. M., O’Gorman D. J. et al. Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor // Clin. Sci. — 1995. — Vol. 89. — P. 171-176.

1521. Siminiak T., Zozulinska D., Zeromska M., Wysocki H. Evidence for plasma-mediated neutrophil superoxide anion production during myocardial infarction // Cardiology. — 1993. — Vol. 82. — P. 377-382.

1522. Simms H. H., D’Amico R. Subcellular location of neutrophil opsonic receptors is altered by exogenous reactive oxygen species // Cell. Immunol. — 1995. — Vol. 166. — P. 71-82.

1523. Simon R., DeHart P., Nadeau D. Resistance of rat pulmonary alveolar epithelial cells to neutrophil- and oxidant-induced injury // Am. J. Respir. Cell Mol. Biol. — 1989. — Vol. 1. — P. 221-229.

1524. Singab A. N., El-Beshbishy H. A., Yonekawa M. et al. Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats // J. Ethnopharmacol. — 2005. — Vol. 100. — P. 333-338.

1525. Singh N., Kamath V., Rajini P. S. Attenuation ofhyperglycemia and associated biochemical parameters in STZ-induced diabetic rats by dietary supplementation of potato peel powder // Clin. Chim. Acta. — 2005. — Vol. 353. — P. 165-175.

1526. Singh R. B., Ghosh S., Niaz M. A. et al. Dietary intake, plasma levels of antioxidant vitamins and oxidative stress in relation to coronary artery disease in elderly subjects // Am. J. Cardiol. — 1995. — Vol. 76. — P. 1233-1238.

1527. Singh R. B., Niaz M. A., Rastogi S. S. et al. Effect of hydrosoluble coenzyme Q₁₀ on blood pressures and insulin resistance in hypertensive patients with coronary artery disease // J. Hum. Hypertens. —

1999. — Vol. 13. — P. 203-208.

1528. Singh S. V., Brunnert S. R., Roberts B., Krishan A. Differential expression of glutathione S-trans- ferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissue // Cancer Lett. — 1990. — Vol. 51. — P. 43-48.

1529. Siwik D. A., Pagano P. J., Colucci W. S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts // Am. J. Physiol. Cell Physiol. — 2001. — Vol. 280. — P. C53-C60.

1530. Sjoholm A., Berggren P. O., Cooney R. V. γ-Tocopherol partially protects insulin-secreting cells against functional inhibition by nitric oxide // Biochem. Biophys. Res. Commun. — 2000. — Vol. 277. — P. 334-340.

1531. Sjoholm A., Honkanen R. E., Berggren P. O. Inhibition of serine/threonine protein phosphatases by secretagogues in insulin-secreting cells // Endocrinology. — 1995. — Vol. 136. — P. 3391-3397.

1532. Skrha J., Sindelka G., Hilgertova J. The effect of fasting and vitamin E on insulin action in obese type 2 diabetes mellitus // J. Ann. N.Y. Acad. Sci. — 1997. — Vol. 827. — P. 556-560.

1533. Skyler J. S. Relationship of metabolic control of diabetes mellitus to chronic complications // Diabetes Mellitus: Theory and Practice. — N.Y.: Elsevier Sci. Publ., 1990. — P. 856-868.

1534. Skyrme-Jones R. A., O’Brien R. C., Luo M., Meredith I. T. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 dia-betes // J. Am. Coll. Cardiol. — 2000. — Vol. 35. — P. 292-299.

1535. Sly L. M., Hingley-Wilson S. M., Reiner N. E., McMaster W. R. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic bcl-2 family member Mcl-1 // J. Immunol. — 2003. — Vol. 170. — P. 430-437.

1536. Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions // Biochem. J. — 1992. — Vol. 286. — P. 901-905.

1537. Smith J. B., Bocchieri M. H., Smith J. B. Jr et al. Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids // Rheum. Int. — 1990. — Vol. 10. — P. 131-134.

1538. Smits P., Kapma J.-A., Jacobs M.-C. et al. Endothelium-dependent vascular relaxation in patients with type I diabetes // Diabetes. — 1993. — Vol. 42. — P. 148-153.

1539. Sobczak A., Skop B., Kula B. Simultaneous determination of serum retinol and α- and γ-tocopherol levels in type II diabetic patients using high-performance liquid chromatography with fluorescence detection // J. Chromatogr. B. Biomed. Sci. Appl. — 1999. — Vol. 730. — P. 265-271.

1540. Sohal R. S., Kamzalov S., Sumien N. et al. Effect of coenzyme Q₁₀ intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice // Free Radic. Biol. Med. — 2006. — Vol. 40. — P. 480-487.

1541. Solomon D. H., Karlson E. W., Rimm E. B. et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis // Circulation. — 2003. — Vol. 107. — P. 1303-1307.

1542. Song F., Qi X., Chen W. et al. Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice: Involvement of heme oxygenase-1 // Eur. J. Nutr. — 2007. — Vol. 46. — P. 61-69.

1543. Southern C., Schulster D., Green I. C. Inhibition of insulin secretion by interleukin-1p and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generation mechanism // FEBS Lett. —

1990. — Vol. 276. — P. 42-44

1544. Sparrow C. P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions // J. Lipid Res. — 1993. — Vol. 34. — P. 1219-1228.

1545. Sparrow C. P., Olszewski J. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases // Proc. Natl. Acad. Sci. USA. — 1992. — Vol. 89. — P. 128-131.

1546. Sparrow C. P., Parthasarathy S., Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification // J. Lipid Res. — 1988. — Vol. 29. — P. 745-753.

1547. Spector W. G., Willoughby D. A. The pharmacology of inflammation. — L., 1968.

1548. Squier T. C. Oxidative stress and protein aggregation during biological aging // Exp. Gerontol. —

2001. — Vol. 36. — P. 1539-1550.

1549. Srinivasan M., Padmanabhan M., Prince P. S. Effect of aqueous Enicostemma littorale Blume extract on key carbohydrate metabolic enzymes, lipid peroxides and antioxidants in alloxan-induced diabetic rats // J. Pharm. Pharmacol. — 2005. — Vol. 57. — P. 497-503.

1550. Stadler J., Harbrecht B. G., Di Silvio M. et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells // J. Leukoc. Biol. — 1993. — Vol. 53. — P. 165-172.

1551. Stadtman E. R., Van Remmen H., Richardson A. et al. Methionine oxidation and aging // Biochim. Biophys. Acta. — 2005. — Vol. 1703. — P. 135-140.

1552. Stampfer M. J., Hennekens C. H., Manson J. E. et al. Vitamin E consumption and the risk of coronary disease in women // New Engl. J. Med. — 1993. — Vol. 328. — P. 1444-1449.

1553. Standaert M. L., Galloway L., Karnam P. et al. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation on rat adipocytes. Potential role on glucose transport // J. Biol. Chem. — 1997. — Vol. 272. — P. 30075-30082.

1554. Standl E., Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing // Diabeto- logia. — 2000. — Vol. 43. — P. 1455-1469.

1555. Stanely Mainzen Prince P., Kamalakkannan N., Menon V. P. Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain // J. Ethnopharmacol. — 2003. — Vol. 84. — P. 205-209.

1556. Stangl K., Cascorbi I., Laule M. et al. High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease // Pharmacogenetics. — 2000. — Vol. 10. — P. 133-140.

1557. Steenbergen C., Murphy E., Levy L., London R. E. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart // Circ. Res. — 1987. — Vol. 60. — P. 700-706.

1558. Stefanovic-Racic M., Meyers K., Meschter C. et al. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats // Arthritis Rheum. — 1994. — Vol. 37. — P. 1062-1069.

1559. Stefek M., Sotnikova R., Okruhlicova L. et al. Effect of dietary supplementation with the pyridoin- dole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium // Acta Diabetol. - 2000. - Vol. 37. - P. 111-117.

1560. Stein M., Keshav S., Harris N., Gordon S. IL-4 potently enhances murine macrophage mannose receptor activity; a marker of alternative immunologic macrophage activation // J. Exp. Med. — 1992. — Vol. 176. — P. 287-292.

1561. Steinberg D. Antioxidants in the prevention of human atherosclerosis // Circulation. — 1992. — Vol. 85. — P. 2338-2345.

1562. Steinberg D., Parthasarathy S., Carew T. E. et al. Beyond cholesterol. Modification of low density lipoprotein that increase its atherogenicity // New Engl. J. Med. — 1989. — Vol. 320. — P. 915-924.

1563. Steinbrecher U. P. Role ofsuperoxide in endothelial-cell modification oflow-density lipoproteins // Biochim. Biophys. Acta. — 1988. — Vol. 959. — P. 20-30.

1564. Steinbrecher U. P., Lougheed M., Kwan W. C., Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation // J. Biol. Chem. — 1989. — Vol. 264. — P. 15216-15223.

1565. Steinbrecher U. P., Parthasarathy S., Leake D. S. et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids // Proc. Natl. Acad. Sci. USA. — 1984. — Vol. 81. — P. 3883-3887.

1566. Steinbrecher U. P., Witztum J. L. Glucosylation oflow-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism // Diabetes. — 1984. — Vol. 33. — P. 130-134.

1567. Steinbrecher U. P., Zang H. F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis // Free Radic. Biol. Med. — 1990. — Vol. 9. — P. 155-168.

1568. Stenger S., Mazzaccaro R. J., Uyemura K. et al. Differential effects of cytolytic T cell subsets on intracellular infection // Science. — 1997. — Vol. 276. — P. 1684-1687.

1569. Stephens N. G., Parsons A., Schofield P. M. et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) // Lancet. — 1996. — Vol. 347. — P. 781-785.

1570. Steppan C. M., Bailey S. T., Bhat S. et al. The hormone resistin links obesity to diabetes // Nature. — 2001. — Vol. 409. — P. 307-312.

1571. Stevens M. D., DiSilvestro R. A., Harris E. D. Specific receptor for ceruloplasmin in membrane fragments from aortic and heart tissues // Biochemistry. — 1984. — Vol. 23. — P. 261-266.

1572. Stevens R. B., Sutherland D. E. R., Ansite J. D. et al. Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes? // J. Immunol. — 1997. — Vol. 159. — P. 5329-5335.

1573. Stevens V. J., Rouzer C. A., Monnier V. M., Cerami A. Diabetic cataract formation: Potential role of glycosylation of lens crystallins // Proc. Natl. Acad. Sci. USA. — 1978. — Vol. 75. — P. 2918-2922.

1574. Stocker R., Bowry V. W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol // Proc. Natl. Acad. Sci. USA. —

1991. — Vol. 88. — P. 1646-1650.

1575. Stone J. R. An assessment of proposed mechanisms for sensing hydrogen peroxide in mammalian systems // Arch. Biochem. Biophys. — 2004. — Vol. 422. — P. 119-124.

1576. Stork P. J., Schmitt J. M. Crosstalk between cAMP and MAP kinase signaling in regulation of cell proliferation // Trends Cell Biol. — 2002. — Vol. 12. — P. 258-266.

1577. Stout R. D., Jiang C., Matta B. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences // J. Immunol. — 2005. — Vol. 175. — P. 342-349.

1578. Stout R. D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments // J. Leukoc. Biol. — 2004. — Vol. 76. — P. 509-513.

1579. Strampfer M. J. Smoking, estrogen, and prevention of heart disease in women // Mayo Clin. Proc. — 1989. — Vol. 84. — P. 1553-1557.

1580. Strnad J., Burke J. R. IkB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges // Trends Pharmacol. Sci. — 2007. — Vol. 28. — P. 142-148.

1581. Stuchbury G., Munch G. Alzheimer’s associated inflammation, potential drug targets and future therapies // J. Neural Transm. — 2005. — Vol. 112. — P. 429-453.

1582. Studer R. K., Craven P. A., DeRubertis F. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium // Diabetes. — 1993. — Vol. 42. — P. 118-126.

1583. Suarna C., Dean R. T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate // Arterioscler. Thromb. Vasc. Biol. - 1995. - Vol. 10. - P. 1616-1624.

1584. Sugiura M., Ohshima M., Ogawa K., Yano M. Chronic administration of Satsuma mandarin fruit (Citrus unshiu Marc.) improves oxidative stress in streptozotocin-induced diabetic rat liver // Biol. Pharm. Bull. - 2006. - Vol. 29. - P. 588-591.

1585. Sun X. J., Wang L. M., Zhang Y. et al. Role of IRS-2 in insulin and cytokine signaling // Nature. - 1995. - Vol. 377. - P. 173-177.

1586. Sushek C., Fehsel K., Kroncke K. D. et al. Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration // Am. J. Pathol. - 1994. - Vol. 145. - P. 685-695.

1587. Suthanthiran M., Anderson M. E., Sharma V. K., Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens // Proc. Natl. Acad. Sci. USA. - 1990. - Vol. 87. - P. 3343-3347.

1588. Sutherland M. W., Nelson J., Harrison G. et al. Effects of t-butyl hydroperoxide on NADPH, glutathione, and respiratory burst of rat alveolar macrophages // Arch. Biochem. Biophys. - 1985. - Vol. 243. - P. 325-331.

1589. Swain J. A., Darley-Usmar V., Gutteridge J. M. C. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis // FEBS Lett. - 1994. - Vol. 342. - P. 49-52.

1590. Swain J., Gutteridge J. M. C. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material // FEBS Lett. - 1995. - Vol. 368. - P. 513-515.

1591. Szefler S. J., Norton C. E., Ball B. et al. IFN-γ and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-α is not essential for monocyte priming // J. Immunol. - 1989. - Vol. 142. - P. 3985-3992.

1592. Szenasi P., Toth L., Ramics L. et al. Platelet hyper- and hypoaggregability different microangiopathic complication of diabetes mellitus // Acta Diabetol. Lat. - 1988. - Vol. 25. - P. 7-12.

1593. Tabatabaie T., Vasquez-Weldon A., Moore D. R., Kotake Y. Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2 // Diabetes. - 2003. - Vol. 52. - P. 1994-1999.

1594. Tada H., Ishii H., Isogai S. Protective effect of D-alpha-tocopherol on the function ofhuman mesangial cells exposed to high glucose concentrations // Metabolism. - 1997. - Vol. 46. - P. 779-784.

1595. Tagan M.-C., Markert M., Schaller M.-D. et al. Oxidative metabolism of circulating granulocytes in adult respiratory distress syndrome // Am. J. Med. - 1991. - Vol. 91, Suppl. 3C. - P. 72S-78S.

1596. Takagi K., Yamada Y., Gong J. S. et al. Association of a 5178C^A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals // Atherosclerosis. - 2004. - Vol. 175. - P. 281-286.

1597. Takahashi S., Yoshikawa T., Naito Y. et al. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes // Lipids. - 1991. - Vol. 26. - P. 1227-1230.

1598. Takamura T., Kato I., Kimura N. et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis // J. Biol. Chem. - 1998. - Vol. 273. - P. 2493-2496.

1599. Takubo K., Nakamura K., Izumiyama N. et al. Telomere shortening with aging in human liver // J. Gerontol. A. Biol. Sci. Med. Sci. - 2000. - Vol. 55. - P. B533-B536.

1600. Tamai M., Furuta H., Kawashima H. et al. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes // Diabetes Res. Clin. Pract. - 2006. - Vol. 71. - P. 140-145.

1601. Tanaka Y., Gleason C. E., Tran P. O. et al. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants // Proc. Natl. Acad. Sci. USA. - 1999. - Vol. 96. - P. 10857-10862.

1602. Tanaka Y., Tran P. O., Harmon J., Robertson R. P. A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity // Proc. Natl. Acad. Sci. USA. - 2002. - Vol. 99. - P. 12363-12368.

1603. Tannenbaum S. R., Fett D., Young V. R. et al. Nitrite and nitrate are formed by endogenous synthesis in the human intestine // Science. - 1978. - Vol. 200. - P. 1487-1489.

1604. Tanswell A. K., Freeman B. A. Liposome-entrapped antioxidant enzymes prevent lethal O₂ toxicity in the newborn rat // J. Appl. Physiol. - 1987. - Vol. 63. - P. 347-352.

1605. Tarp U., Stengaardpedersen K., Hansen J. C., Thorling E. B. Glutathione redox cycle enzymes and selenium in severe rheumatoid arthritis — Lack of antioxidative response to selenium supplementation in polymorphonuclear leucocytes // Ann. Rheum. Dis. — 1992. — Vol. 51. — P. 1044—1049.

1606. Tarry-Adkins J. L., Ozanne S. E., Norden A. et al. Lower antioxidant capacity and elevated p53 and p21 may be a link between gender disparity in renal telomere shortening, albuminuria, and longevity // Am. J. Physiol. Renal Physiol. — 2006. — Vol. 290. — P. F509—F516.

1607. Taskiran D., Stefanovic-Racic M., Georgescu H., Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1 // Biochem. Biophys. Res. Commun. — 1994. — Vol. 200. — P. 142-148.

1608. Tate R. M., Morris H. G., Schroeder W. R., Repine J. E. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline perfused rabbit lung // J. Clin. Invest. — 1984. — Vol. 74. — P. 608-613.

1609. Tavani A., Negri E., DAvanzo B., La Vecchia C. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women // Eur. J. Epidemiol. — 1997. — Vol. 13. — P. 631-637.

1610. Taverna M. J., Elgrably F., Selmi H. et al. The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy // Nitric Oxide. — 2005. — Vol. 13. — P. 88-92.

1611. Tennenberg S. D., Fey D. E., Lieser M. J. Oxidative priming of neutrophils by interferon-γ // J. Leukoc. Biol. — 1993. — Vol. 53. — P. 301-308.

1612. Terentis A. C., Thomas S. R., Burr J. A. et al. Vitamin E oxidation in human atherosclerotic lesions // Circ. Res. — 2002. — Vol. 90. — P. 333-339.

1613. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction // Free Radic. Biol. Med. — 1994. — Vol. 16. — P. 383-391.

1614. Tesfamariam B., Brown M. L., Deykin D., Cohen R. A. Elevated glucose impairs endothelium-dependent relaxations by activating protein kinase C // J. Clin. Invest. — 1991. — Vol. 87. — P. 1643-1648.

1615. The alpha-tocopherol, beta-carotene cancer prevention study group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers // New Engl. J. Med. — 1994. — Vol. 330. — P. 1029-1035.

1616. Thibeault D. W., Rezaiekhaligh M., Marby S. Lung antioxidant enzymes and cardiopulmonary responses in young rats exposed to hyperoxia and treated intratracheally with PEG catalase and superoxide dismutase // Exp. Lung Res. — 1993. — Vol. 19. — P. 137-151.

1617. Thirunavukkarasu V., Anitha Nandhini A. T., Anuradha C. V. Lipoic acid improves glucose utilisation and prevents protein glycation and AGE formation // Pharmazie. — 2005. — Vol. 60. — P. 772-775.

1618. Thomas J. P., Geiger P. G., Girotti A. W. Lethal damage to endothelial cells by oxidized low density lipoprotein — role of selenoperoxidases in cytoprotection against lipid hydroperoxide-mediated and iron-mediated reactions // J. Lipid Res. — 1993. — Vol. 34. — P. 479-490.

1619. Thomas J. P., Geiger P. G., Maiorino M. et al. Enzymatic reduction of phospholipid and cholesterol hydroperoxides in artificial bilayers and lipoproteins // Biochim. Biophys. Acta. — 1990. — Vol. 1045. — P. 252-260.

1620. Thomas J. P., Kalyanaraman B., Girotti A. W. Involvement ofpreexisting lipid hydroperoxides in Cu²+- stimulated oxidation of low-density lipoprotein // Arch. Biochem. Biophys. — 1994. — Vol. 315. — P. 244-254.

1621. Thomas M. J. Urate causes the human polymorphonuclear leukocyte to secrete superoxide // Free Radic. Biol. Med. — 1992. — Vol. 12. — P. 89-91.

1622. Thommasen H. V. The role of polymorphonuclear leukocytes in the pathogenesis of the adult respiratory distress syndrome // Clin. Invest. Med. — 1985. — Vol. 8. — P. 185-194.

1623. Thompson A. L., Lim-Fraser M., Kraegen E. W. et al. Effect of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro // Am. J. Physiol. Lung Cell. Mol. Physiol. —

2000. — Vol. 279. — P. E577-E584.

1624. Thompson-Gorman S. L., Zweier J. L. Evaluation of the role of xanthine oxidase in myocardial reperfusion injury // J. Biol. Chem. — 1990. — Vol. 266. — P. 6656-6663.

1625. Thornalley P. J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification — a role in pathogenesis and antiproliferative chemotherapy // Gen. Pharmacol. — 1996. — Vol. 27. — P. 565-573.

1626. Tiedge M., Lortz S., Drinkgem J., Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells // Diabetes. — 1997. — Vol. 46. — P. 1733-1742.

1627. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group // Br. Med. J. — 1998. — Vol. 317. — P. 703-713.

1628. Tikhaze A., Lankin V., Konovalova G. et al. The influence of antioxidative drug probucol on the enzymatical lipoperoxides utilization // Atherosclerosis. — 1997. — Vol. 134. — P. 208.

1629. Till G. O., Friedl H. P., Ward P. A. Lung injury and complement activation: role of neutrophils and xanthine oxidase // Free Radic. Biol. Med. — 1991. — Vol. 10. — P. 379-386.

1630. Timimi F. K., Ting H. H., Haley E. A. et al. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus // J. Am. Coll. Cardiol. — 1998. — Vol. 31. — P. 552-557.

1631. Timmins G. S., Master S., Rusnak F., Deretic V. Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo // J. Bacteriol. — 2004. — Vol. 186. — P. 5427-5431.

1632. Ting H. H., Timimi F. K., Boles K. S. et al. Vitamin C acutely improves endothelium-dependent vasodilatation in patients with non-insulin-dependent diabetes mellitus // Circulation. — 1996. — Vol. 92, Suppl. 1. — P. 367.

1633. Tipton C. L., Shih M., Magat W. J. Isolation and characterization of calmodulin-inactivating cholesterol hydroperoxides // J. Lipid Res. — 1991. — Vol. 32. — P. 1403-1408.

1634. Tirosh A., Potashnik R., Bashan N., Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes: A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation // J. Biol. Chem. — 1999. — Vol. 274. — P. 10595-10602.

1635. Toker A., Cantley L. C. Signaling through the lipid products of phospho-inositide-3-OH-kinase // Nature. — 1997. — Vol. 387. — P. 673-676.

1636. Tomlinson D. R. Mitogen-activated protein kinases as glucose transducers for diabetic complications // Diabetologia. — 1999. — Vol. 42. — P. 1271-1281.

1637. Tonks N. K. Redox redux: revisiting PTPs and the control of cell signaling // Cell. — 2005. — Vol. 121. — P. 667-670.

1638. Tonks N. K., Neel B. G. Combinatorial control of the specificity of protein tyrosine phosphatases // Curr. Opin. Cell Biol. — 2001. — Vol. 13. — P. 182-195.

1639. Torrielli M. V., Dianzani M. U. Free radicals in inflammatory disease // Free Radicals in Molecular Biology, Aging, and Disease. — N.Y.: Raven Press, 1984. — P. 355-379.

1640. Torun M., Avci N., Yardim S. Serum levels of vitamin E in relation to cardiovascular diseases // J. Clin. Pharm. Ther. — 1995. — Vol. 20. — P. 335-340.

1641. Tosaki A., Bagchi D., Pali T. et al. Comparisons of ESR and HPLC methods for the detection of OH· radicals in ischemic reperfused rat hearts — a relationship between the genesis of free radicals and reperfusion arrhythmias // Biochem. Pharmacol. — 1993. — Vol. 45. — P. 961-969.

1642. Touyz R. M., Schiffrin E. Growth factors mediate intra-cellular signalling in vascular smooth muscle cells through protein kinase C-linked pathways // Hypertension. — 1997. — Vol. 30. — P. 14401447.

1643. Traber M. G., Burton G. W., Ingold K. U., Kayden H. J. RRR- and SRR-a-tocopherols are secreted without discrimination in human chylomicrons, but RRR-a-tocopherol is preferentially secreted in very low density lipoproteins // J. Lipid Res. — 1990. — Vol. 31. — P. 675-685.

1644. Traber M. G., Elsner A., Brigelius-Flohe R. Synthetic as compared with natural vitamin E is preferentially excreted as a-CEHC in human urine: studies using deuterated a-tocopheryl acetates // FEBS Lett. — 1998. — Vol. 16. — P. 145-148.

1645. Trajkovic V., Singh G., Singh B. et al. Effect of Mycobacterium tuberculosis-specific 10-kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide // Infect. Immun. —

2002. — Vol. 70. — P. 6558-6566.

1646. Tribble D. L., Barcellos-Hoff M. H., Chu B. M., Gong E. L. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes // Arterioscler. Thromb. Vasc. Biol. — 1999. — Vol. 19. — P. 1387-1392.

1647. Tribble D. L., Giuliano L. J., Fortmann S. P. Reduced plasma ascorbic acid concentrations in nonsmokers regularly exposed to environmental tobacco smoke // Am. J. Clin. Nutr. — 1993. — Vol. 58. — P. 886-890.

1648. Tribble D. L., Gong E. L., Leeuwenburgh C. et al. Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase // Circ. Res. — 1997. — Vol. 17. — P. 1734-1740.

1649. Tribble D. L., Holl L. G., Wood P. D., Krauss R. M. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size // Atherosclerosis. —

1992. — Vol. 93. — P. 189-199.

1650. Trovati M., Massucco P., Mattiello L. The insulin-induced increase ofguanosine-3,5-cyclic monophosphate in human platelets is mediated by nitric oxide // Diabetes. — 1996. — Vol. 45. — P. 768-770.

1651. Trulson A., Nilsson S., Venge P. Lucigenin-enhanced chemiluminescence in blood is increased in cancer // Am. J. Clin. Pathol. — 1989. — Vol. 91. — P. 441-446.

1652. Tsai E. C., Hirsch I. B., Brunzell J. D. et al. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM // Diabetes. — 1994. — Vol. 43. — P. 1010-1014.

1653. Tsan M.-F., White J. E., Caska B. et al. Susceptibility of heterozygous MnSOD gene-knockout mice to oxygen toxicity // Am. J. Respir. Cell Mol. Biol. — 1998. — Vol. 19. — P. 114-120.

1654. Tsan M.-F., White J. E., Santana T. A., Lee C. Y. Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity // J. Appl. Physiol. — 1990. — Vol. 68. — P. 1211-1219.

1655. Tsao T. C., Hong J., Huang C. et al. Increased TNF-α, IL-1p and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis // Tuber. Lung Dis. — 1999. — Vol. 79. — P. 279-285.

1656. Tsopanoglou N. E., Pipili-Synetos E., Maragoudakis M. E. Protein kinase C involvement in the regulation of angiogenesis // J. Vasc. Res. — 1993. — Vol. 30. — P. 202-208.

1657. Tullius M. V., Harth G., Horwitz M. A. High extracellular levels of Mycobacterium tuberculosisglu- tamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism // Infect. Immun. —

2001. — Vol. 69. — P. 6348-6363.

1658. Turgan N., Boydak B., Habif S. et al. Urinary hypoxanthine and xanthine levels in acute coronary syndromes // Int. J. Clin. Lab. Res. — 1999. — Vol. 29. — P. 162-165.

1659. Turner R., Cull C., Holman R. United Kingdom Prospective Diabetes Study 17: The effect of improved metabolic control on complications in NIDDM // Ann. Intern. Med. — 1996. — Vol. 124. — P. 136-145.

1660. Turrens J. F., Crapo J. D., Freeman B. A. Protection against oxygen toxicity by intravenous injection ofli- posome-entrapped catalase and superoxide dismutase // J. Clin. Invest. — 1984. — Vol. 73. — P. 87-95.

1661. Turrens J. F., Freeman B. A., Crapo J. D. Hyperoxia increases H₂O₂ release by lung mitochondria and microsomes // Arch. Biochem. Biophys. — 1982. — Vol. 217. — P. 411-421.

1662. Tutuncu N. B., Bayraktar M., Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study // Diabetes Care. — 1998. — Vol. 21. — P. 1915-1918.

1663. Ueda S., Kato S., Matsuoka H. et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase // Circ. Res. — 2003. — Vol. 92. — P. 226-233.

1664. Ugochukwu N. H., Babady N. E., Cobourne M., Gasset S. R. The effect of Gongronema latifolium extracts on serum lipid profile and oxidative stress in hepatocytes of diabetic rats // J. Biosci. —

2003. — Vol. 28. — P. 1-5.

1665. Ugochukwu N. H., Cobourne M. K. Modification of renal oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with extracts from Gongronema latifolium leaves // Clin. Chim. Acta. — 2003. — Vol. 336. — P. 73-81.

1666. Ulicna O., Vancova O., Bozek P. et al. Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats // Physiol. Res. — 2006. — Vol. 55. — P. 157-164.

1667. Ulrich A., Bell J. R., Chen E. Y. et al. Human insulin receptor and its relationship to the tyrosine kinasee family of oncogenes // Nature. — 1985. — Vol. 313. — P. 756-761.

1668. Unger R. H., Zhou Y. T. Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover // Diabetes. — 2001. — Vol. 50, Suppl. 1. — P. S118-S121.

1669. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin-dependent diabetes followed for three years // Br. Med. J. — 1995. — Vol. 310. — P. 83—88.

1670. Umeki S. Anti-inflammatory action of gentamycin through inhibitory effect on neutrophil NADPH oxidase activity // Comp. Biochem. Physiol. [B]. — 1995. — Vol. 110. — P. 817—821.

1671. Upritchard J. E., Sutherland W. H., Mann J. I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes // Diabetes Care. — 2000. — Vol. 23. — P. 733-738.

1672. Ursini F., Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes // Chem. Phys. Lipids. — 1987. — Vol. 44. — P. 255-276.

1673. Utsumi T., Klostergaard J., Akimaru K. et al. Modulation of TNF-a-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors // Arch. Biochem. Biophys. — 1992. — Vol. 294. — P. 271-278.

1674. Vague P., Vialettes B., Lassmann-Vague V., Vallo J. J. Nicotinamide may extend remission phase in insulin-dependent diabetes // Lancet. — 1987. — Vol. 1. — P. 619-620.

1675. Van Campenhout A., Van Campenhout C., Lagrou A. R. et al. Iron-binding antioxidant capacity is impaired in diabetes mellitus // Free Radic. Biol. Med. — 2006. — Vol. 40. — P. 1749-1755.

1676. Vander Jagt D. L., Robinson B., Taylor K. K., Hunsaker L. A. Reduction of trioses by NADPH- dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications // J. Biol. Chem. — 1992. — Vol. 267. — P. 4364-4369.

1677. Vanderbruggen T., Kok P. T. M., Raaijmakers J. A. M. et al. Cytokine priming of the respiratory burst in human eosinophils is Ca²+ independent and accompanied by induction of tyrosine kinase activity // J. Leukoc. Biol. — 1993. — Vol. 53. — P. 347-353.

1678. Vandervliet A., Hu M. L., O’Neill C. A. et al. Interactions of human blood plasma with hydrogen peroxide and hypochlorous acid // J. Lab. Clin. Med. — 1994. — Vol. 124. — P. 701-707.

1679. Vandervliet A., Smith D., O’Neill C. A. et al. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion // Biochem. J. — 1994. — Vol. 303. — P. 295-301.

1680. Vangossum A., Decuyper J., Ooms H. et al. Assessment of lipid peroxidation in humans by breath pentane output measurement // Clin. Nutr. — 1993. — Vol. 12. — P. 121-122.

1681. Van Hinsberg V. W., Scheffer M., Havekes L., Kempen H. J. Role of endothelial cells and their products in the modification of low density lipoproteins // Biohcim. Biophys. Acta. — 1986. — Vol. 878. — P. 49-64.

1682. Vanhoutte P. M. Hypercholesterolemia, atherosclerosis and release of endothelium-derived relaxing factor by aggregating platelets // Eur. Heart J. — 1991. — Vol. 12, Suppl. E. — P. 25-32.

1683. Varvarovska J., Racek J., Stetina R. et al. Aspects of oxidative stress in children with type 1 diabetes mellitus // Biomed. Pharmacother. — 2004. — Vol. 58. — P. 539-545.

1684. Vasto S., Mocchegiani E., Malavolta M. et al. Zinc and inflammatory/immune response in aging // Ann. N.Y. Acad. Sci. — 2007. — Vol. 1100. — P. 111-122.

1685. Venkateswaran S., Pari L. Effect of Coccinia indica leaves on antioxidant status in streptozotocin- induced diabetic rats // J. Ethnopharmacol. — 2003. — Vol. 84. — P. 163-168.

1686. Venketaraman V., Dayaram Y. K., Amin A. G. et al. Role of glutathione in macrophage control of mycobacteria // Infect. Immun. — 2003. — Vol. 71. — P. 1864-1871.

1687. Verbeuren T. J., Bonhomme E., Laubie M., Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits // J. Cardiovasc. Pharmacol. — 1993. — Vol. 21. — P. 841-845.

1688. Verlangieri A. J., Bush M. J. Effect of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis // J. Am. Coll. Nutr. — 1992. — Vol. 11. — P. 131-138.

1689. Verweij C. L., Gringhuis S. I. Oxidants and tyrosine phosphorylation: role of acute and chronic oxidative stress in T- and B-lymphocyte signaling // Antioxid. Redox. Signal. — 2002. — Vol. 4. — P. 543-551.

1690. Vesosky B., Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis // Immunol. Rev. — 2005. — Vol. 205. — P. 229-243.

1691. Vessby J., Basu S., Mohsen R. et al. Oxidative stress and antioxidant status in type 1 diabetes mellitus // J. Intern. Med. — 2002. — Vol. 251. — P. 69-76.

1692. Viana M., Castro M., Barbas C. et al. Effect of different doses of vitamin E on the incidence of malformations in pregnant diabetic rats // Ann. Nutr. Metab. — 2003. — Vol. 47. — P. 6—10.

1693. Vidal F., Colome C., Martinezgonzalez J., Badimon L. Atherogenic concentrations of native low- density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cells // Eur. J. Biochem. — 1998. — Vol. 252. — P. 378-384.

1694. Vijayakumar M., Govindarajan R., Rao G. M. et al. Action of Hygrophila auriculata against strepto- zotocin-induced oxidative stress // J. Ethnopharmacol. — 2006. — Vol. 104. — P. 356-361.

1695. Vijayalingam S., Parthiban A., Shanmugasundaram K. R., Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus // Diabet. Med. — 1996. — Vol. 13. — P. 715-719.

1696. Vica J., Borras C., Gambini J. et al. Why females live longer than males? Importance of the upregula- tion of longevity-associated genes by oestrogenic compounds // FEBS Lett. — 2005. — Vol. 579. — P. 2541-2545.

1697. Vina J., Sastre J., Pallardo F., Borras C. Mitochondrial theory of aging: importance to explain why females live longer than males // Antioxid. Redox Signal. — 2003. — Vol. 5. — P. 549-556.

1698. Vinceti M., Rovesti S., Marchesi C. et al. Changes in drinking water selenium and mortality for coronary disease in a residential cohort // Biol. Trace Elem. Res. — 1994. — Vol. 40. — P. 267-275.

1699. Vinnikova A. K., Kukreja R. C., Hess M. L. Singlet oxygen-induced inhibition of cardiac sarcolem- mal Na⁺K⁺-ATPase // J. Mol. Cell. Cardiol. — 1992. — Vol. 24. — P. 465-470.

1700. Visner G. A., Chesrown S. E., Monnier J. et al. Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells // Biochem. Bio- phys. Res. Commun. — 1992. — Vol. 188. — P. 453-462.

1701. Vlassara H. Recent progress in advanced glycation end products and diabetic complicatins // Diabetes. — 1997. — Vol. 46, Suppl. 2. — P. S19-S25.

1702. Vlassara H., Brownlee M., Manogue K. R. et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling // Science. — 1988. — Vol. 240. — P. 1546-1548.

1703. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging // Lab. Invest. — 1994. — Vol. 70. — P. 138-151.

1704. Von Jaarsveld H., Kuyl J. M., Alberts D. W. Antioxidant vitamin supplementation of smoke-exposed rats partially protects against myocardial ischaemic/reperfusion injury // Free Radic. Res. Commun. — 1992. — Vol. 17. — P. 263-269.

1705. Voss P., Siems W. Clinical oxidation parameters of aging // Free Radic. Res. — 2006. — Vol. 40. — P. 1339-1349.

1706. Wade C. R., Jackson P. G., Highton J., Van Rij A. M. Lipid peroxidation and malondialdehyde in the synovial fluid and plasma of patients with rheumatoid arthritis // Clin. Chim. Acta. — 1987. — Vol. 164. — P. 245-251.

1707. Wagner P. D., Mathieu-Costello O., Bebout D. E. et al. Protection against pulmonary O₂ toxicity by N-acetylcysteine // Eur. Respir. J. — 1989. — Vol. 2. — P. 116-126.

1708. Wahlund G., Marklund S. L., Sjoquist P. O. Extracellular-superoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion // Free Radic. Res. Commun. — 1992. — Vol. 17. — P. 41-47.

1709. Wainwright C. L., Martorana P. L. Pirsidomine, a novel nitric oxide donor, suppresses ishemic ar- rhytmias in anesthetized pigs // J. Cardiovasc. Pharmacol. — 1993. — Vol. 22. — P. S44-S50.

1710. Wakabayashi I., Hatake K., Kimura N. et al. Modulation of vascular tonus by the endothelium in experimental diabetes // Life Sci. — 1987. — Vol. 40. — P. 643-648.

1711. Wali R. K., Jaffe S., Kumar D., Kalra V. K. Alterations in organization of phospholipids in erythrocytes as factor in adherence to endotelial cells in diabetes mellitus // Diabetes. — 1988. — Vol. 37. — P. 104-111.

1712. Wallace D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine // Annu. Rev. Genet. — 2005. — Vol. 39. — P. 359-407.

1713. Walther F. J., Nunez F. L., Davidcu R., Hill K. E. Mitigation of pulmonary oxygen toxicity in rats by intratracheal instillation of polyethylene glycol-conjugated antioxidant enzymes // Pediatr. Res. — 1993. — Vol. 33. — P. 332-335.

1714. Wang B. Y., Ho H. K., Lin P. S. et al. Regression of atherosclerosis: role of nitric oxide and apoptosis // Circulation. — 1999. — Vol. 99. — P. 1236-1241.

1715. Wang C. H., Kuo H. P. Nitric oxide modulates interleukin-ΐβ and tumour necrosis factor-α synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis // Respirology. — 2001. — Vol. 6. — P. 79-84.

1716. Wang C. H., Liu C. Y., Lin H. C. et al. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages // Eur. Respir. J. — 1998. — Vol. 11. — P. 809-815.

1717. Wang J., Zhen E., Zhauzheng G., Yongcai L. Effect ofhyperlipidaemic serum on lipid peroxidation, synthesis of prostacyclin and thromboxane by cultured endothelial cells: Protective effect of antioxidants // Free Radic. Biol. Med. — 1989. — Vol. 7. — P. 243-249.

1718. Wang Q. D., Uriuda Y., Li X. S. et al. Beneficial effects of H290/51, a new lipid peroxidation inhibitor, on functional recovery after ischemia and reperfusion in isolated cold-arrested rat hearts // J. Cardiovasc. Pharmacol. — 1995. — Vol. 25. — P. 924-929.

1719. Wang W., Schulze C. J., Suarez-Pinzon W. L. et al. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury // Circulation. — 2002. — Vol. 106. — P. 1543-1549.

1720. Ward C., Wong T. H., Murray J. et al. Induction of human neutrophil apoptosis by nitric oxide donors: evidence for a caspase-dependent, cyclic-GMP-independent, mechanism // Biochem. Pharmacol. — 2000. — Vol. 59. — P. 305-314.

1721. Ward P. A. Mechanisms of endothelial cell injury // J. Lab. Clin. Med. — 1991. — Vol. 118. — P. 421-426.

1722. Ward W. F., Qi W., Van Remmen H. et al. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels // J. Gerontol. A. Biol. Sci. Med. Sci. — 2005. — Vol. 60. — P. 847-851.

1723. Warner R. L., Paine R., Christensen P. J. et al. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase // Am. J. Respir. Cell Mol. Biol. — 1995. — Vol. 12. — P. 649-661.

1724. Warren J. B. Vascular control of inflammatory oedema // Clin. Sci. — 1993. — Vol. 84. — P. 581-584.

1725. Wasawa T., Matsuoka A., Tajima G. et al. Hydrogen peroxide plays a key role in the oxidation reaction of myoglobin by molecular oxygen — A computer simulation // Biophys. J. — 1992. — Vol. 63. — P. 544-550.

1726. Wasowicz W., Kantorski J. Perek D. Popadiuk S. Concentration of zinc and zinc-copper superoxide dismutase activity in red blood cells in normals and children with cancer // J. Clin. Chem. Clin. Biochem. — 1989. — Vol. 27. — P. 413-418.

1727. Watanabe B. I., Premarante S., Limm W. et al. High-dose and low-dose superoxide dismutase plus catalase does not reduce myocardial infarct size in a subhuman primate model // Am. Heart J. —

1993. — Vol. 126. — P. 840-846.

1728. Watanabe T., Fan J. Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis // Int. J. Cardiol. — 1998. — Vol. 66, Suppl. 1. — P. S45-S53.

1729. Watts G. F., Playford D. A., Croft K. D. et al. Coenzyme Q₁₀ improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus // Diabetologia. — 2002. — Vol. 45. — P. 420-426.

1730. Wautier J. L., Zoukourian C., Chappey O. et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats // J. Clin. Invest. — 1996. — Vol. 97. — P. 238-243.

1731. Wautier M. P., Chappey O., Corda S. et al. Activation ofNADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE // Am. J. Physiol. Endocrinol. Metab. — 1999. — Vol. 280. — P. E685-E694.

1732. Weber H., Heilmann P., Meyer B., Maier K. L. Effect of canine surfactant protein (SP-A) on the respiratory burst of phagocytic cells // FEBS Lett. — 1990. — Vol. 270. — P. 90-94.

1733. Wei H. Activation of oncogenes and or inactivation of anti-oncogenes by reactive oxygen species // Med. Hypotheses. — 1992. — Vol. 39. — P. 267-270.

1734. Weidtmann A., Scheithe R., Hrboticky N. et al. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2 // Arterioscler. Thromb. Vasc. Biol. — 1995. — Vol. 15. — P. 1131-1138.

1735. Weiland J. E., Davis W. B., Holter J. F. et al. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance // Ann. Rev. Respir. Dis. — 1986. — Vol. 133. — P. 218-225.

1736. Weinberg J. B. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review // Mol. Med. — 1998. — Vol. 4. — P. 557—591.

1737. Weinberg J. B., Misukonis M. A., Shami P. J. et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages // Blood. — 1995. — Vol. 86. — P. 1184—1195.

1738. Weinert B. T., Paola S. T. Physiology of Aging. Invited Review: Theories of aging // J. Appl. Physiol. — 2003. — Vol. 95. — P. 1706-1716.

1739. Weisfeldt M. L., Zweier J. L., Flaherty J. T. Oxygen-derived free radicals and myocardial ischemic injury // Heart Dis. — 1988. — № 3. — P. 60-72.

1740. Weiss S. J. Tissue destruction by neutrophils // New Engl. J. Med. — 1989. — Vol. 320. — P. 365-376.

1741. Weissmann G., Korchak H. Rheumatoid arthritis: the role of neutrophil activation // Inflammation. — 1984. — Vol. 8, Suppl. — P. S3-S14.

1742. Welch J. S., Escoubet-Lozach L., Sykes D. B. et al. T_H2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism // J. Biol. Chem. — 2002. — Vol. 277. — P. 42821-42829.

1743. Welsh N. Interleukin-1p-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F // J. Biol. Chem. — 1996. — Vol. 271. — P. 8307-8312.

1744. Welsh N., Eizirik D. L., Bendtzen K., Sandler S. Interleukin-1p-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of Krebs cycle enzyme aconitase // Endocrinology. — 1991. — Vol. 129. — P. 3167-3171.

1745. Wengenack N. L., Jensen M. P., Rusnak F., Stern M. K. Mycobacterium tuberculosis KatG is a per- oxynitritase // Biochem. Biophys. Res. Commun. — 1999. — Vol. 256. — P. 485-487.

1746. Wengenack N. L., Lopes H., Kennedy M. J. et al. Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation // Biochemistry. — 2000. — Vol. 39. — P. 11508-11513.

1747. Wentworth P., Jones L. H., Wentworth A. D. et al. Antibody catalysis of the oxidation of water // Science. — 2001. — Vol. 293. — P. 1806-1811.

1748. West I. C. Radicals and oxidative stress in diabetes // Diabet. Med. — 2000. — Vol. 17. — P. 171-180.

1749. White C. R., Brock T. A., Chang L. Y. et al. Superoxide and peroxynitrite in atherosclerosis // Proc. Natl. Acad. Sci. USA. — 1994. — Vol. 91. — P. 1044-1048.

1750. White C. W., Ghezzi P., Dinarello C. A. et al. Recombinant tumor necrosis factor/cachectin and interleukin-1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia // J. Clin. Invest. — 1987. — Vol. 79. — P. 1868-1873.

1751. White C. W., Jackson J. H., Abuchowski A. et al. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats // J. Appl. Physiol. — 1989. — Vol. 66. — P. 584-590.

1752. White C. W., Repine J. E. Pulmonary antioxidant defense mechanisms // Exp. Lung Res. — 1985. — Vol. 8. — P. 81-96.

1753. White M. F., Maron R., Kahn C. R. Insulin rapidly stimulates tyrosine phosphorylation of a Mr- 185,000 protein in intact cells // Nature. — 1985. — Vol. 318. — P. 183-186.

1754. Wierusz-Wysocka B., Wysocki H., Byks H. et al. Metabolic control quality and free radical activity in diabetic patients // Diabetes Res. Clin. Pract. — 1995. — Vol. 27. — P. 193-197.

1755. Wierusz-Wysocka B., Wysocki H., Siekierka H. et al. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus // J. Leukoc. Biol. — 1987. — Vol. 42. — P. 519-523.

1756. Wierusz-Wysocka B., Wysocki H., Wykretowicz A., Klimas R. The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils // Acta Diabetol. Lat. — 1988. — Vol. 25. — P. 283-288.

1757. Wigginton J. M., Kuhns D. B., Back T. C. et al. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice. Implications for the antitumor activity of interleukin 12 and/or interleukin 2 // Cancer Res. — 1996. — Vol. 56. — P. 1131-1136.

1758. Wilkins G. M., Leake D. S. Free radicals and low-density lipoprotein oxidation by macrophages // Biochem. Soc. Trans. — 1990. — Vol. 18. — P. 1170-1171.

1759. Wilkins G. M., Leake D. S. The effect of inhibitors of free radical generating enzymes on low-density lipoprotein oxidation by macrophages // Biochim. Biophys. Acta. — 1994. — Vol. 1211. — P. 69-78.

1760. Wilkins G. M., Segal A. W., Leake D. S. HADPH oxidase is not essential for low density lipoprotein oxidation by human monocyte-derived macrophages // Biochem. Biophys. Res. Commun. —

1994. — Vol. 202. — P. 1300-1307.

1761. Williams B., Gallacher B., Patel H., Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro // Diabetes. — 1997. — Vol. 46. — P. 1497-1503.

1762. Williams J. G., Jutkovich G. J., Hahnel G. B., Mailer R. W. Macrophage priming by interferon γ: a selective process with potential harmful effects // J. Leukoc. Biol. — 1992. — Vol. 52. — P. 579-584.

1763. Williams R. E., Zweier J. L., Flaherty J. T. Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts // Circulation. — 1991. — Vol. 83. — P. 1006-1014.

1764. Williamson J. R., Chang K., Frangos M. et al. Hyperglycemic pseudohypoxia and diabetic complications // Diabetes. — 1993. — Vol. 42. — P. 801-813.

1765. Willment J. A., Lin H. H., Reid D. M. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexa- methasone, and lipopolysaccharide // J. Immunol. — 2003. — Vol. 171. — P. 4569-4573.

1766. Wilson M. J., Richter-Lowney K., Daleke D. L. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes // Biochemistry. — 1993. — Vol. 32. — P. 11302-11310.

1767. Windsor A. C. J., Walsh C. J., Mullen P. G. et al. Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor up-regulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation // J. Clin. Invest. — 1993. — Vol. 91. — P. 1459-1468.

1768. Wing E. J., Ampel N. M., Waheed A., Shadduck R. K. Macrophage colony stimulating factor (M- CSF) enhances the capacity of murine macrophages to secrete oxygen products // J. Immunol. — 1985. — Vol. 135. — P. 2052-2056.

1769. Winocour P. D. Platelets, vascular disease, and diabetes mellitus // Can. J. Physiol. Pharmacol. — 1994. — Vol. 72. — P. 295-303.

1770. Winyard P. G., Pall H., Lunec J., Blake D. R. Nonceruloplasmin-bound copper (‘phenanthroline copper’) is not detectable in fresh serum or synovial fluid patients with rheumatoid arthritis // Biochem. J. — 1987. — Vol. 247. — P. 245-246.

1771. Winyard P. G., Tatzeber F., Esterbauer H. et al. Presence of foam cells containing oxidised low density lipoprotein in rheumatoid synovial membrane // Ann. Rheum. Dis. — 1993. — Vol. 52. — P. 677-680.

1772. Witschi H. Effects of oxygen and ozone on mouse lung tumorigenesis // Exp. Lung Res. — 1991. — Vol. 17. — P. 473-483.

1773. Witting P. K., Pettersson K., Letters J., Stocker R. Anti-atherogenic effect of coenzyme Q-10 in apo- lipoprotein E gene knockout mice // Free Radic. Biol. Med. — 2000. — Vol. 29. — P. 295-305.

1774. Witting P. K., Pettersson K., Letters J., Stocker R. Site-specific antiatherogenic effect ofprobucol in apo- lipoprotein E-deficient mice // Arterioscler. Thromb. Vasc. Biol. — 2000. — Vol. 20. — P. E26-E33.

1775. Witting P. K., Pettersson K., Ostlund-Lindqvist A. M. et al. Dissociation of atherogenesis from aortic accumulation of lipid hydroperoxides in Watanabe heritable hyperlipidemic rabbits // J. Clin. Invest. — 1999. — Vol. 104. — P. 213-220.

1776. Witting P. K., Pettersson K., Ostlund-Lindqvist A. M. et al. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice // FASEB J. — 1999. — Vol. 13. — P. 667-675.

1777. Witz G. Active oxygen species as factors in multistage carcinogenesis // Proc. Soc. Exp. Biol. — 1991. — Vol. 198. — P. 675-682.

1778. Witz G., Lawrie N. J., Amoruzo M. A., Goldstein B. D. Inhibition by reactive aldehydes of superoxide anion radical production from stimulated polymorphonuclear leukocytes and pulmonary alveolar macrophages. Affects on cellular sulfhydryl groups and NADPH oxidase activity // Biochem. Pharmacol. — 1987. — Vol. 36. — P. 721-726.

1779. Witztum J. L., Steinberg D. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? // Trends Cardiovasc. Med. — 2001. — Vol. 11. — P. 93-102.

1780. Woditsch I., Schror K. Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia // Am. J. Physiol. — 1992. — Vol. 263. — P. H1390-H1396.

1781. Wolff S. P., Dean R. T. Glucose autoxidation and protein modification: the potential role of «auto- oxidative glycosylation» in diabetes // Biochem. J. — 1987. — Vol. 245. — P. 243-250.

1782. Wozniak A., Betts W. H., Murphy G. A., Rokinski M. Interleukin-8 primes human neutrophils for enhanced superoxide anion production // Immunology. — 1993. — Vol. 79. — P. 608—615.

1783. Wright D. T., Cohn L. A., Li H. et al. Interactions of oxygen radicals with airway epithelium // Environ. Health Perspect. — 1994. — Vol. 102, Suppl. 10. — P. 85—90.

1784. Wu C. H., Tsai-Wu J. J., Huang Y. T. et al. Identification and subcellular localization of a novel Cu,Zn superoxide dismutase of Mycobacterium tuberculosis // FEBS Lett. — 1998. — Vol. 439. — P. 192—196.

1785. Wu F. H., Liang J. Y., Yu P., Cai S. F. Studies on the hypoglycemia and lipids regulating effects of Plantago depressa var. montana // Zhongguo Zhong Yao Za Zhi. — 2005. — Vol. 30. — P. 1179—1183.

1786. Wu J. H., Ward N. C., Indrawan A. P. et al. Effects of α-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes // Clin. Chem. — 2007. — Vol. 53. — P. 511-519.

1787. Wu S., Li Q., Du M. et al. Cardiac-specific overexpression of catalase prolongs lifespan and attenuates ageing-induced cardiomyocyte contractile dysfunction and protein damage // Clin. Exp. Pharmacol. Physiol. — 2007. — Vol. 34. — P. 81-87.

1788. Wyche K. E., Wang S. S., Griendling K. K. et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils // Hypertension. — 2004. — Vol. 43. — P. 1246-1251.

1789. Xia P., Aiello L. P., Ishii H. et al. Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth // J. Clin. Invest. — 1996. — Vol. 98. — P. 2018-2026.

1790. Xia P., Inoguchi T., Kern T. S. et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C in diabetes and hypergalactosaemia // Diabetes. — 1994. — Vol. 43. — P. 1122-1129.

1791. Xie W., Xing D., Sun H. et al. The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet // Am. J. Chin. Med. — 2005. — Vol. 33. — P. 95-105.

1792. Xie Y., Yang H., Cunanan C. et al. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors // Cancer Res. — 2004. — Vol. 64. — P. 3096-3102.

1793. Xu L., Eu J. P., Meissner G., Stamler J. R. Activation ofthe cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation // Science. — 1998. — Vol. 279. — P. 234-237.

1794. Yamagishi S. I., Edelstein D., Du X. L. et al. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A // J. Biol. Chem. — 2001. — Vol. 276. — P. 25096-25100.

1795. Yamamoto A., Matsuzawa Y., Kishino B. et al. Effects of probucol on homozygous cases of familial hypercholesterolemia // Atherosclerosis. — 1983. — Vol. 48. — P. 157-166.

1796. Yan L. J., Levine R. L., Sohal R. S. Oxidative damage during aging targets mitochondrial aconi- tase // Proc. Natl. Acad. Sci. USA. — 1997. — Vol. 94. — P. 11168-11172.

1797. Yan L. J., Sohal R. S. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging // Proc. Natl. Acad. Sci. USA. — 1998. — Vol. 95. — P. 12896-12901.

1798. Yan S. D., Schmidt A. M., Anderson G. M. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins // J. Biol. Chem. — 1994. — Vol. 269. — P. 9889-9897.

1799. Yang C. S., Lee D. S., Song C. H. et al. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock // J. Exp. Med. — 2007. — Vol. 204. — P. 583-594.

1800. Yang G. Alteration on fatty acid components of erythrocyte membrane and insulin resistance in diabetic patients // Chin. Med. J. — 2000 . — Vol. 78. — P. 269-271.

1801. Yang W. D., Debono D. Myoglobin protects against endothelial cell membrane damage associated with hydrogen peroxide or xanthine + xanthine oxidase // FEBS Lett. — 1993. — Vol. 319. — P. 145-150.

1802. Yang X., Cai B., Sciacca R. R., Cannon P. J. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins // Circ. Res. — 1994. — Vol. 74. — P. 318-328.

1803. Yang X., Doser T. A., Fang C. X. et al. Metallothionein prolongs survival and antagonizes senescence associated cardiomyocyte diastolic dysfunction: role of oxidative stress // FASEB J. — 2006. — Vol. 20. — P. E260-E270.

1804. Yang Y., Dieter M. Z., Chen Y. et al. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm~^/~ knockout mouse. Novel model system for a severely compromised oxidative stress response // J. Biol. Chem. — 2002. — Vol. 277. — P. 49446—49452.

1805. Yant L. J., Ran Q., Rao L. et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults // Free Radic. Biol. Med. — 2003. — Vol. 34. — P. 496-502.

1806. Yao K., Karasawa A. Protective effects of benidipine against myocardial damage following ischemia and reperfusion in time isolated perfused rat heart // Biol. Pharm. Bull. — 1994. — Vol. 17. — P. 517-521.

1807. Yardim-Akaydin S., Sepici A., Ozkan Y. et al. Oxidation of uric acid in rheumatoid arthritis: is al- lantoin a marker of oxidative stress? // Free Radic. Res. — 2004. — Vol. 38. — P. 623-628.

1808. Yasukawa M., Inoue Y., Ohminami H. et al. Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection // J. Gen. Virol. — 1998. — Vol. 79. — P. 143-147.

1809. Yates M. T., Lambert L. E., Whitten J. P. et al. A protective role for nitric oxide in the oxidative modification oflow density lipoprotein by mouse macrophages // FEBS Lett. — 1992. — Vol. 309. — P. 135-138.

1810. Yaworsky K., Somwar R., Ramlal T. et al. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes // Diabetologia. — 2000. — Vol. 43. — P. 294-303.

1811. Yazdanparast R., Ardestani A., Jamshidi S. Experimental diabetes treated with Achillea santolina: Effect on pancreatic oxidative parameters // J. Ethnopharmacol. — 2007. — Vol. 112. — P. 13-18.

1812. Yeramian A., Martin L., Serrat N. et al. Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages // J. Immunol. — 2006. — Vol. 176. — P. 5918-5924.

1813. Yesner L. M., Huh H. Y., Pearce S. F., Silverstein R. L. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators // Arterioscler. Thromb. Vasc. Biol. — 1996. — Vol. 16. — P. 1019-1025.

1814. Yessoufou A., Moutairou K., Girard A. et al. Antioxidant status in alcohol-related diabetes mellitus in Beninese subjects // Cell. Mol. Biol. — 2005. — Vol. 51, Suppl. — P. OL849-OL858.

1815. Yim M. B., Yim H. S., Lee C. et al. Protein glycation: creation of catalytic sites for free radical generation // Ann. N.Y. Acad. Sci. — 2001. — Vol. 928. — P. 48-53.

1816. Yla-Herttuala S. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis // Ann. Med. — 1991. — Vol. 23. — P. 561-567.

1817. Yla-Herttuala S., Luoma J., Viita H. et al. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein // J. Clin. Invest. — 1995. — Vol. 95. — P. 2692-2698.

1818. Yla-Herttuala S., Palinski W., Rosenfeld M. E. et al. Lipoproteins in normal and atherosclerotic aorta // Eur. Heart J. — 1990. — Vol. 11, Suppl. E. — P. 88-99.

1819. Yla-Herttuala S., Rosenfeld M. E., Parthasarthy S. et al. Co-localisation of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage rich areas of atherosclerotic lesions // Proc. Natl. Acad. Sci. USA. — 1990. — Vol. 87. — P. 6959-6963.

1820. Yla-Herttuala S., Rosenfeld M. E., Parthasarathy S. et al. Gene expression in macrophage-rich human atherosclerotic lesion: 15-lipoxygenase and acetyl-LDL receptor mRNA colocalize with specific lipid-laden products // J. Clin. Invest. — 1991. — Vol. 87. — P. 1146-1152.

1821. Yoda B., Goto Y., Sato K. et al. Ultra-weak chemiluminescence of smokers’ blood // Arch. Environ. Health. — 1985. — Vol. 40. — P. 148-151.

1822. Yokoi H., Daida H., Kuwabara Y. et al. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the probucol angoplasty restenosis trial // J. Am. Coll. Cardiol. — 1997. — Vol. 30. — P. 855-862.

1823. Yokota T., Igarashi K., Uchihara T. et al. Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress // Proc. Natl. Acad. Sci. USA. — 2001. — Vol. 98. — P. 15185-15190.

1824. Yokoyama T., Yamane K., Minamoto A. et al. High glucose concentration induces elevated expression of anti-oxidant and proteolytic enzymes in cultured human retinal pigment epithelial cells // Exp. Eye Res. — 2006. — Vol. 83. — P. 602-609.

1825. Yokoyama Y., Beckman J. S., Beckman T. K. et al. Circulating xanthine oxidase: Potential mediator of ischemic injury // Am. J. Physiol. — 1990. — Vol. 258. — P. G564—G570.

1826. Yoshida M., Kimura H., Kyuki K., Ito M. Combined effect of vitamin E and insulin on cataracts of diabetic rats fed a high cholesterol diet // Biol. Pharm. Bull. — 2004. — Vol. 27. — P. 338—344.

1827. Yoshikawa H., Tajiri Y., Sako Y. et al. Effects of free fatty acids on β-cell functions: a possible involvement of peroxisome proliferator-activated receptors α or pancreatic/duodenal homeobox // Metabolism. — 2001. — Vol. 50. — P. 613-618.

1828. Yoshimura M., Yasue H., Nakayama M. et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese // Hum. Genet. —

1998. — Vol. 103. — P. 65-69.

1829. Yu K., Mitchell C., Xing Y et al. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion // Tuberc. Lung Dis. — 1999. — Vol. 79. — P. 191198.

1830. Yuan M., Konstantopoulos N., Lee J. et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IK^ // Science. — 2001. — Vol. 293. — P. 1673-1677.

1831. Yuo A., Kitagawa S., Motoyoshi K. et al. Rapid priming ofhuman monocytes by human hematopoietic growth factor: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists // Blood. — 1992. — Vol. 79. — P. 1553-1557.

1832. Yusuf S., Dagenais G., Pogue J. et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators // New Engl. J. Med. — 2000. — Vol. 342. — P. 154-160.

1833. Zahrt T. C., Deretic V. Reactive nitrogen and oxygen intermediates and bacterial defenses: Unusual adaptations in Mycobacterium tuberculosis // Antioxid. Redox Signal. — 2002. — Vol. 4. — P. 141159.

1834. Zarrouki B., Soares A. F., Guichardant M. et al. The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell // FEBS Lett. — 2007. — Vol. 581. — P. 2394-2400.

1835. Zhang H. N., He J. H., Yuan L., Lin Z. B. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage // Life Sci. — 2003. — Vol. 73. — P. 2307-2319.

1836. Zhang R., Brennan M.-L., Shen Z. et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation // J. Biol. Chem. — 2002. — Vol. 277. — P. 46116-46122.

1837. Zhang W., Chen S. G., Ju H. S. et al. Mechanisms ofprotective effects ofberbamine on ischemia/re- perfusion injury in isolated rat heart // Methods Find. Exp. Clin. Pharmacol. — 1992. — Vol. 14. — P. 677-684.

1838. Zhang Y., Lathigra R., Garbe T. et al. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis// Mol. Microbiol. — 1991. — Vol. 5. — P. 381-391.

1839. Zhang Z., Apse K., Pang J., Stanton R. C. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells // J. Biol. Chem. — 2003. — Vol. 275. — P. 40042-40047.

1840. Zhu L., Gunn C., Beckman J. S. Bactericidal activity of peroxynitrite // Arch. Biochem. Biophys. — 1992. — Vol. 298. — P. 452-457.

1841. Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling // Trends Cell Biol. — 2001. — Vol. 11. — P. 437-441.

1842. Ziegler D., Hanefeld M., Ruhnau K. J. et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant apha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study) // Diabetologia. — 1995. — Vol. 38. — P. 1425-1433.

1843. Ziegler D., Hanefeld M., Ruhnau K. J. et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALA- DIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy // Diabetes Care. — 1999. — Vol. 22. — P. 1296-1301.

1844. Ziegler D., Reljanovic M., Mehnert H., Gries F. A. α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials // Exp. Clin. Endocrin. Diabet. —

1999. — Vol. 107. — P. 421-430.

1845. Ziegler D., Schatz H., Conrad F. et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie // Diabetes Care. — 1997. — Vol. 20. — P. 369-373.

1846. Zhou Y. P., Grill V. Long term exposure to fatty acids and ketones inhibits β-cell functions in human pancreatic islets of Langerhans // J. Clin. Endocrinol. Metab. — 1995. — Vol. 80. — P. 1584-1590.

1847. Zhou Y.-T., Grayburn P., Karim A. et al. Lipotoxic heart disease in obese rats: implications for human obesity // Proc. Natl. Acad. Sci. USA. — 2000. — Vol. 97. — P. 1784-1789.

1848. Zimmerman G. A., Prescott S. M., McIntyre T. M. Oxidatively fragmented phospholipids as inflammatory mediators: the dark side of polyunsaturated lipids // J. Nutr. — 1995. — Vol. 125. — P. S1661-1665.

1849. Zoschke D. C., Staite N. D. Suppression ofhuman lymphocyte proliferation by activated neutrophils or H₂O₂: surviving cells have an altered T helper/T suppressor ratio and an increased resistance to secondary oxidant exposure // Clin. Immunol. Immunopathol. — 1987. — Vol. 42. — P. 160-170.

1850. Zwaal R., Schroit A. Pathophysiologic implication of membrane phospholipid asymmetry in blood cells // Blood. — 1997. — Vol. 89. — P. 1121-1132.

1851. Zweier J. L., Rayburn B. K., Flaherty J. T., Weisfeldt M. L. Recombinant superoxide dismutase reduces oxygen free radical concentration in reperfused myocardium // J. Clin. Invest. — 1987. — Vol. 80. — P. 1728-1734.